{"source": "HomoSapiens", "value": 1, "ngenes": 32713, "description": "Homo Sapiens", "id": "716aeb02-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168256", "value": 0.4264543148937853, "ngenes": 3372, "description": "Immune System", "id": "716aeb03-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1280215", "value": 0.5355822698760702, "ngenes": 1238, "description": "Cytokine Signaling in Immune system", "id": "716aeb04-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-449147", "value": 0.3506260567546662, "ngenes": 820, "description": "Signaling by Interleukins", "id": "716aeb05-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6783589", "value": 0.9817424710436718, "ngenes": 37, "description": "Interleukin-6 family signaling", "id": "716aeb06-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1059683", "value": 0.2804925133709207, "ngenes": 20, "description": "Interleukin-6 signaling", "id": "716aeb07-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6788467", "value": 0.025116695354688363, "ngenes": 23, "description": "IL-6-type cytokine receptor ligand interactions", "id": "716aeb08-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1266695", "value": 0.12721138533759097, "ngenes": 55, "description": "Interleukin-7 signaling", "id": "716aeb09-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-448424", "value": 0.2153381452695285, "ngenes": 149, "description": "Interleukin-17 signaling", "id": "716aeb0a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aeb0b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aeb0c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aeb0d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aeb0e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aeb0f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aeb10-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aeb11-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aeb12-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aeb13-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-446652", "value": 0.21079354458763944, "ngenes": 258, "description": "Interleukin-1 family signaling", "id": "716aeb14-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9020702", "value": 0.2744947037358761, "ngenes": 180, "description": "Interleukin-1 signaling", "id": "716aeb15-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aeb16-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aeb17-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-448706", "value": 0.14370902915281253, "ngenes": 12, "description": "Interleukin-1 processing", "id": "716aeb18-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9007892", "value": 0.029064648965216745, "ngenes": 7, "description": "Interleukin-38 signaling", "id": "716aeb19-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9008059", "value": 0.597610338839184, "ngenes": 49, "description": "Interleukin-37 signaling", "id": "716aeb1a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9012546", "value": 0.1872141768100771, "ngenes": 17, "description": "Interleukin-18 signaling", "id": "716aeb1b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9014826", "value": 0.8724822540138668, "ngenes": 13, "description": "Interleukin-36 pathway", "id": "716aeb1c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9014843", "value": 0.815357460027517, "ngenes": 9, "description": "Interleukin-33 signaling", "id": "716aeb1d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-449836", "value": 0.7747820596378019, "ngenes": 37, "description": "Other interleukin signaling", "id": "716aeb1e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6783783", "value": 0.4213112267409292, "ngenes": 71, "description": "Interleukin-10 signaling", "id": "716aeb1f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6785807", "value": 0.661335104045452, "ngenes": 195, "description": "Interleukin-4 and Interleukin-13 signaling", "id": "716aeb20-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854691", "value": 0.6982777686526725, "ngenes": 40, "description": "Interleukin-20 family signaling", "id": "716aeb21-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447115", "value": 0.6095580619164416, "ngenes": 91, "description": "Interleukin-12 family signaling", "id": "716aeb22-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9020591", "value": 0.2013230289964383, "ngenes": 75, "description": "Interleukin-12 signaling", "id": "716aeb23-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8950505", "value": 0.3612874023335522, "ngenes": 64, "description": "Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation", "id": "716aeb24-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8984722", "value": 0.7449226606453779, "ngenes": 17, "description": "Interleukin-35 Signalling", "id": "716aeb25-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020933", "value": 0.6918274157723723, "ngenes": 14, "description": "Interleukin-23 signaling", "id": "716aeb26-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020956", "value": 0.30810968965148233, "ngenes": 16, "description": "Interleukin-27 signaling", "id": "716aeb27-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-451927", "value": 0.6368456040852555, "ngenes": 85, "description": "Interleukin-2 family signaling", "id": "716aeb28-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8983432", "value": 0.047224016530099736, "ngenes": 26, "description": "Interleukin-15 signaling", "id": "716aeb29-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8985947", "value": 0.35152275332793925, "ngenes": 16, "description": "Interleukin-9 signaling", "id": "716aeb2a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020558", "value": 0.13600904106624143, "ngenes": 19, "description": "Interleukin-2 signaling", "id": "716aeb2b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020958", "value": 0.9877644889517833, "ngenes": 17, "description": "Interleukin-21 signaling", "id": "716aeb2c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912526", "value": 0.24424018962773714, "ngenes": 46, "description": "Interleukin receptor SHC signaling", "id": "716aeb2d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-512988", "value": 0.6616015634349643, "ngenes": 80, "description": "Interleukin-3, Interleukin-5 and GM-CSF signaling", "id": "716aeb2e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-912526", "value": 0.24424018962773714, "ngenes": 46, "description": "Interleukin receptor SHC signaling", "id": "716aeb2f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912631", "value": 0.7202442219959402, "ngenes": 39, "description": "Regulation of signaling by CBL", "id": "716aeb30-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-913531", "value": 0.9694129607641102, "ngenes": 339, "description": "Interferon Signaling", "id": "716aeb31-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1169410", "value": 0.9283131377503262, "ngenes": 139, "description": "Antiviral mechanism by IFN-stimulated genes", "id": "716aeb32-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1169408", "value": 0.10504083093934342, "ngenes": 121, "description": "ISG15 antiviral mechanism", "id": "716aeb33-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8983711", "value": 0.2734645247591602, "ngenes": 19, "description": "OAS antiviral response", "id": "716aeb34-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-877300", "value": 0.7936599036367434, "ngenes": 167, "description": "Interferon gamma signaling", "id": "716aeb35-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-877312", "value": 0.47778786183803407, "ngenes": 21, "description": "Regulation of IFNG signaling", "id": "716aeb36-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-909733", "value": 0.44837609902021125, "ngenes": 111, "description": "Interferon alpha/beta signaling", "id": "716aeb37-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-912694", "value": 0.5275723678547117, "ngenes": 36, "description": "Regulation of IFNA signaling", "id": "716aeb38-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1170546", "value": 0.793336034435932, "ngenes": 26, "description": "Prolactin receptor signaling", "id": "716aeb39-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9607240", "value": 0.8287833772265509, "ngenes": 77, "description": "FLT3 Signaling", "id": "716aeb3a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-109704", "value": 0.007950428030311853, "ngenes": 80, "description": "PI3K Cascade", "id": "716aeb3b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165158", "value": 0.3398799314680016, "ngenes": 10, "description": "Activation of AKT2", "id": "716aeb3c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5673001", "value": 0.12013537038193475, "ngenes": 499, "description": "RAF/MAP kinase cascade", "id": "716aeb3d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5658442", "value": 0.23031307864038617, "ngenes": 119, "description": "Regulation of RAS by GAPs", "id": "716aeb3e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5673000", "value": 0.13550006748569263, "ngenes": 57, "description": "RAF activation", "id": "716aeb3f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5674135", "value": 0.7822640962366303, "ngenes": 68, "description": "MAP2K and MAPK activation", "id": "716aeb40-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5675221", "value": 0.1655260481081655, "ngenes": 70, "description": "Negative regulation of MAPK pathway", "id": "716aeb41-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5674499", "value": 0.5189060091438052, "ngenes": 10, "description": "Negative feedback regulation of MAPK pathway", "id": "716aeb42-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9648002", "value": 0.11013301982060077, "ngenes": 49, "description": "RAS processing", "id": "716aeb43-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9645135", "value": 0.000754535607733383, "ngenes": 10, "description": "STAT5 Activation", "id": "716aeb44-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5668541", "value": 0.2873636204741825, "ngenes": 176, "description": "TNFR2 non-canonical NF-kB pathway", "id": "716aeb45-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5669034", "value": 0.9144323278772918, "ngenes": 51, "description": "TNFs bind their physiological receptors", "id": "716aeb46-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5676590", "value": 0.2876365673974739, "ngenes": 105, "description": "NIK-->noncanonical NF-kB signaling", "id": "716aeb47-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5676594", "value": 0.7246233652196656, "ngenes": 29, "description": "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway", "id": "716aeb48-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-982772", "value": 0.9788666536950346, "ngenes": 44, "description": "Growth hormone receptor signaling", "id": "716aeb49-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1280218", "value": 0.44837609902021125, "ngenes": 1297, "description": "Adaptive Immune System", "id": "716aeb4a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-983705", "value": 0.47446362455073504, "ngenes": 201, "description": "Signaling by the B Cell Receptor (BCR)", "id": "716aeb4b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1168372", "value": 0.27947274237296965, "ngenes": 146, "description": "Downstream signaling events of B Cell Receptor (BCR)", "id": "716aeb4c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1169091", "value": 0.2253272691770601, "ngenes": 118, "description": "Activation of NF-kappaB in B cells", "id": "716aeb4d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1169092", "value": 0.6442541815088558, "ngenes": 7, "description": "Activation of RAS in B cells", "id": "716aeb4e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2025928", "value": 0.43207995013501255, "ngenes": 21, "description": "Calcineurin activates NFAT", "id": "716aeb4f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5690714", "value": 0.620166166577032, "ngenes": 21, "description": "CD22 mediated BCR regulation", "id": "716aeb50-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-983695", "value": 0.7469619402445666, "ngenes": 56, "description": "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers", "id": "716aeb51-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-983169", "value": 0.17018607580231904, "ngenes": 661, "description": "Class I MHC mediated antigen processing & presentation", "id": "716aeb52-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1236975", "value": 0.38824660548152273, "ngenes": 167, "description": "Antigen processing-Cross presentation", "id": "716aeb53-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1236973", "value": 0.23567954260240084, "ngenes": 17, "description": "Cross-presentation of particulate exogenous antigens (phagosomes)", "id": "716aeb54-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1236974", "value": 0.2953326301551339, "ngenes": 137, "description": "ER-Phagosome pathway", "id": "716aeb55-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1236977", "value": 0.8900873185580673, "ngenes": 21, "description": "Endosomal/Vacuolar pathway", "id": "716aeb56-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1236978", "value": 0.3286278429220936, "ngenes": 84, "description": "Cross-presentation of soluble exogenous antigens (endosomes)", "id": "716aeb57-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-983168", "value": 0.12721138533759097, "ngenes": 561, "description": "Antigen processing: Ubiquitination & Proteasome degradation", "id": "716aeb58-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-983170", "value": 0.4277589160618119, "ngenes": 44, "description": "Antigen Presentation: Folding, assembly and peptide loading of class I MHC", "id": "716aeb59-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-198933", "value": 0.7042117159600336, "ngenes": 220, "description": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell", "id": "716aeb5a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202403", "value": 0.25412800810412073, "ngenes": 214, "description": "TCR signaling", "id": "716aeb5b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202424", "value": 0.16684831396657582, "ngenes": 171, "description": "Downstream TCR signaling", "id": "716aeb5c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202427", "value": 0.36522847845102924, "ngenes": 35, "description": "Phosphorylation of CD3 and TCR zeta chains", "id": "716aeb5d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202430", "value": 0.33371619310763434, "ngenes": 29, "description": "Translocation of ZAP-70 to Immunological synapse", "id": "716aeb5e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202433", "value": 0.493014100163527, "ngenes": 52, "description": "Generation of second messenger molecules", "id": "716aeb5f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2132295", "value": 0.3951299353978155, "ngenes": 181, "description": "MHC class II antigen presentation", "id": "716aeb60-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-388841", "value": 0.497167775938151, "ngenes": 125, "description": "Costimulation by the CD28 family", "id": "716aeb61-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389356", "value": 0.5154913467538436, "ngenes": 72, "description": "CD28 co-stimulation", "id": "716aeb62-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389357", "value": 0.34849102280520805, "ngenes": 51, "description": "CD28 dependent PI3K/Akt signaling", "id": "716aeb63-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389359", "value": 0.8978764811258031, "ngenes": 27, "description": "CD28 dependent Vav1 pathway", "id": "716aeb64-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-389513", "value": 0.6345136696653251, "ngenes": 47, "description": "CTLA4 inhibitory signaling", "id": "716aeb65-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389948", "value": 0.41310618774038277, "ngenes": 29, "description": "PD-1 signaling", "id": "716aeb66-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392517", "value": 0.3131828135641375, "ngenes": 30, "description": "Rap1 signalling", "id": "716aeb67-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851680", "value": 0.37385879578412473, "ngenes": 17, "description": "Butyrophilin (BTN) family interactions", "id": "716aeb68-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168249", "value": 0.35068211229937996, "ngenes": 1745, "description": "Innate Immune System", "id": "716aeb69-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1222556", "value": 0.5531410090729686, "ngenes": 59, "description": "ROS and RNS production in phagocytes", "id": "716aeb6a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803157", "value": 0.6906051136277114, "ngenes": 117, "description": "Antimicrobial peptides", "id": "716aeb6b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1461973", "value": 0.24742324413768846, "ngenes": 60, "description": "Defensins", "id": "716aeb6c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1461957", "value": 0.1210646748522668, "ngenes": 48, "description": "Beta defensins", "id": "716aeb6d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1462054", "value": 0.8948992163866106, "ngenes": 12, "description": "Alpha-defensins", "id": "716aeb6e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6799990", "value": 0.1040506828516798, "ngenes": 7, "description": "Metal sequestration by antimicrobial proteins", "id": "716aeb6f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803544", "value": 0.48619589422838555, "ngenes": 4, "description": "Ion influx/efflux at host-pathogen interface", "id": "716aeb70-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1834949", "value": 0.023622320651264708, "ngenes": 98, "description": "Cytosolic sensors of pathogen-associated DNA ", "id": "716aeb71-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1606322", "value": 0.0594537139956224, "ngenes": 30, "description": "ZBP1(DAI) mediated induction of type I IFNs", "id": "716aeb72-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1606341", "value": 0.7347562045131799, "ngenes": 5, "description": "IRF3 mediated activation of type 1 IFN", "id": "716aeb73-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1810476", "value": 0.09218528826601044, "ngenes": 26, "description": "RIP-mediated NFkB activation via ZBP1", "id": "716aeb74-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3134963", "value": 0.12223851496961394, "ngenes": 13, "description": "DEx/H-box helicases activate type I IFN and inflammatory cytokines production ", "id": "716aeb75-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3134973", "value": 0.25719478847059046, "ngenes": 12, "description": "LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production", "id": "716aeb76-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3134975", "value": 0.2696625260967302, "ngenes": 19, "description": "Regulation of innate immune responses to cytosolic DNA", "id": "716aeb77-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1834941", "value": 0.000758633623098557, "ngenes": 21, "description": "STING mediated induction of host immune responses", "id": "716aeb78-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3249367", "value": 0.9612002556848329, "ngenes": 3, "description": "STAT6-mediated induction of chemokines", "id": "716aeb79-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3270619", "value": 0.0008300757846824834, "ngenes": 18, "description": "IRF3-mediated induction of type I IFN", "id": "716aeb7a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168898", "value": 0.2734285518976704, "ngenes": 287, "description": "Toll-like Receptor Cascades", "id": "716aeb7b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166016", "value": 0.13460548036517922, "ngenes": 242, "description": "Toll Like Receptor 4 (TLR4) Cascade", "id": "716aeb7c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166020", "value": 0.6479593604970333, "ngenes": 3, "description": "Transfer of LPS from LBP carrier to CD14", "id": "716aeb7d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166058", "value": 0.2552869492378058, "ngenes": 187, "description": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "id": "716aeb7e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aeb7f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aeb80-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aeb81-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aeb82-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aeb83-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aeb84-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aeb85-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aeb86-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aeb87-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aeb88-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.497167775938151, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "716aeb89-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.5427128083070796, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "716aeb8a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-166166", "value": 0.1298088881737574, "ngenes": 198, "description": "MyD88-independent TLR4 cascade ", "id": "716aeb8b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-937061", "value": 0.1298088881737574, "ngenes": 198, "description": "TRIF(TICAM1)-mediated TLR4 signaling ", "id": "716aeb8c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aeb8d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aeb8e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aeb8f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aeb90-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aeb91-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aeb92-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aeb93-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aeb94-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aeb95-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2562578", "value": 0.4597633015904427, "ngenes": 15, "description": "TRIF-mediated programmed cell death", "id": "716aeb96-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aeb97-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-936964", "value": 0.05693528045723856, "ngenes": 30, "description": "Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon", "id": "716aeb98-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937041", "value": 0.11475312669900828, "ngenes": 45, "description": "IKK complex recruitment mediated by RIP1", "id": "716aeb99-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937072", "value": 0.5644922054187091, "ngenes": 30, "description": "TRAF6-mediated induction of TAK1 complex within TLR4 complex", "id": "716aeb9a-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-1679131", "value": 0.7656635943411512, "ngenes": 23, "description": "Trafficking and processing of endosomal TLR", "id": "716aeb9b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168164", "value": 0.12634473973374397, "ngenes": 194, "description": "Toll Like Receptor 3 (TLR3) Cascade", "id": "716aeb9c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168927", "value": 0.09219611882665504, "ngenes": 41, "description": "TICAM1, RIP1-mediated IKK complex recruitment", "id": "716aeb9d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aeb9e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aeb9f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aeba0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aeba1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aeba2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aeba3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aeba4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aeba5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aeba6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aeba7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013957", "value": 0.007950428030311853, "ngenes": 12, "description": "TLR3-mediated TICAM1-dependent programmed cell death", "id": "716aeba8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013973", "value": 0.040493699154052605, "ngenes": 25, "description": "TICAM1-dependent activation of IRF3/IRF7", "id": "716aeba9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9014325", "value": 0.3123437336578039, "ngenes": 25, "description": "TICAM1,TRAF6-dependent induction of TAK1 complex", "id": "716aebaa-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168138", "value": 0.24897477630011242, "ngenes": 180, "description": "Toll Like Receptor 9 (TLR9) Cascade", "id": "716aebab-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975155", "value": 0.24300286806696403, "ngenes": 176, "description": "MyD88 dependent cascade initiated on endosome", "id": "716aebac-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975138", "value": 0.2627261527178871, "ngenes": 172, "description": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation", "id": "716aebad-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aebae-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aebaf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aebb0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aebb1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aebb2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aebb3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aebb4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aebb5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aebb6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aebb7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975144", "value": 0.497167775938151, "ngenes": 26, "description": "IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation", "id": "716aebb8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975163", "value": 0.6616015634349643, "ngenes": 29, "description": "IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation", "id": "716aebb9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975110", "value": 0.3773747397906554, "ngenes": 27, "description": "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling", "id": "716aebba-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168142", "value": 0.2552869492378058, "ngenes": 167, "description": "Toll Like Receptor 10 (TLR10) Cascade", "id": "716aebbb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975871", "value": 0.2552869492378058, "ngenes": 167, "description": "MyD88 cascade initiated on plasma membrane", "id": "716aebbc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aebbd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aebbe-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aebbf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aebc0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aebc1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aebc2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aebc3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aebc4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aebc5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aebc6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.497167775938151, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "716aebc7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.5427128083070796, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "716aebc8-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168176", "value": 0.2552869492378058, "ngenes": 167, "description": "Toll Like Receptor 5 (TLR5) Cascade", "id": "716aebc9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975871", "value": 0.2552869492378058, "ngenes": 167, "description": "MyD88 cascade initiated on plasma membrane", "id": "716aebca-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aebcb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aebcc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aebcd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aebce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aebcf-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aebd0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aebd1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aebd2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aebd3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aebd4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.497167775938151, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "716aebd5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.5427128083070796, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "716aebd6-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168181", "value": 0.2297302620557261, "ngenes": 179, "description": "Toll Like Receptor 7/8 (TLR7/8) Cascade", "id": "716aebd7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975155", "value": 0.24300286806696403, "ngenes": 176, "description": "MyD88 dependent cascade initiated on endosome", "id": "716aebd8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975138", "value": 0.2627261527178871, "ngenes": 172, "description": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation", "id": "716aebd9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aebda-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aebdb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aebdc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aebdd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aebde-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aebdf-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aebe0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aebe1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aebe2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aebe3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975144", "value": 0.497167775938151, "ngenes": 26, "description": "IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation", "id": "716aebe4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975163", "value": 0.6616015634349643, "ngenes": 29, "description": "IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation", "id": "716aebe5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975110", "value": 0.3773747397906554, "ngenes": 27, "description": "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling", "id": "716aebe6-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-181438", "value": 0.255912321114492, "ngenes": 192, "description": "Toll Like Receptor 2 (TLR2) Cascade", "id": "716aebe7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168179", "value": 0.255912321114492, "ngenes": 192, "description": "Toll Like Receptor TLR1:TLR2 Cascade", "id": "716aebe8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166058", "value": 0.2552869492378058, "ngenes": 187, "description": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "id": "716aebe9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aebea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aebeb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aebec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aebed-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aebee-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aebef-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aebf0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aebf1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aebf2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aebf3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.497167775938151, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "716aebf4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.5427128083070796, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "716aebf5-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168188", "value": 0.2552869492378058, "ngenes": 187, "description": "Toll Like Receptor TLR6:TLR2 Cascade", "id": "716aebf6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166058", "value": 0.2552869492378058, "ngenes": 187, "description": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "id": "716aebf7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.21241078843995015, "ngenes": 131, "description": "MAP kinase activation", "id": "716aebf8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.11777218870458916, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "716aebf9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aebfa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aebfb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aebfc-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30929660160862277, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "716aebfd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.13271067227571115, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "716aebfe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.6600113262056719, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "716aebff-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.9432039160649744, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "716aec00-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.3056236055452598, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "716aec01-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.497167775938151, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "716aec02-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.5427128083070796, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "716aec03-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-5686938", "value": 0.0655147590850284, "ngenes": 34, "description": "Regulation of TLR by endogenous ligand", "id": "716aec04-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-166658", "value": 0.8328275490577551, "ngenes": 105, "description": "Complement cascade", "id": "716aec05-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166665", "value": 0.9255427833653975, "ngenes": 10, "description": "Terminal pathway of complement", "id": "716aec06-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166663", "value": 0.6491257092345148, "ngenes": 51, "description": "Initial triggering of complement", "id": "716aec07-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166786", "value": 0.7360781070546978, "ngenes": 40, "description": "Creation of C4 and C2 activators", "id": "716aec08-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-173623", "value": 0.7780233755635348, "ngenes": 23, "description": "Classical antibody-mediated complement activation", "id": "716aec09-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166662", "value": 0.7384120043645542, "ngenes": 17, "description": "Lectin pathway of complement activation", "id": "716aec0a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2855086", "value": 0.33371619310763434, "ngenes": 13, "description": "Ficolins bind to repetitive carbohydrate structures on the target cell surface", "id": "716aec0b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-173736", "value": 0.40914664296745806, "ngenes": 8, "description": "Alternative complement activation", "id": "716aec0c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-174577", "value": 0.5107207141060185, "ngenes": 10, "description": "Activation of C3 and C5", "id": "716aec0d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-977606", "value": 0.8756110438803343, "ngenes": 85, "description": "Regulation of Complement cascade", "id": "716aec0e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168643", "value": 0.3056236055452598, "ngenes": 110, "description": "Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways", "id": "716aec0f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168638", "value": 0.13502730330498747, "ngenes": 75, "description": "NOD1/2 Signaling Pathway", "id": "716aec10-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-622312", "value": 0.6987802414711779, "ngenes": 38, "description": "Inflammasomes", "id": "716aec11-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-844455", "value": 0.019743705974171, "ngenes": 9, "description": "The NLRP1 inflammasome", "id": "716aec12-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-844456", "value": 0.30879983683992257, "ngenes": 26, "description": "The NLRP3 inflammasome", "id": "716aec13-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-844615", "value": 0.4579525902843404, "ngenes": 7, "description": "The AIM2 inflammasome", "id": "716aec14-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-844623", "value": 0.9205334438476622, "ngenes": 4, "description": "The IPAF inflammasome", "id": "716aec15-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2029480", "value": 0.8900873185580673, "ngenes": 179, "description": "Fcgamma receptor (FCGR) dependent phagocytosis", "id": "716aec16-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2029481", "value": 0.932297575391846, "ngenes": 39, "description": "FCGR activation", "id": "716aec17-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2029482", "value": 0.6816951806341134, "ngenes": 135, "description": "Regulation of actin dynamics for phagocytic cup formation", "id": "716aec18-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2029485", "value": 0.7640857680183397, "ngenes": 57, "description": "Role of phospholipids in phagocytosis", "id": "716aec19-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2172127", "value": 0.6693101490581971, "ngenes": 76, "description": "DAP12 interactions", "id": "716aec1a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2424491", "value": 0.7241660073060857, "ngenes": 57, "description": "DAP12 signaling", "id": "716aec1b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2454202", "value": 0.2644148643914418, "ngenes": 259, "description": "Fc epsilon receptor (FCERI) signaling", "id": "716aec1c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2730905", "value": 0.8528975889120445, "ngenes": 47, "description": "Role of LAT2/NTAL/LAB on calcium mobilization", "id": "716aec1d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2871796", "value": 0.8577754555504388, "ngenes": 70, "description": "FCERI mediated MAPK activation", "id": "716aec1e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2871809", "value": 0.745200724443715, "ngenes": 60, "description": "FCERI mediated Ca+2 mobilization", "id": "716aec1f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2871837", "value": 0.23097925092629357, "ngenes": 160, "description": "FCERI mediated NF-kB activation", "id": "716aec20-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5621481", "value": 0.12810076497154332, "ngenes": 261, "description": "C-type lectin receptors (CLRs)", "id": "716aec21-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5607764", "value": 0.1655260481081655, "ngenes": 187, "description": "CLEC7A (Dectin-1) signaling", "id": "716aec22-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5607761", "value": 0.2687739042572299, "ngenes": 108, "description": "Dectin-1 mediated noncanonical NF-kB signaling", "id": "716aec23-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5607763", "value": 0.45999115347354297, "ngenes": 20, "description": "CLEC7A (Dectin-1) induces NFAT activation", "id": "716aec24-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5660668", "value": 0.023657916076338107, "ngenes": 12, "description": "CLEC7A/inflammasome pathway", "id": "716aec25-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5621480", "value": 0.3551733330522627, "ngenes": 49, "description": "Dectin-2 family", "id": "716aec26-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5621575", "value": 1.0, "ngenes": 35, "description": "CD209 (DC-SIGN) signaling", "id": "716aec27-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6798695", "value": 0.497167775938151, "ngenes": 762, "description": "Neutrophil degranulation", "id": "716aec28-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-879415", "value": 0.7036890066754523, "ngenes": 24, "description": "Advanced glycosylation endproduct receptor signaling", "id": "716aec29-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168928", "value": 0.10404356720284604, "ngenes": 132, "description": "DDX58/IFIH1-mediated induction of interferon-alpha/beta", "id": "716aec2a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-918233", "value": 0.10049563801011191, "ngenes": 22, "description": "TRAF3-dependent IRF activation pathway", "id": "716aec2b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-933541", "value": 0.049906047571374505, "ngenes": 44, "description": "TRAF6 mediated IRF7 activation", "id": "716aec2c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-933542", "value": 0.2987330602038509, "ngenes": 44, "description": "TRAF6 mediated NF-kB activation", "id": "716aec2d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-933543", "value": 0.009554036908535702, "ngenes": 22, "description": "NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10", "id": "716aec2e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-936440", "value": 0.07999861398585909, "ngenes": 57, "description": "Negative regulators of DDX58/IFIH1 signaling", "id": "716aec2f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9645460", "value": 0.3418729196939897, "ngenes": 23, "description": "Alpha-protein kinase 1 signaling pathway", "id": "716aec30-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-162582", "value": 0.21313654160356282, "ngenes": 4377, "description": "Signal Transduction", "id": "716aec31-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5683057", "value": 0.0988187702894675, "ngenes": 588, "description": "MAPK family signaling cascades", "id": "716aec32-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5684996", "value": 0.11878145556087756, "ngenes": 509, "description": "MAPK1/MAPK3 signaling", "id": "716aec33-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112409", "value": 0.5406415304478467, "ngenes": 35, "description": "RAF-independent MAPK1/3 activation", "id": "716aec34-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110056", "value": 0.824833333983243, "ngenes": 15, "description": "MAPK3 (ERK1) activation", "id": "716aec35-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-112411", "value": 0.2552869492378058, "ngenes": 14, "description": "MAPK1 (ERK2) activation", "id": "716aec36-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5673001", "value": 0.12013537038193475, "ngenes": 499, "description": "RAF/MAP kinase cascade", "id": "716aec37-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5658442", "value": 0.23031307864038617, "ngenes": 119, "description": "Regulation of RAS by GAPs", "id": "716aec38-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5673000", "value": 0.13550006748569263, "ngenes": 57, "description": "RAF activation", "id": "716aec39-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5674135", "value": 0.7822640962366303, "ngenes": 68, "description": "MAP2K and MAPK activation", "id": "716aec3a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5675221", "value": 0.1655260481081655, "ngenes": 70, "description": "Negative regulation of MAPK pathway", "id": "716aec3b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5674499", "value": 0.5189060091438052, "ngenes": 10, "description": "Negative feedback regulation of MAPK pathway", "id": "716aec3c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9648002", "value": 0.11013301982060077, "ngenes": 49, "description": "RAS processing", "id": "716aec3d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5687128", "value": 0.16645519673075324, "ngenes": 167, "description": "MAPK6/MAPK4 signaling", "id": "716aec3e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-372790", "value": 0.40008475307698405, "ngenes": 1638, "description": "Signaling by GPCR", "id": "716aec3f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-388396", "value": 0.3515966687368494, "ngenes": 1536, "description": "GPCR downstream signalling", "id": "716aec40-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-418594", "value": 0.5332010701839299, "ngenes": 589, "description": "G alpha (i) signalling events", "id": "716aec41-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111885", "value": 0.18660575292357806, "ngenes": 158, "description": "Opioid Signalling", "id": "716aec42-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112040", "value": 0.956417469773011, "ngenes": 95, "description": "G-protein mediated events", "id": "716aec43-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112043", "value": 0.9694129607641102, "ngenes": 94, "description": "PLC beta mediated events", "id": "716aec44-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111996", "value": 0.8486149166851668, "ngenes": 73, "description": "Ca-dependent events", "id": "716aec45-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111997", "value": 0.8636052042095431, "ngenes": 69, "description": "CaM pathway", "id": "716aec46-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111933", "value": 0.8636052042095431, "ngenes": 69, "description": "Calmodulin induced events", "id": "716aec47-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111932", "value": 0.8577754555504388, "ngenes": 28, "description": "CaMK IV-mediated phosphorylation of CREB", "id": "716aec48-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111957", "value": 0.49152531324563853, "ngenes": 9, "description": "Cam-PDE 1 activation", "id": "716aec49-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111931", "value": 0.22786606779846047, "ngenes": 33, "description": "PKA-mediated phosphorylation of CREB", "id": "716aec4a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163615", "value": 0.9211583862945798, "ngenes": 28, "description": "PKA activation", "id": "716aec4b-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-111995", "value": 0.6760936852298406, "ngenes": 4, "description": "phospho-PLA2 pathway", "id": "716aec4c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-170660", "value": 0.8978764811258031, "ngenes": 12, "description": "Adenylate cyclase activating pathway", "id": "716aec4d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-170670", "value": 0.7747820596378019, "ngenes": 17, "description": "Adenylate cyclase inhibitory pathway", "id": "716aec4e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-180024", "value": 0.0594537139956224, "ngenes": 47, "description": "DARPP-32 events", "id": "716aec4f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202040", "value": 0.3418729196939897, "ngenes": 42, "description": "G-protein activation", "id": "716aec50-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2187338", "value": 0.3056236055452598, "ngenes": 123, "description": "Visual phototransduction", "id": "716aec51-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2187335", "value": 0.31330737074318804, "ngenes": 7, "description": "The retinoid cycle in cones (daylight vision)", "id": "716aec52-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2453902", "value": 0.6428686182805571, "ngenes": 27, "description": "The canonical retinoid cycle in rods (twilight vision)", "id": "716aec53-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2514856", "value": 0.8099322879194534, "ngenes": 40, "description": "The phototransduction cascade", "id": "716aec54-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2485179", "value": 0.03333898376158171, "ngenes": 10, "description": "Activation of the phototransduction cascade", "id": "716aec55-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2514859", "value": 0.744208245029506, "ngenes": 39, "description": "Inactivation, recovery and regulation of the phototransduction cascade", "id": "716aec56-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975634", "value": 0.3346263399090412, "ngenes": 57, "description": "Retinoid metabolism and transport", "id": "716aec57-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-416476", "value": 0.4058135272353899, "ngenes": 340, "description": "G alpha (q) signalling events", "id": "716aec58-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-881907", "value": 0.25945780556828607, "ngenes": 37, "description": "Gastrin-CREB signalling pathway via PKC and MAPK", "id": "716aec59-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2179392", "value": 0.9840218606791472, "ngenes": 15, "description": "EGFR Transactivation by Gastrin", "id": "716aec5a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-114508", "value": 0.5856668610407034, "ngenes": 49, "description": "Effects of PIP2 hydrolysis", "id": "716aec5b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-426048", "value": 0.40071333678837345, "ngenes": 10, "description": "Arachidonate production from DAG", "id": "716aec5c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-418555", "value": 0.16392587730721794, "ngenes": 647, "description": "G alpha (s) signalling events", "id": "716aec5d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381753", "value": 0.16540425323191138, "ngenes": 449, "description": "Olfactory Signaling Pathway", "id": "716aec5e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-397795", "value": 0.05581192516772321, "ngenes": 52, "description": "G-protein beta:gamma signalling", "id": "716aec5f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-392451", "value": 0.06962729134710448, "ngenes": 41, "description": "G beta:gamma signalling through PI3Kgamma", "id": "716aec60-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418217", "value": 0.2987330602038509, "ngenes": 26, "description": "G beta:gamma signalling through PLC beta", "id": "716aec61-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964315", "value": 0.29862921047105073, "ngenes": 23, "description": "G beta:gamma signalling through BTK", "id": "716aec62-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964616", "value": 0.22195357555611497, "ngenes": 28, "description": "G beta:gamma signalling through CDC42", "id": "716aec63-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-416482", "value": 0.25945780556828607, "ngenes": 135, "description": "G alpha (12/13) signalling events", "id": "716aec64-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418597", "value": 0.7917294943119937, "ngenes": 65, "description": "G alpha (z) signalling events", "id": "716aec65-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-500792", "value": 0.5778343842322387, "ngenes": 647, "description": "GPCR ligand binding", "id": "716aec66-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373076", "value": 0.597610338839184, "ngenes": 478, "description": "Class A/1 (Rhodopsin-like receptors)", "id": "716aec67-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3296197", "value": 0.5672045315875678, "ngenes": 4, "description": "Hydroxycarboxylic acid-binding receptors", "id": "716aec68-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-375281", "value": 0.8166729563989763, "ngenes": 15, "description": "Hormone ligand-binding receptors", "id": "716aec69-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-375276", "value": 0.7043248661103585, "ngenes": 281, "description": "Peptide ligand-binding receptors", "id": "716aec6a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380095", "value": 0.7656635943411512, "ngenes": 11, "description": "Tachykinin receptors bind tachykinins", "id": "716aec6b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380108", "value": 0.44462231799796176, "ngenes": 87, "description": "Chemokine receptors bind chemokines", "id": "716aec6c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-388479", "value": 0.7821808457374256, "ngenes": 7, "description": "Vasopressin-like receptors", "id": "716aec6d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389397", "value": 0.4645672406858624, "ngenes": 10, "description": "Orexin and neuropeptides FF and QRFP bind to their respective receptors", "id": "716aec6e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444473", "value": 0.7385767683939968, "ngenes": 14, "description": "Formyl peptide receptors bind formyl peptides and many other ligands", "id": "716aec6f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444821", "value": 0.014899827032134105, "ngenes": 9, "description": "Relaxin receptors", "id": "716aec70-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-375280", "value": 0.9694129607641102, "ngenes": 60, "description": "Amine ligand-binding receptors", "id": "716aec71-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-390648", "value": 0.6029333190939079, "ngenes": 10, "description": "Muscarinic acetylcholine receptors", "id": "716aec72-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390650", "value": 0.9943788370040808, "ngenes": 4, "description": "Histamine receptors", "id": "716aec73-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390651", "value": 0.8188851183205769, "ngenes": 9, "description": "Dopamine receptors", "id": "716aec74-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390666", "value": 0.7735755158743595, "ngenes": 17, "description": "Serotonin receptors", "id": "716aec75-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390696", "value": 0.8263249123262675, "ngenes": 12, "description": "Adrenoceptors", "id": "716aec76-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-391903", "value": 0.28659552610130756, "ngenes": 25, "description": "Eicosanoid ligand-binding receptors", "id": "716aec77-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-391906", "value": 0.168798340892524, "ngenes": 5, "description": "Leukotriene receptors", "id": "716aec78-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-391908", "value": 0.2216914222993782, "ngenes": 19, "description": "Prostanoid ligand receptors", "id": "716aec79-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-418038", "value": 0.5093130689984309, "ngenes": 30, "description": "Nucleotide-like (purinergic) receptors", "id": "716aec7a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-417957", "value": 0.256683910934971, "ngenes": 22, "description": "P2Y receptors", "id": "716aec7b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-417973", "value": 0.11714404748625261, "ngenes": 8, "description": "Adenosine P1 receptors", "id": "716aec7c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-419408", "value": 0.597610338839184, "ngenes": 22, "description": "Lysosphingolipid and LPA receptors", "id": "716aec7d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-419771", "value": 0.5845774467976105, "ngenes": 13, "description": "Opsins", "id": "716aec7e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444209", "value": 0.31035936990768287, "ngenes": 5, "description": "Free fatty acid receptors", "id": "716aec7f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-373080", "value": 0.4328923470896947, "ngenes": 123, "description": "Class B/2 (Secretin family receptors)", "id": "716aec80-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-419812", "value": 0.9694129607641102, "ngenes": 12, "description": "Calcitonin-like ligand receptors", "id": "716aec81-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-420092", "value": 0.23103431986956088, "ngenes": 44, "description": "Glucagon-type ligand receptors", "id": "716aec82-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-420499", "value": 0.45463702787274884, "ngenes": 47, "description": "Class C/3 (Metabotropic glutamate/pheromone receptors)", "id": "716aec83-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006925", "value": 0.12721138533759097, "ngenes": 559, "description": "Intracellular signaling by second messengers", "id": "716aec84-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1489509", "value": 0.9899449009012773, "ngenes": 77, "description": "DAG and IP3 signaling", "id": "716aec85-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111997", "value": 0.8636052042095431, "ngenes": 69, "description": "CaM pathway", "id": "716aec86-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111933", "value": 0.8636052042095431, "ngenes": 69, "description": "Calmodulin induced events", "id": "716aec87-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111932", "value": 0.8577754555504388, "ngenes": 28, "description": "CaMK IV-mediated phosphorylation of CREB", "id": "716aec88-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111957", "value": 0.49152531324563853, "ngenes": 9, "description": "Cam-PDE 1 activation", "id": "716aec89-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111931", "value": 0.22786606779846047, "ngenes": 33, "description": "PKA-mediated phosphorylation of CREB", "id": "716aec8a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163615", "value": 0.9211583862945798, "ngenes": 28, "description": "PKA activation", "id": "716aec8b-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-1257604", "value": 0.11123985527576696, "ngenes": 486, "description": "PIP3 activates AKT signaling", "id": "716aec8c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-198323", "value": 0.0030380796069060336, "ngenes": 27, "description": "AKT phosphorylates targets in the cytosol", "id": "716aec8d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198693", "value": 0.00957467144529456, "ngenes": 23, "description": "AKT phosphorylates targets in the nucleus", "id": "716aec8e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-199418", "value": 0.5313607867764857, "ngenes": 209, "description": "Negative regulation of the PI3K/AKT network", "id": "716aec8f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6811558", "value": 0.5681053584551917, "ngenes": 198, "description": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling", "id": "716aec90-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6807070", "value": 0.18659526827185155, "ngenes": 243, "description": "PTEN Regulation", "id": "716aec91-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8943724", "value": 0.1792094027655885, "ngenes": 96, "description": "Regulation of PTEN gene transcription", "id": "716aec92-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8943723", "value": 0.7216204964976543, "ngenes": 19, "description": "Regulation of PTEN mRNA translation", "id": "716aec93-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8948700", "value": 0.7278516075355951, "ngenes": 17, "description": "Competing endogenous RNAs (ceRNAs) regulate PTEN translation", "id": "716aec94-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8948747", "value": 0.4786510760851275, "ngenes": 24, "description": "Regulation of PTEN localization", "id": "716aec95-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8948751", "value": 0.27563549025504425, "ngenes": 124, "description": "Regulation of PTEN stability and activity", "id": "716aec96-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9006934", "value": 0.2878165673866203, "ngenes": 906, "description": "Signaling by Receptor Tyrosine Kinases", "id": "716aec97-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2404192", "value": 0.03660290336117946, "ngenes": 99, "description": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)", "id": "716aec98-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2428924", "value": 0.02356151101886743, "ngenes": 98, "description": "IGF1R signaling cascade", "id": "716aec99-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2428928", "value": 0.025451934977419145, "ngenes": 95, "description": "IRS-related events triggered by IGF1R", "id": "716aec9a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112399", "value": 0.007950428030311853, "ngenes": 86, "description": "IRS-mediated signalling", "id": "716aec9b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112412", "value": 0.7043248661103585, "ngenes": 10, "description": "SOS-mediated signalling", "id": "716aec9c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-109704", "value": 0.007950428030311853, "ngenes": 80, "description": "PI3K Cascade", "id": "716aec9d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165158", "value": 0.3398799314680016, "ngenes": 10, "description": "Activation of AKT2", "id": "716aec9e-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-2428933", "value": 0.49758653978869916, "ngenes": 19, "description": "SHC-related events triggered by IGF1R", "id": "716aec9f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-74752", "value": 0.08296202590391369, "ngenes": 140, "description": "Signaling by Insulin receptor", "id": "716aeca0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-74751", "value": 0.040347340440439375, "ngenes": 100, "description": "Insulin receptor signalling cascade", "id": "716aeca1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112399", "value": 0.007950428030311853, "ngenes": 86, "description": "IRS-mediated signalling", "id": "716aeca2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112412", "value": 0.7043248661103585, "ngenes": 10, "description": "SOS-mediated signalling", "id": "716aeca3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-109704", "value": 0.007950428030311853, "ngenes": 80, "description": "PI3K Cascade", "id": "716aeca4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165158", "value": 0.3398799314680016, "ngenes": 10, "description": "Activation of AKT2", "id": "716aeca5-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-74713", "value": 0.977160570679591, "ngenes": 8, "description": "IRS activation", "id": "716aeca6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-74749", "value": 0.4743305089781697, "ngenes": 19, "description": "Signal attenuation", "id": "716aeca7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-77387", "value": 0.6409142517743235, "ngenes": 42, "description": "Insulin receptor recycling", "id": "716aeca8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1227986", "value": 0.13722040384198414, "ngenes": 105, "description": "Signaling by ERBB2", "id": "716aeca9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1250196", "value": 0.34419391778404373, "ngenes": 42, "description": "SHC1 events in ERBB2 signaling", "id": "716aecaa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1251932", "value": 0.10404356720284604, "ngenes": 10, "description": "PLCG1 events in ERBB2 signaling", "id": "716aecab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1306955", "value": 4.840344389421222e-05, "ngenes": 16, "description": "GRB7 events in ERBB2 signaling", "id": "716aecac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8863795", "value": 0.06179051941079923, "ngenes": 59, "description": "Downregulation of ERBB2 signaling", "id": "716aecad-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1358803", "value": 0.011842495778521525, "ngenes": 34, "description": "Downregulation of ERBB2:ERBB3 signaling", "id": "716aecae-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1963640", "value": 0.786700270596591, "ngenes": 29, "description": "GRB2 events in ERBB2 signaling", "id": "716aecaf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1963642", "value": 0.7225100776986413, "ngenes": 36, "description": "PI3K events in ERBB2 signaling", "id": "716aecb0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6785631", "value": 0.8999358089859023, "ngenes": 29, "description": "ERBB2 Regulates Cell Motility", "id": "716aecb1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8847993", "value": 0.2136830286654327, "ngenes": 26, "description": "ERBB2 Activates PTK6 Signaling", "id": "716aecb2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9652282", "value": 0.04216998412170033, "ngenes": 8, "description": "Drug-mediated inhibition of ERBB2 signaling", "id": "716aecb3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1236394", "value": 0.6745839803438778, "ngenes": 110, "description": "Signaling by ERBB4", "id": "716aecb4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1250342", "value": 0.8696264530591605, "ngenes": 20, "description": "PI3K events in ERBB4 signaling", "id": "716aecb5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1250347", "value": 0.30057555648381573, "ngenes": 24, "description": "SHC1 events in ERBB4 signaling", "id": "716aecb6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1251985", "value": 0.35068211229937996, "ngenes": 55, "description": "Nuclear signaling by ERBB4", "id": "716aecb7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1253288", "value": 0.7640857680183397, "ngenes": 19, "description": "Downregulation of ERBB4 signaling", "id": "716aecb8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190236", "value": 0.04216998412170033, "ngenes": 154, "description": "Signaling by FGFR", "id": "716aecb9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654736", "value": 0.07950691798899079, "ngenes": 98, "description": "Signaling by FGFR1", "id": "716aecba-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654726", "value": 0.03870375445735832, "ngenes": 65, "description": "Negative regulation of FGFR1 signaling", "id": "716aecbb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.04527965242338859, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "716aecbc-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190242", "value": 0.08241871150523546, "ngenes": 27, "description": "FGFR1 ligand binding and activation", "id": "716aecbd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190370", "value": 0.4104577232688403, "ngenes": 11, "description": "FGFR1b ligand binding and activation", "id": "716aecbe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190373", "value": 0.19047600542969775, "ngenes": 23, "description": "FGFR1c ligand binding and activation", "id": "716aecbf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190374", "value": 0.2627261527178871, "ngenes": 6, "description": "FGFR1c and Klotho ligand binding and activation", "id": "716aecc0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654687", "value": 0.2972309005976041, "ngenes": 60, "description": "Downstream signaling of activated FGFR1", "id": "716aecc1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654219", "value": 0.07120392686915648, "ngenes": 28, "description": "Phospholipase C-mediated cascade: FGFR1", "id": "716aecc2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654688", "value": 0.1489636657235728, "ngenes": 37, "description": "SHC-mediated cascade:FGFR1", "id": "716aecc3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654689", "value": 0.1963525286626569, "ngenes": 43, "description": "PI-3K cascade:FGFR1", "id": "716aecc4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654693", "value": 0.13271067227571115, "ngenes": 40, "description": "FRS-mediated FGFR1 signaling", "id": "716aecc5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5658623", "value": 0.155870532999355, "ngenes": 19, "description": "FGFRL1 modulation of FGFR1 signaling", "id": "716aecc6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654738", "value": 0.053565012963375146, "ngenes": 133, "description": "Signaling by FGFR2", "id": "716aecc7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654727", "value": 0.03333898376158171, "ngenes": 67, "description": "Negative regulation of FGFR2 signaling", "id": "716aecc8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.04527965242338859, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "716aecc9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190241", "value": 0.09855815827986986, "ngenes": 32, "description": "FGFR2 ligand binding and activation", "id": "716aecca-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190375", "value": 0.32022994358517787, "ngenes": 23, "description": "FGFR2c ligand binding and activation", "id": "716aeccb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190377", "value": 0.30057555648381573, "ngenes": 15, "description": "FGFR2b ligand binding and activation", "id": "716aeccc-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654696", "value": 0.16392587730721794, "ngenes": 58, "description": "Downstream signaling of activated FGFR2", "id": "716aeccd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654221", "value": 0.10049563801011191, "ngenes": 31, "description": "Phospholipase C-mediated cascade; FGFR2", "id": "716aecce-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654695", "value": 0.25409736888038054, "ngenes": 46, "description": "PI-3K cascade:FGFR2", "id": "716aeccf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654699", "value": 0.06896937371942653, "ngenes": 40, "description": "SHC-mediated cascade:FGFR2", "id": "716aecd0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654700", "value": 0.07703404798296609, "ngenes": 43, "description": "FRS-mediated FGFR2 signaling", "id": "716aecd1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6803529", "value": 0.07940660854331556, "ngenes": 42, "description": "FGFR2 alternative splicing", "id": "716aecd2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654741", "value": 0.06980941466577938, "ngenes": 82, "description": "Signaling by FGFR3", "id": "716aecd3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654732", "value": 0.03753487028863252, "ngenes": 60, "description": "Negative regulation of FGFR3 signaling", "id": "716aecd4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.04527965242338859, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "716aecd5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190239", "value": 0.08716451175468608, "ngenes": 22, "description": "FGFR3 ligand binding and activation", "id": "716aecd6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190371", "value": 0.6306636022567056, "ngenes": 14, "description": "FGFR3b ligand binding and activation", "id": "716aecd7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190372", "value": 0.08716451175468608, "ngenes": 22, "description": "FGFR3c ligand binding and activation", "id": "716aecd8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654708", "value": 0.28009372044607456, "ngenes": 51, "description": "Downstream signaling of activated FGFR3", "id": "716aecd9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654227", "value": 0.08441202489623618, "ngenes": 24, "description": "Phospholipase C-mediated cascade; FGFR3", "id": "716aecda-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654704", "value": 0.07571005029484179, "ngenes": 33, "description": "SHC-mediated cascade:FGFR3", "id": "716aecdb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654706", "value": 0.2040875476271411, "ngenes": 36, "description": "FRS-mediated FGFR3 signaling", "id": "716aecdc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654710", "value": 0.5332010701839299, "ngenes": 39, "description": "PI-3K cascade:FGFR3", "id": "716aecdd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5654743", "value": 0.04216998412170033, "ngenes": 85, "description": "Signaling by FGFR4", "id": "716aecde-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654733", "value": 0.019266969905597602, "ngenes": 63, "description": "Negative regulation of FGFR4 signaling", "id": "716aecdf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.04527965242338859, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "716aece0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190322", "value": 0.050955201772694206, "ngenes": 25, "description": "FGFR4 ligand binding and activation", "id": "716aece1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1307965", "value": 0.0001861364965424263, "ngenes": 5, "description": "betaKlotho-mediated ligand binding", "id": "716aece2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654716", "value": 0.02694840780403818, "ngenes": 54, "description": "Downstream signaling of activated FGFR4", "id": "716aece3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654228", "value": 0.007950428030311853, "ngenes": 27, "description": "Phospholipase C-mediated cascade; FGFR4", "id": "716aece4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654712", "value": 0.001836721552893203, "ngenes": 39, "description": "FRS-mediated FGFR4 signaling", "id": "716aece5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654719", "value": 0.002799706126077655, "ngenes": 36, "description": "SHC-mediated cascade:FGFR4", "id": "716aece6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654720", "value": 0.7640857680183397, "ngenes": 42, "description": "PI-3K cascade:FGFR4", "id": "716aece7-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-1433557", "value": 0.956417469773011, "ngenes": 82, "description": "Signaling by SCF-KIT", "id": "716aece8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1433559", "value": 0.9588255298330869, "ngenes": 28, "description": "Regulation of KIT signaling", "id": "716aece9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-166520", "value": 0.18216397966082798, "ngenes": 242, "description": "Signaling by NTRKs", "id": "716aecea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187037", "value": 0.15186601137059674, "ngenes": 194, "description": "Signaling by NTRK1 (TRKA)", "id": "716aeceb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167021", "value": 0.9789196000086503, "ngenes": 6, "description": "PLC-gamma1 signalling", "id": "716aecec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-187687", "value": 0.17663939628701752, "ngenes": 63, "description": "Signalling to ERKs", "id": "716aeced-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-169893", "value": 0.12749798477878355, "ngenes": 28, "description": "Prolonged ERK activation events", "id": "716aecee-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170968", "value": 0.5107862430249993, "ngenes": 23, "description": "Frs2-mediated activation", "id": "716aecef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-170984", "value": 0.08745396501449292, "ngenes": 15, "description": "ARMS-mediated activation", "id": "716aecf0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-167044", "value": 0.19761029591210805, "ngenes": 37, "description": "Signalling to RAS", "id": "716aecf1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-171007", "value": 0.39150926674486164, "ngenes": 23, "description": "p38MAPK events", "id": "716aecf2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-187706", "value": 0.2847204040347201, "ngenes": 8, "description": "Signalling to p38 via RIT and RIN", "id": "716aecf3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-177504", "value": 0.13510321437115413, "ngenes": 24, "description": "Retrograde neurotrophin signalling", "id": "716aecf4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-187015", "value": 0.028454209634405297, "ngenes": 11, "description": "Activation of TRKA receptors", "id": "716aecf5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187024", "value": 0.018125679217150362, "ngenes": 10, "description": "NGF-independant TRKA activation", "id": "716aecf6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-187042", "value": 0.9205519421979803, "ngenes": 4, "description": "TRKA activation by NGF", "id": "716aecf7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-198203", "value": 0.514071134545724, "ngenes": 16, "description": "PI3K/AKT activation", "id": "716aecf8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198745", "value": 0.037126356197780395, "ngenes": 7, "description": "Signalling to STAT3", "id": "716aecf9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198765", "value": 0.705766976117149, "ngenes": 6, "description": "Signalling to ERK5", "id": "716aecfa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198725", "value": 0.18905048243690628, "ngenes": 98, "description": "Nuclear Events (kinase and transcription factor activation)", "id": "716aecfb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.12187139342920543, "ngenes": 17, "description": "CREB phosphorylation", "id": "716aecfc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.08044307893162102, "ngenes": 48, "description": "ERK/MAPK targets", "id": "716aecfd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.0594537139956224, "ngenes": 29, "description": "ERKs are inactivated", "id": "716aecfe-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9031628", "value": 0.45874598119107074, "ngenes": 50, "description": "NGF-stimulated transcription", "id": "716aecff-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9036866", "value": 0.7343283884525103, "ngenes": 10, "description": "Expression and Processing of Neurotrophins", "id": "716aed00-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167060", "value": 0.7343283884525103, "ngenes": 10, "description": "NGF processing", "id": "716aed01-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9006115", "value": 0.2734285518976704, "ngenes": 58, "description": "Signaling by NTRK2 (TRKB)", "id": "716aed02-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9024909", "value": 0.028678592139156807, "ngenes": 10, "description": "BDNF activates NTRK2 (TRKB) signaling", "id": "716aed03-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9025046", "value": 0.029683941631055907, "ngenes": 4, "description": "NTF3 activates NTRK2 (TRKB) signaling", "id": "716aed04-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026357", "value": 0.025116695354688363, "ngenes": 4, "description": "NTF4 activates NTRK2 (TRKB) signaling", "id": "716aed05-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026519", "value": 0.02731217692035844, "ngenes": 22, "description": "Activated NTRK2 signals through RAS", "id": "716aed06-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026527", "value": 0.02694840780403818, "ngenes": 13, "description": "Activated NTRK2 signals through PLCG1", "id": "716aed07-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9028335", "value": 0.04192679278644834, "ngenes": 23, "description": "Activated NTRK2 signals through PI3K", "id": "716aed08-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9028731", "value": 0.025116695354688363, "ngenes": 25, "description": "Activated NTRK2 signals through FRS2 and FRS3", "id": "716aed09-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9032500", "value": 0.34336174924769963, "ngenes": 23, "description": "Activated NTRK2 signals through FYN", "id": "716aed0a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9032759", "value": 0.31746694710813544, "ngenes": 18, "description": "NTRK2 activates RAC1", "id": "716aed0b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9032845", "value": 0.03672027965843921, "ngenes": 17, "description": "Activated NTRK2 signals through CDK5", "id": "716aed0c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9034015", "value": 0.4264543148937853, "ngenes": 39, "description": "Signaling by NTRK3 (TRKC)", "id": "716aed0d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9034013", "value": 0.34839593834831734, "ngenes": 5, "description": "NTF3 activates NTRK3 signaling", "id": "716aed0e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9034793", "value": 0.3574173135775487, "ngenes": 7, "description": "Activated NTRK3 signals through PLCG1", "id": "716aed0f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9034864", "value": 0.35265833466820323, "ngenes": 16, "description": "Activated NTRK3 signals through RAS", "id": "716aed10-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9603381", "value": 0.32968063215624954, "ngenes": 16, "description": "Activated NTRK3 signals through PI3K", "id": "716aed11-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9603505", "value": 0.389015257163283, "ngenes": 10, "description": "NTRK3 as a dependence receptor", "id": "716aed12-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-177929", "value": 0.3517237535199379, "ngenes": 92, "description": "Signaling by EGFR", "id": "716aed13-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-179812", "value": 0.5564408072129327, "ngenes": 19, "description": "GRB2 events in EGFR signaling", "id": "716aed14-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180292", "value": 0.31728904773450806, "ngenes": 31, "description": "GAB1 signalosome", "id": "716aed15-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180336", "value": 0.6446645846777671, "ngenes": 22, "description": "SHC1 events in EGFR signaling", "id": "716aed16-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-182971", "value": 0.7335009493065999, "ngenes": 53, "description": "EGFR downregulation", "id": "716aed17-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-212718", "value": 0.2931391690347714, "ngenes": 13, "description": "EGFR interacts with phospholipase C-gamma", "id": "716aed18-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-186797", "value": 0.0936489608787932, "ngenes": 102, "description": "Signaling by PDGF", "id": "716aed19-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-186763", "value": 0.0006384724975130942, "ngenes": 56, "description": "Downstream signal transduction", "id": "716aed1a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-194138", "value": 0.13600904106624143, "ngenes": 223, "description": "Signaling by VEGF", "id": "716aed1b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-194306", "value": 0.16901033558716677, "ngenes": 7, "description": "Neurophilin interactions with VEGF and VEGFR", "id": "716aed1c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-194313", "value": 0.008266147785476085, "ngenes": 14, "description": "VEGF ligand-receptor interactions", "id": "716aed1d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-195399", "value": 0.008266147785476085, "ngenes": 14, "description": "VEGF binds to VEGFR leading to receptor dimerization", "id": "716aed1e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4420097", "value": 0.07946149738361624, "ngenes": 206, "description": "VEGFA-VEGFR2 Pathway", "id": "716aed1f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5218920", "value": 0.13375822907700052, "ngenes": 64, "description": "VEGFR2 mediated vascular permeability", "id": "716aed20-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5218921", "value": 0.08420618191760897, "ngenes": 42, "description": "VEGFR2 mediated cell proliferation", "id": "716aed21-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-6806834", "value": 0.5644922054187091, "ngenes": 146, "description": "Signaling by MET", "id": "716aed22-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6806942", "value": 0.5347233122540755, "ngenes": 12, "description": "MET Receptor Activation", "id": "716aed23-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807004", "value": 0.3263095817972339, "ngenes": 37, "description": "Negative regulation of MET activity", "id": "716aed24-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851805", "value": 0.03333898376158171, "ngenes": 19, "description": "MET activates RAS signaling", "id": "716aed25-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851907", "value": 1.0, "ngenes": 17, "description": "MET activates PI3K/AKT signaling", "id": "716aed26-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8865999", "value": 0.5541477302483739, "ngenes": 11, "description": "MET activates PTPN11", "id": "716aed27-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875878", "value": 0.09569700782383074, "ngenes": 79, "description": "MET promotes cell motility", "id": "716aed28-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8874081", "value": 0.0594537139956224, "ngenes": 58, "description": "MET activates PTK2 signaling", "id": "716aed29-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875513", "value": 0.989794880331431, "ngenes": 12, "description": "MET interacts with TNS proteins", "id": "716aed2a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875555", "value": 0.09479157878146452, "ngenes": 24, "description": "MET activates RAP1 and RAC1", "id": "716aed2b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8875656", "value": 0.14559197423145173, "ngenes": 21, "description": "MET receptor recycling", "id": "716aed2c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875791", "value": 0.056392672786659014, "ngenes": 8, "description": "MET activates STAT3", "id": "716aed2d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8852405", "value": 0.9200343981809691, "ngenes": 8, "description": "Signaling by MST1", "id": "716aed2e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-165159", "value": 0.11013301982060077, "ngenes": 74, "description": "MTOR signalling", "id": "716aed2f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165181", "value": 0.12527119187622013, "ngenes": 7, "description": "Inhibition of TSC complex formation by PKB", "id": "716aed30-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166208", "value": 0.2297302620557261, "ngenes": 38, "description": "mTORC1-mediated signalling", "id": "716aed31-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380972", "value": 0.08256565189037975, "ngenes": 50, "description": "Energy dependent regulation of mTOR by LKB1-AMPK", "id": "716aed32-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-157118", "value": 0.14559197423145173, "ngenes": 377, "description": "Signaling by NOTCH", "id": "716aed33-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1912422", "value": 0.9070407823460007, "ngenes": 154, "description": "Pre-NOTCH Expression and Processing", "id": "716aed34-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1912399", "value": 0.002799706126077655, "ngenes": 15, "description": "Pre-NOTCH Processing in the Endoplasmic Reticulum", "id": "716aed35-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1912408", "value": 0.8636052042095431, "ngenes": 122, "description": "Pre-NOTCH Transcription and Translation", "id": "716aed36-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1912420", "value": 0.2068045782527938, "ngenes": 35, "description": "Pre-NOTCH Processing in Golgi", "id": "716aed37-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1980143", "value": 0.13148837817314624, "ngenes": 121, "description": "Signaling by NOTCH1", "id": "716aed38-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2122947", "value": 0.23878794867339573, "ngenes": 78, "description": "NOTCH1 Intracellular Domain Regulates Transcription", "id": "716aed39-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2122948", "value": 0.05508234659751904, "ngenes": 53, "description": "Activated NOTCH1 Transmits Signal to the Nucleus", "id": "716aed3a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1980145", "value": 0.07571005029484179, "ngenes": 63, "description": "Signaling by NOTCH2", "id": "716aed3b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2197563", "value": 0.10115100214101994, "ngenes": 23, "description": "NOTCH2 intracellular domain regulates transcription", "id": "716aed3c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2979096", "value": 0.0707229434916646, "ngenes": 46, "description": "NOTCH2 Activation and Transmission of Signal to the Nucleus", "id": "716aed3d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9012852", "value": 0.07198809218653225, "ngenes": 75, "description": "Signaling by NOTCH3", "id": "716aed3e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9013508", "value": 0.5307958638542406, "ngenes": 32, "description": "NOTCH3 Intracellular Domain Regulates Transcription", "id": "716aed3f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013507", "value": 0.07571005029484179, "ngenes": 44, "description": "NOTCH3 Activation and Transmission of Signal to the Nucleus", "id": "716aed40-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9017802", "value": 0.5914364094827842, "ngenes": 15, "description": "Noncanonical activation of NOTCH3", "id": "716aed41-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9013694", "value": 0.1634376037286026, "ngenes": 146, "description": "Signaling by NOTCH4", "id": "716aed42-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9013695", "value": 0.04216998412170033, "ngenes": 32, "description": "NOTCH4 Intracellular Domain Regulates Transcription", "id": "716aed43-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013700", "value": 0.0668395590901676, "ngenes": 19, "description": "NOTCH4 Activation and Transmission of Signal to the Nucleus", "id": "716aed44-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9604323", "value": 0.17051089002980763, "ngenes": 99, "description": "Negative regulation of NOTCH4 signaling", "id": "716aed45-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-73887", "value": 0.08256565189037975, "ngenes": 249, "description": "Death Receptor Signalling", "id": "716aed46-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193704", "value": 0.1298088881737574, "ngenes": 171, "description": "p75 NTR receptor-mediated signalling", "id": "716aed47-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193697", "value": 0.17713663564843804, "ngenes": 15, "description": "p75NTR regulates axonogenesis", "id": "716aed48-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193634", "value": 0.2987330602038509, "ngenes": 14, "description": "Axonal growth inhibition (RHOA activation)", "id": "716aed49-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209563", "value": 0.840730938395067, "ngenes": 4, "description": "Axonal growth stimulation", "id": "716aed4a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-204998", "value": 0.1733582004768865, "ngenes": 143, "description": "Cell death signalling via NRAGE, NRIF and NADE", "id": "716aed4b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193648", "value": 0.20766893128451225, "ngenes": 108, "description": "NRAGE signals death through JNK", "id": "716aed4c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-205025", "value": 0.39004786383157547, "ngenes": 11, "description": "NADE modulates death signalling", "id": "716aed4d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-205043", "value": 0.305171668366271, "ngenes": 31, "description": "NRIF signals cell death from the nucleus", "id": "716aed4e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-193670", "value": 0.6342125850176571, "ngenes": 6, "description": "p75NTR negatively regulates cell cycle via SC1", "id": "716aed4f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193681", "value": 0.17293277209696895, "ngenes": 3, "description": "Ceramide signalling", "id": "716aed50-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193692", "value": 0.14636450425981812, "ngenes": 20, "description": "Regulated proteolysis of p75NTR", "id": "716aed51-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193639", "value": 0.2966129799925685, "ngenes": 24, "description": "p75NTR signals via NF-kB", "id": "716aed52-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-209543", "value": 0.5938448597540531, "ngenes": 21, "description": "p75NTR recruits signalling complexes", "id": "716aed53-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209560", "value": 0.39556458831374086, "ngenes": 21, "description": "NF-kB is activated and signals survival", "id": "716aed54-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-75893", "value": 0.0463470603268933, "ngenes": 81, "description": "TNF signaling", "id": "716aed55-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5357786", "value": 0.03353723961526887, "ngenes": 24, "description": "TNFR1-induced proapoptotic signaling", "id": "716aed56-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5357905", "value": 0.045276884174000616, "ngenes": 63, "description": "Regulation of TNFR1 signaling", "id": "716aed57-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5357956", "value": 0.0448987883185281, "ngenes": 54, "description": "TNFR1-induced NFkappaB signaling pathway", "id": "716aed58-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5626978", "value": 0.7191844659971434, "ngenes": 8, "description": "TNFR1-mediated ceramide production", "id": "716aed59-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75157", "value": 0.054926230642477945, "ngenes": 11, "description": "FasL/ CD95L signaling", "id": "716aed5a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75158", "value": 0.07249273226070745, "ngenes": 15, "description": "TRAIL  signaling", "id": "716aed5b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-194315", "value": 0.7496807230196615, "ngenes": 790, "description": "Signaling by Rho GTPases", "id": "716aed5c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-194840", "value": 0.8948992163866106, "ngenes": 281, "description": "Rho GTPase cycle", "id": "716aed5d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-195258", "value": 0.7252733398072027, "ngenes": 539, "description": "RHO GTPase Effectors", "id": "716aed5e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5625740", "value": 0.7342518756688405, "ngenes": 131, "description": "RHO GTPases activate PKNs", "id": "716aed5f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5625886", "value": 0.6627019483454317, "ngenes": 82, "description": "Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3", "id": "716aed60-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5625900", "value": 0.9162699788361499, "ngenes": 30, "description": "RHO GTPases activate CIT", "id": "716aed61-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5625970", "value": 0.21084566240421138, "ngenes": 26, "description": "RHO GTPases activate KTN1", "id": "716aed62-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5626467", "value": 0.9427540666136551, "ngenes": 55, "description": "RHO GTPases activate IQGAPs", "id": "716aed63-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5627083", "value": 0.824833333983243, "ngenes": 3, "description": "RHO GTPases regulate CFTR trafficking", "id": "716aed64-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5627117", "value": 0.21196612854459962, "ngenes": 34, "description": "RHO GTPases Activate ROCKs", "id": "716aed65-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5627123", "value": 0.2983135692417298, "ngenes": 42, "description": "RHO GTPases activate PAKs", "id": "716aed66-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5663213", "value": 0.26355477932994203, "ngenes": 73, "description": "RHO GTPases Activate WASPs and WAVEs", "id": "716aed67-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5663220", "value": 0.05217194830537929, "ngenes": 235, "description": "RHO GTPases Activate Formins", "id": "716aed68-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5666185", "value": 0.25040660510874796, "ngenes": 14, "description": "RHO GTPases Activate Rhotekin and Rhophilins", "id": "716aed69-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5668599", "value": 0.4132363613103597, "ngenes": 46, "description": "RHO GTPases Activate NADPH Oxidases", "id": "716aed6a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-195721", "value": 0.1655260481081655, "ngenes": 522, "description": "Signaling by WNT", "id": "716aed6b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-195253", "value": 0.14040042790827242, "ngenes": 155, "description": "Degradation of beta-catenin by the destruction complex", "id": "716aed6c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196299", "value": 0.08161862671404954, "ngenes": 37, "description": "Beta-catenin phosphorylation cascade", "id": "716aed6d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641265", "value": 0.03870375445735832, "ngenes": 24, "description": "Repression of WNT target genes", "id": "716aed6e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-201681", "value": 0.24760791804928345, "ngenes": 368, "description": "TCF dependent signaling in response to WNT", "id": "716aed6f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-201688", "value": 0.8139788693257981, "ngenes": 19, "description": "WNT mediated activation of DVL", "id": "716aed70-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3769402", "value": 0.03753487028863252, "ngenes": 79, "description": "Deactivation of the beta-catenin transactivating complex", "id": "716aed71-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3772470", "value": 0.8614988870353867, "ngenes": 24, "description": "Negative regulation of TCF-dependent signaling by WNT ligand antagonists", "id": "716aed72-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-201722", "value": 0.7358876309289297, "ngenes": 125, "description": "Formation of the beta-catenin:TCF transactivating complex", "id": "716aed73-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4411364", "value": 0.09233152408106514, "ngenes": 21, "description": "Binding of TCF/LEF:CTNNB1 to target gene promoters", "id": "716aed74-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4641257", "value": 0.28688218493792816, "ngenes": 93, "description": "Degradation of AXIN", "id": "716aed75-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641258", "value": 0.3056236055452598, "ngenes": 101, "description": "Degradation of DVL", "id": "716aed76-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641262", "value": 0.12279976789558063, "ngenes": 59, "description": "Disassembly of the destruction complex and recruitment of AXIN to the membrane", "id": "716aed77-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641263", "value": 0.6691567371995883, "ngenes": 33, "description": "Regulation of FZD by ubiquitination", "id": "716aed78-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5368598", "value": 0.06100298779926902, "ngenes": 8, "description": "Negative regulation of TCF-dependent signaling by DVL-interacting proteins", "id": "716aed79-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3238698", "value": 0.5717562759015913, "ngenes": 39, "description": "WNT ligand biogenesis and trafficking", "id": "716aed7a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3858494", "value": 0.1454035285371808, "ngenes": 246, "description": "Beta-catenin independent WNT signaling", "id": "716aed7b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4086398", "value": 0.12013537038193475, "ngenes": 96, "description": "Ca2+ pathway", "id": "716aed7c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4086400", "value": 0.19579527196730193, "ngenes": 158, "description": "PCP/CE pathway", "id": "716aed7d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4608870", "value": 0.2531335480764134, "ngenes": 108, "description": "Asymmetric localization of PCP proteins", "id": "716aed7e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5099900", "value": 0.4543335448357411, "ngenes": 27, "description": "WNT5A-dependent internalization of FZD4", "id": "716aed7f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5140745", "value": 0.4937728506749121, "ngenes": 22, "description": "WNT5A-dependent internalization of FZD2, FZD5 and ROR2", "id": "716aed80-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9006936", "value": 0.1747195608928016, "ngenes": 180, "description": "Signaling by TGFB family members", "id": "716aed81-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-201451", "value": 0.698386134013551, "ngenes": 45, "description": "Signaling by BMP", "id": "716aed82-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-170834", "value": 0.14551769760612, "ngenes": 134, "description": "Signaling by TGF-beta Receptor Complex", "id": "716aed83-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173789", "value": 0.46999768261844505, "ngenes": 56, "description": "TGF-beta receptor signaling activates SMADs", "id": "716aed84-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173788", "value": 0.2767727737172947, "ngenes": 46, "description": "Downregulation of TGF-beta receptor signaling", "id": "716aed85-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2173791", "value": 0.9162699788361499, "ngenes": 33, "description": "TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)", "id": "716aed86-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173793", "value": 0.09219611882665504, "ngenes": 83, "description": "Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer", "id": "716aed87-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173795", "value": 0.17385995892110886, "ngenes": 48, "description": "Downregulation of SMAD2/3:SMAD4 transcriptional activity", "id": "716aed88-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173796", "value": 0.06949697316721493, "ngenes": 59, "description": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription", "id": "716aed89-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1502540", "value": 0.14340066214355904, "ngenes": 23, "description": "Signaling by Activin", "id": "716aed8a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2473224", "value": 0.5458505462315973, "ngenes": 5, "description": "Antagonism of Activin by Follistatin", "id": "716aed8b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2028269", "value": 0.712210928221573, "ngenes": 28, "description": "Signaling by Hippo", "id": "716aed8c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2586552", "value": 0.016465066986736502, "ngenes": 19, "description": "Signaling by Leptin", "id": "716aed8d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-354192", "value": 0.0009734218695103252, "ngenes": 55, "description": "Integrin signaling", "id": "716aed8e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-354194", "value": 0.007950428030311853, "ngenes": 29, "description": "GRB2:SOS provides linkage to MAPK signaling for Integrins ", "id": "716aed8f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-372708", "value": 0.0033249014799327436, "ngenes": 30, "description": "p130Cas linkage to MAPK signaling for integrins", "id": "716aed90-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5358351", "value": 0.27093534552585813, "ngenes": 234, "description": "Signaling by Hedgehog", "id": "716aed91-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5358346", "value": 0.2506530239039547, "ngenes": 106, "description": "Hedgehog ligand biogenesis", "id": "716aed92-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5362798", "value": 0.9113332740058939, "ngenes": 10, "description": "Release of Hh-Np from the secreting cell", "id": "716aed93-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5610787", "value": 0.32587929910617475, "ngenes": 180, "description": "Hedgehog 'off' state", "id": "716aed94-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5610780", "value": 0.26325298548501824, "ngenes": 106, "description": "Degradation of GLI1 by the proteasome", "id": "716aed95-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5610783", "value": 0.23383639840230797, "ngenes": 107, "description": "Degradation of GLI2 by the proteasome", "id": "716aed96-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5610785", "value": 0.2274371502377419, "ngenes": 107, "description": "GLI3 is processed to GLI3R by the proteasome", "id": "716aed97-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5632684", "value": 0.23103431986956088, "ngenes": 141, "description": "Hedgehog 'on' state", "id": "716aed98-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5632681", "value": 0.9689625471354482, "ngenes": 13, "description": "Ligand-receptor interactions", "id": "716aed99-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5635838", "value": 0.628896611280733, "ngenes": 27, "description": "Activation of SMO", "id": "716aed9a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5635851", "value": 0.7027433857399764, "ngenes": 9, "description": "GLI proteins bind promoters of Hh responsive genes to promote transcription", "id": "716aed9b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006931", "value": 0.1447416105765235, "ngenes": 459, "description": "Signaling by Nuclear Receptors", "id": "716aed9c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5362517", "value": 0.09616732965572938, "ngenes": 68, "description": "Signaling by Retinoic Acid", "id": "716aed9d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5365859", "value": 0.4021713371668776, "ngenes": 36, "description": "RA biosynthesis pathway", "id": "716aed9e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8939211", "value": 0.1655260481081655, "ngenes": 341, "description": "ESR-mediated signaling", "id": "716aed9f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9018519", "value": 0.745200724443715, "ngenes": 214, "description": "Estrogen-dependent gene expression", "id": "716aeda0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9009391", "value": 0.2700329737544026, "ngenes": 137, "description": "Extra-nuclear estrogen signaling", "id": "716aeda1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9634635", "value": 0.12223851496961394, "ngenes": 20, "description": "Estrogen-stimulated signaling through PRKCZ", "id": "716aeda2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9634638", "value": 0.9062540649274546, "ngenes": 48, "description": "Estrogen-dependent nuclear events downstream of ESR-membrane signaling", "id": "716aeda3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9024446", "value": 0.7976729997657158, "ngenes": 75, "description": "NR1H2 and NR1H3-mediated signaling", "id": "716aeda4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9029558", "value": 0.8695417430113445, "ngenes": 13, "description": "NR1H2 & NR1H3 regulate gene expression linked to lipogenesis", "id": "716aeda5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9029569", "value": 0.9518708468083799, "ngenes": 60, "description": "NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux", "id": "716aeda6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9031525", "value": 0.09215430307755697, "ngenes": 6, "description": "NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ", "id": "716aeda7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9031528", "value": 0.12398964310425166, "ngenes": 6, "description": "NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose", "id": "716aeda8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9623433", "value": 0.5332010701839299, "ngenes": 15, "description": "NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis", "id": "716aeda9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9632974", "value": 0.6917037066508774, "ngenes": 7, "description": "NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ", "id": "716aedaa-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006927", "value": 0.09628388693353743, "ngenes": 108, "description": "Signaling by Non-Receptor Tyrosine Kinases", "id": "716aedab-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8848021", "value": 0.09628388693353743, "ngenes": 108, "description": "Signaling by PTK6", "id": "716aedac-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8847993", "value": 0.2136830286654327, "ngenes": 26, "description": "ERBB2 Activates PTK6 Signaling", "id": "716aedad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849468", "value": 0.5073692428747247, "ngenes": 7, "description": "PTK6 Regulates Proteins Involved in RNA Processing", "id": "716aedae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849469", "value": 0.02259031855457533, "ngenes": 19, "description": "PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1", "id": "716aedaf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849470", "value": 0.08221002105767727, "ngenes": 12, "description": "PTK6 Regulates Cell Cycle", "id": "716aedb0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849471", "value": 0.08678692708025547, "ngenes": 29, "description": "PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases", "id": "716aedb1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849472", "value": 0.11475312669900828, "ngenes": 4, "description": "PTK6 Down-Regulation", "id": "716aedb2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849473", "value": 0.602800044414918, "ngenes": 10, "description": "PTK6 Expression", "id": "716aedb3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849474", "value": 0.3908204897464367, "ngenes": 11, "description": "PTK6 Activates STAT3", "id": "716aedb4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8857538", "value": 0.941541324821503, "ngenes": 14, "description": "PTK6 promotes HIF1A stabilization", "id": "716aedb5-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006335", "value": 0.34227815052936994, "ngenes": 38, "description": "Signaling by Erythropoietin", "id": "716aedb6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9027276", "value": 0.5541124339543797, "ngenes": 19, "description": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)", "id": "716aedb7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9027277", "value": 0.16645519673075324, "ngenes": 8, "description": "Erythropoietin activates Phospholipase C gamma (PLCG)", "id": "716aedb8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9027283", "value": 0.0008552920800305216, "ngenes": 7, "description": "Erythropoietin activates STAT5", "id": "716aedb9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9027284", "value": 0.5235198228942736, "ngenes": 19, "description": "Erythropoietin activates RAS", "id": "716aedba-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-73894", "value": 0.07661561155969829, "ngenes": 569, "description": "DNA Repair", "id": "716aedbb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73893", "value": 0.0941349133560622, "ngenes": 84, "description": "DNA Damage Bypass", "id": "716aedbc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110313", "value": 0.1572795042215164, "ngenes": 67, "description": "Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template", "id": "716aedbd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110312", "value": 0.05222005670444407, "ngenes": 31, "description": "Translesion synthesis by REV1", "id": "716aedbe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110320", "value": 0.091596951382805, "ngenes": 38, "description": "Translesion Synthesis by POLH", "id": "716aedbf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5655862", "value": 0.053565012963375146, "ngenes": 32, "description": "Translesion synthesis by POLK", "id": "716aedc0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5656121", "value": 0.05201334607998943, "ngenes": 32, "description": "Translesion synthesis by POLI", "id": "716aedc1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5656169", "value": 0.12721138533759097, "ngenes": 56, "description": "Termination of translesion DNA synthesis", "id": "716aedc2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-110314", "value": 0.037126356197780395, "ngenes": 54, "description": "Recognition of DNA damage by PCNA-containing replication complex", "id": "716aedc3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73884", "value": 0.7619834152822049, "ngenes": 124, "description": "Base Excision Repair", "id": "716aedc4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73929", "value": 0.786700270596591, "ngenes": 78, "description": "Base-Excision Repair, AP Site Formation", "id": "716aedc5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73928", "value": 0.786700270596591, "ngenes": 72, "description": "Depyrimidination", "id": "716aedc6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110328", "value": 0.786700270596591, "ngenes": 72, "description": "Recognition and association of DNA glycosylase with site containing an affected pyrimidine", "id": "716aedc7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110329", "value": 0.786700270596591, "ngenes": 72, "description": "Cleavage of the damaged pyrimidine ", "id": "716aedc8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73927", "value": 0.745200724443715, "ngenes": 68, "description": "Depurination", "id": "716aedc9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110330", "value": 0.745200724443715, "ngenes": 68, "description": "Recognition and association of DNA glycosylase with site containing an affected purine", "id": "716aedca-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110331", "value": 0.745200724443715, "ngenes": 68, "description": "Cleavage of the damaged purine", "id": "716aedcb-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-73933", "value": 0.07373709906444208, "ngenes": 64, "description": "Resolution of Abasic Sites (AP sites)", "id": "716aedcc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110357", "value": 0.0590432594241244, "ngenes": 18, "description": "Displacement of DNA glycosylase by APEX1", "id": "716aedcd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110373", "value": 0.12802366902554624, "ngenes": 41, "description": "Resolution of AP sites via the multiple-nucleotide patch replacement pathway", "id": "716aedce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110362", "value": 0.621571373307688, "ngenes": 13, "description": "POLB-Dependent Long Patch Base Excision Repair", "id": "716aedcf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5651801", "value": 0.099122820807317, "ngenes": 34, "description": "PCNA-Dependent Long Patch Base Excision Repair", "id": "716aedd0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5649702", "value": 0.6753956513919458, "ngenes": 10, "description": "APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway", "id": "716aedd1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110381", "value": 0.6917037066508774, "ngenes": 7, "description": "Resolution of AP sites via the single-nucleotide replacement pathway", "id": "716aedd2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73930", "value": 0.9520129933550934, "ngenes": 3, "description": "Abasic sugar-phosphate removal via the single-nucleotide replacement pathway", "id": "716aedd3-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-73942", "value": 0.7640857680183397, "ngenes": 12, "description": "DNA Damage Reversal", "id": "716aedd4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73943", "value": 0.7771244720416621, "ngenes": 11, "description": "Reversal of alkylation damage by DNA dioxygenases", "id": "716aedd5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112126", "value": 0.9800706538300357, "ngenes": 7, "description": "ALKBH3 mediated reversal of alkylation damage", "id": "716aedd6-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5358508", "value": 0.03832642827093361, "ngenes": 27, "description": "Mismatch Repair", "id": "716aedd7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5358565", "value": 0.03870375445735832, "ngenes": 26, "description": "Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)", "id": "716aedd8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358606", "value": 0.015513662319995954, "ngenes": 25, "description": "Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)", "id": "716aedd9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693532", "value": 0.06962729134710448, "ngenes": 306, "description": "DNA Double-Strand Break Repair", "id": "716aedda-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693538", "value": 0.1040506828516798, "ngenes": 245, "description": "Homology Directed Repair", "id": "716aeddb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693567", "value": 0.06980941466577938, "ngenes": 236, "description": "HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)", "id": "716aeddc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5685938", "value": 0.4612636962180745, "ngenes": 84, "description": "HDR through Single Strand Annealing (SSA)", "id": "716aeddd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5685942", "value": 0.0707229434916646, "ngenes": 137, "description": "HDR through Homologous Recombination (HRR)", "id": "716aedde-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693537", "value": 0.9774502008149097, "ngenes": 76, "description": "Resolution of D-Loop Structures", "id": "716aeddf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693554", "value": 1.0, "ngenes": 61, "description": "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)", "id": "716aede0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5693568", "value": 0.9694129607641102, "ngenes": 71, "description": "Resolution of D-loop Structures through Holliday Junction Intermediates", "id": "716aede1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693579", "value": 0.09848451730235223, "ngenes": 90, "description": "Homologous DNA Pairing and Strand Exchange", "id": "716aede2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693616", "value": 0.07571005029484179, "ngenes": 87, "description": "Presynaptic phase of homologous DNA pairing and strand exchange", "id": "716aede3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5693607", "value": 0.12721138533759097, "ngenes": 168, "description": "Processing of DNA double-strand break ends", "id": "716aede4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5685939", "value": 0.09480799100842513, "ngenes": 20, "description": "HDR through MMEJ (alt-NHEJ)", "id": "716aede5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693606", "value": 0.5873547449207005, "ngenes": 140, "description": "DNA Double Strand Break Response", "id": "716aede6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693548", "value": 0.155870532999355, "ngenes": 20, "description": "Sensing of DNA Double Strand Breaks", "id": "716aede7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5693565", "value": 0.7042117159600336, "ngenes": 135, "description": "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks", "id": "716aede8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693571", "value": 0.4566748544820098, "ngenes": 111, "description": "Nonhomologous End-Joining (NHEJ)", "id": "716aede9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5696398", "value": 0.08929005184763417, "ngenes": 188, "description": "Nucleotide Excision Repair", "id": "716aedea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5696399", "value": 0.07999861398585909, "ngenes": 141, "description": "Global Genome Nucleotide Excision Repair (GG-NER)", "id": "716aedeb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5696394", "value": 0.06896937371942653, "ngenes": 63, "description": "DNA Damage Recognition in GG-NER", "id": "716aedec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5696395", "value": 0.09480799100842513, "ngenes": 73, "description": "Formation of Incision Complex in GG-NER", "id": "716aeded-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5696397", "value": 0.06980941466577938, "ngenes": 43, "description": "Gap-filling DNA repair synthesis and ligation in GG-NER", "id": "716aedee-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5696400", "value": 0.050955201772694206, "ngenes": 75, "description": "Dual Incision in GG-NER", "id": "716aedef-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6781827", "value": 0.10404356720284604, "ngenes": 140, "description": "Transcription-Coupled Nucleotide Excision Repair (TC-NER)", "id": "716aedf0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6781823", "value": 0.1397147794174645, "ngenes": 98, "description": "Formation of TC-NER Pre-Incision Complex", "id": "716aedf1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6782135", "value": 0.08044307893162102, "ngenes": 121, "description": "Dual incision in TC-NER", "id": "716aedf2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6782210", "value": 0.09480799100842513, "ngenes": 118, "description": "Gap-filling DNA repair synthesis and ligation in TC-NER", "id": "716aedf3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-6783310", "value": 0.08256565189037975, "ngenes": 70, "description": "Fanconi Anemia Pathway", "id": "716aedf4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8953854", "value": 0.09219611882665504, "ngenes": 1106, "description": "Metabolism of RNA", "id": "716aedf5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75067", "value": 0.09631275944087282, "ngenes": 51, "description": "Processing of Capped Intronless Pre-mRNA", "id": "716aedf6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111367", "value": 0.5225090917618829, "ngenes": 17, "description": "SLBP independent Processing of Histone Pre-mRNAs", "id": "716aedf7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77588", "value": 0.4290311116784511, "ngenes": 19, "description": "SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs", "id": "716aedf8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77595", "value": 0.09848451730235223, "ngenes": 36, "description": "Processing of Intronless Pre-mRNAs", "id": "716aedf9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72203", "value": 0.09480799100842513, "ngenes": 389, "description": "Processing of Capped Intron-Containing Pre-mRNA", "id": "716aedfa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72202", "value": 0.06048874616558646, "ngenes": 143, "description": "Transport of Mature Transcript to Cytoplasm", "id": "716aedfb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159234", "value": 0.06896937371942653, "ngenes": 76, "description": "Transport of Mature mRNAs Derived from Intronless Transcripts", "id": "716aedfc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159227", "value": 0.07571005029484179, "ngenes": 59, "description": "Transport of the SLBP independent Mature mRNA", "id": "716aedfd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159230", "value": 0.06988359763883936, "ngenes": 61, "description": "Transport of the SLBP Dependant Mature mRNA", "id": "716aedfe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159231", "value": 0.07118843359992003, "ngenes": 74, "description": "Transport of Mature mRNA Derived from an Intronless Transcript", "id": "716aedff-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-159236", "value": 0.056885312755178406, "ngenes": 123, "description": "Transport of Mature mRNA derived from an Intron-Containing Transcript", "id": "716aee00-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72172", "value": 0.10134780461299894, "ngenes": 293, "description": "mRNA Splicing", "id": "716aee01-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72163", "value": 0.1040506828516798, "ngenes": 280, "description": "mRNA Splicing - Major Pathway", "id": "716aee02-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72165", "value": 0.09961856503478693, "ngenes": 73, "description": "mRNA Splicing - Minor Pathway", "id": "716aee03-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72187", "value": 0.06980941466577938, "ngenes": 99, "description": "mRNA 3'-end processing", "id": "716aee04-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-194441", "value": 0.12488689795927407, "ngenes": 85, "description": "Metabolism of non-coding RNA", "id": "716aee05-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-191859", "value": 0.12488689795927407, "ngenes": 85, "description": "snRNP Assembly", "id": "716aee06-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-429914", "value": 0.11013301982060077, "ngenes": 82, "description": "Deadenylation-dependent mRNA decay", "id": "716aee07-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-429947", "value": 0.046199443510615404, "ngenes": 42, "description": "Deadenylation of mRNA", "id": "716aee08-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-429958", "value": 0.5794963642995326, "ngenes": 22, "description": "mRNA decay by 3' to 5' exoribonuclease", "id": "716aee09-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-430039", "value": 0.14462859621967175, "ngenes": 18, "description": "mRNA decay by 5' to 3' exoribonuclease", "id": "716aee0a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450531", "value": 0.20233158451401723, "ngenes": 151, "description": "Regulation of mRNA stability by proteins that bind AU-rich elements", "id": "716aee0b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450385", "value": 0.09479157878146452, "ngenes": 27, "description": "Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA", "id": "716aee0c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450408", "value": 0.3011863589356739, "ngenes": 100, "description": "AUF1 (hnRNP D0) binds and destabilizes mRNA", "id": "716aee0d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450513", "value": 0.4350498048142162, "ngenes": 28, "description": "Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA", "id": "716aee0e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450520", "value": 0.5052304479607739, "ngenes": 10, "description": "HuR (ELAVL1) binds and stabilizes mRNA", "id": "716aee0f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450604", "value": 0.03942446780434165, "ngenes": 28, "description": "KSRP (KHSRP) binds and destabilizes mRNA", "id": "716aee10-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72306", "value": 0.07946149738361624, "ngenes": 162, "description": "tRNA processing", "id": "716aee11-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6782315", "value": 0.6243870029764075, "ngenes": 63, "description": "tRNA modification in the nucleus and cytosol", "id": "716aee12-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6782861", "value": 0.11428231250219291, "ngenes": 7, "description": "Synthesis of wybutosine at G37 of tRNA(Phe)", "id": "716aee13-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6784531", "value": 0.06450044587440303, "ngenes": 87, "description": "tRNA processing in the nucleus", "id": "716aee14-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6785470", "value": 0.15609774319060718, "ngenes": 8, "description": "tRNA processing in the mitochondrion", "id": "716aee15-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6787450", "value": 1.0, "ngenes": 16, "description": "tRNA modification in the mitochondrion", "id": "716aee16-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72312", "value": 0.12589526399266987, "ngenes": 360, "description": "rRNA processing", "id": "716aee17-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8868773", "value": 0.12527119187622013, "ngenes": 348, "description": "rRNA processing in the nucleus and cytosol", "id": "716aee18-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6790901", "value": 0.9165025423780552, "ngenes": 95, "description": "rRNA modification in the nucleus and cytosol", "id": "716aee19-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6791226", "value": 0.12398964310425166, "ngenes": 332, "description": "Major pathway of rRNA processing in the nucleolus and cytosol", "id": "716aee1a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8868766", "value": 0.3574173135775487, "ngenes": 12, "description": "rRNA processing in the mitochondrion", "id": "716aee1b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6793080", "value": 0.7822039303659291, "ngenes": 7, "description": "rRNA modification in the mitochondrion", "id": "716aee1c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-72086", "value": 0.1963525286626569, "ngenes": 42, "description": "mRNA Capping", "id": "716aee1d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75072", "value": 0.9788666536950346, "ngenes": 18, "description": "mRNA Editing", "id": "716aee1e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72200", "value": 0.9877644889517833, "ngenes": 12, "description": "mRNA Editing: C to U Conversion", "id": "716aee1f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75094", "value": 0.9877644889517833, "ngenes": 12, "description": "Formation of the Editosome", "id": "716aee20-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75064", "value": 0.9366905000603821, "ngenes": 6, "description": "mRNA Editing: A to I Conversion", "id": "716aee21-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75102", "value": 0.9366905000603821, "ngenes": 6, "description": "C6 deamination of adenosine", "id": "716aee22-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77042", "value": 0.9366905000603821, "ngenes": 6, "description": "Formation of editosomes by ADAR proteins", "id": "716aee23-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-927802", "value": 0.12634473973374397, "ngenes": 241, "description": "Nonsense-Mediated Decay (NMD)", "id": "716aee24-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975956", "value": 0.15043543902668774, "ngenes": 206, "description": "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)", "id": "716aee25-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975957", "value": 0.12634473973374397, "ngenes": 241, "description": "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)", "id": "716aee26-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5357801", "value": 0.09064546717103535, "ngenes": 357, "description": "Programmed Cell Death", "id": "716aee27-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-109581", "value": 0.07614569057503914, "ngenes": 332, "description": "Apoptosis", "id": "716aee28-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-109606", "value": 0.035253484889292405, "ngenes": 104, "description": "Intrinsic Pathway for Apoptosis", "id": "716aee29-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-114452", "value": 0.050955201772694206, "ngenes": 53, "description": "Activation of BH3-only proteins", "id": "716aee2a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111446", "value": 0.09801247999294281, "ngenes": 7, "description": "Activation of BIM and translocation to mitochondria ", "id": "716aee2b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111447", "value": 0.8750385678618968, "ngenes": 30, "description": "Activation of BAD and translocation to mitochondria ", "id": "716aee2c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111448", "value": 0.000754535607733383, "ngenes": 6, "description": "Activation of NOXA and translocation to mitochondria", "id": "716aee2d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-139910", "value": 0.13722040384198414, "ngenes": 8, "description": "Activation of BMF and translocation to mitochondria", "id": "716aee2e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-139915", "value": 0.0002140191013682398, "ngenes": 10, "description": "Activation of PUMA and translocation to mitochondria", "id": "716aee2f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-111452", "value": 0.5053088339313788, "ngenes": 4, "description": "Activation and oligomerization of BAK protein", "id": "716aee30-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111453", "value": 0.04341555259176416, "ngenes": 22, "description": "BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members", "id": "716aee31-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111471", "value": 0.03333898376158171, "ngenes": 39, "description": "Apoptotic factor-mediated response", "id": "716aee32-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111457", "value": 0.7141420736921184, "ngenes": 12, "description": "Release of apoptotic factors from the mitochondria", "id": "716aee33-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111461", "value": 0.07940660854331556, "ngenes": 26, "description": "Cytochrome c-mediated apoptotic response", "id": "716aee34-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111459", "value": 0.08981617914127761, "ngenes": 11, "description": "Activation of caspases through apoptosome-mediated cleavage", "id": "716aee35-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111458", "value": 0.11475312669900828, "ngenes": 21, "description": "Formation of apoptosome", "id": "716aee36-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9627069", "value": 0.11475312669900828, "ngenes": 21, "description": "Regulation of the apoptosome activity", "id": "716aee37-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-111469", "value": 0.23774361745488784, "ngenes": 19, "description": "SMAC, XIAP-regulated apoptotic response", "id": "716aee38-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111463", "value": 0.1655260481081655, "ngenes": 14, "description": "SMAC (DIABLO) binds to IAPs ", "id": "716aee39-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111464", "value": 0.1655260481081655, "ngenes": 14, "description": "SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ", "id": "716aee3a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-114294", "value": 0.37582395900431764, "ngenes": 6, "description": "Activation, translocation and oligomerization of BAX", "id": "716aee3b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75108", "value": 0.10656915761067158, "ngenes": 10, "description": "Activation, myristolyation of BID and translocation to mitochondria", "id": "716aee3c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75153", "value": 0.03942446780434165, "ngenes": 113, "description": "Apoptotic execution phase", "id": "716aee3d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140342", "value": 0.9588255298330869, "ngenes": 18, "description": "Apoptosis induced DNA fragmentation", "id": "716aee3e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211736", "value": 0.22195357555611497, "ngenes": 4, "description": "Stimulation of the cell death response by PAK-2p34", "id": "716aee3f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111465", "value": 0.040493699154052605, "ngenes": 92, "description": "Apoptotic cleavage of cellular proteins", "id": "716aee40-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-264870", "value": 0.03333898376158171, "ngenes": 35, "description": "Caspase-mediated cleavage of cytoskeletal proteins", "id": "716aee41-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-351906", "value": 0.1883442475986383, "ngenes": 29, "description": "Apoptotic cleavage of cell adhesion  proteins", "id": "716aee42-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-352238", "value": 0.06842346660567004, "ngenes": 6, "description": "Breakdown of the nuclear lamina", "id": "716aee43-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-169911", "value": 0.2552869492378058, "ngenes": 93, "description": "Regulation of Apoptosis", "id": "716aee44-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211728", "value": 0.4264543148937853, "ngenes": 3, "description": "Regulation of PAK-2p34 activity by PS-GAP/RHG10", "id": "716aee45-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211733", "value": 0.2813353547022226, "ngenes": 88, "description": "Regulation of activated PAK-2p34 by proteasome mediated degradation", "id": "716aee46-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5357769", "value": 0.09613649703393125, "ngenes": 43, "description": "Caspase activation via extrinsic apoptotic signalling pathway", "id": "716aee47-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140534", "value": 0.10897363655092387, "ngenes": 27, "description": "Caspase activation via Death Receptors in the presence of ligand", "id": "716aee48-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371378", "value": 0.015513662319995954, "ngenes": 20, "description": "Regulation by c-FLIP", "id": "716aee49-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69416", "value": 0.015513662319995954, "ngenes": 20, "description": "Dimerization of procaspase-8", "id": "716aee4a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-418889", "value": 0.60483961746507, "ngenes": 16, "description": "Caspase activation via Dependence Receptors in the absence of ligand", "id": "716aee4b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5218859", "value": 0.06132645578947821, "ngenes": 58, "description": "Regulated Necrosis", "id": "716aee4c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5213460", "value": 0.06132645578947821, "ngenes": 58, "description": "RIPK1-mediated regulated necrosis", "id": "716aee4d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5675482", "value": 0.06132645578947821, "ngenes": 58, "description": "Regulation of necroptotic cell death", "id": "716aee4e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5218900", "value": 0.015513662319995954, "ngenes": 20, "description": "CASP8 activity is inhibited", "id": "716aee4f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9686347", "value": 0.322964685665524, "ngenes": 11, "description": "Microbial modulation of RIPK1-mediated regulated necrosis", "id": "716aee50-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-112316", "value": 0.5703496275689125, "ngenes": 717, "description": "Neuronal System", "id": "716aee51-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112307", "value": 0.8724822540138668, "ngenes": 6, "description": "Transmission across Electrical Synapses ", "id": "716aee52-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112303", "value": 0.8724822540138668, "ngenes": 6, "description": "Electric Transmission Across Gap Junctions", "id": "716aee53-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-112315", "value": 0.7536881160807625, "ngenes": 460, "description": "Transmission across Chemical Synapses", "id": "716aee54-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112308", "value": 0.5635225138846839, "ngenes": 23, "description": "Presynaptic depolarization and calcium channel opening", "id": "716aee55-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-112314", "value": 0.4729459489441784, "ngenes": 351, "description": "Neurotransmitter receptors and postsynaptic signal transmission", "id": "716aee56-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-977443", "value": 0.5225090917618829, "ngenes": 84, "description": "GABA receptor activation", "id": "716aee57-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-977444", "value": 0.6252388102354799, "ngenes": 59, "description": "GABA B receptor activation", "id": "716aee58-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-991365", "value": 0.6252388102354799, "ngenes": 59, "description": "Activation of GABAB receptors", "id": "716aee59-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170670", "value": 0.7747820596378019, "ngenes": 17, "description": "Adenylate cyclase inhibitory pathway", "id": "716aee5a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-997272", "value": 0.41147580749515345, "ngenes": 42, "description": "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits", "id": "716aee5b-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-399721", "value": 0.9694129607641102, "ngenes": 64, "description": "Glutamate binding, activation of AMPA receptors and synaptic plasticity", "id": "716aee5c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-399710", "value": 0.15043543902668774, "ngenes": 7, "description": "Activation of AMPA receptors", "id": "716aee5d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399719", "value": 0.9694129607641102, "ngenes": 64, "description": "Trafficking of AMPA receptors", "id": "716aee5e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-416993", "value": 0.4743305089781697, "ngenes": 37, "description": "Trafficking of GluR2-containing AMPA receptors", "id": "716aee5f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-442755", "value": 0.8380666757952182, "ngenes": 175, "description": "Activation of NMDA receptors and postsynaptic events", "id": "716aee60-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-438066", "value": 0.42714885815625286, "ngenes": 42, "description": "Unblocking of NMDA receptors, glutamate binding and activation", "id": "716aee61-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-438064", "value": 0.8504477706613561, "ngenes": 156, "description": "Post NMDA receptor activation events", "id": "716aee62-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-442720", "value": 0.1655260481081655, "ngenes": 23, "description": "CREB1 phosphorylation through the activation of Adenylate Cyclase", "id": "716aee63-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-442729", "value": 0.97476199387356, "ngenes": 23, "description": "CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde", "id": "716aee64-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-442742", "value": 0.6084982973503572, "ngenes": 64, "description": "CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling", "id": "716aee65-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-442982", "value": 0.6949750387077899, "ngenes": 38, "description": "Ras activation upon Ca2+ influx through NMDA receptor", "id": "716aee66-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444257", "value": 0.24960810533117772, "ngenes": 22, "description": "RSK activation", "id": "716aee67-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9619229", "value": 0.7347562045131799, "ngenes": 14, "description": "Activation of RAC1 downstream of NMDARs", "id": "716aee68-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9619483", "value": 0.055169294981411474, "ngenes": 40, "description": "Activation of AMPK downstream of NMDARs", "id": "716aee69-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9620244", "value": 0.6345597075407005, "ngenes": 47, "description": "Long-term potentiation", "id": "716aee6a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9609736", "value": 0.37887630892770696, "ngenes": 68, "description": "Assembly and cell surface presentation of NMDA receptors", "id": "716aee6b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9617324", "value": 0.46276647000992366, "ngenes": 40, "description": "Negative regulation of NMDA receptor-mediated neuronal transmission", "id": "716aee6c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-451326", "value": 0.40849522621170387, "ngenes": 46, "description": "Activation of kainate receptors upon glutamate binding", "id": "716aee6d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-451306", "value": 0.33534221780851486, "ngenes": 20, "description": "Ionotropic activity of kainate receptors", "id": "716aee6e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-451307", "value": 0.191844675793726, "ngenes": 7, "description": "Activation of Na-permeable kainate receptors", "id": "716aee6f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-451308", "value": 0.33534221780851486, "ngenes": 20, "description": "Activation of Ca-permeable Kainate Receptor", "id": "716aee70-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-500657", "value": 0.30057555648381573, "ngenes": 28, "description": "Presynaptic function of Kainate receptors", "id": "716aee71-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-181431", "value": 0.5703496275689125, "ngenes": 21, "description": "Acetylcholine binding and downstream events", "id": "716aee72-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-622323", "value": 0.45557617332056405, "ngenes": 15, "description": "Presynaptic nicotinic acetylcholine receptors", "id": "716aee73-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-629587", "value": 0.9099295685519893, "ngenes": 7, "description": "Highly sodium permeable postsynaptic acetylcholine nicotinic receptors", "id": "716aee74-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-629597", "value": 0.4634865775882911, "ngenes": 12, "description": "Highly calcium permeable nicotinic acetylcholine receptors", "id": "716aee75-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-622327", "value": 0.5703496275689125, "ngenes": 21, "description": "Postsynaptic nicotinic acetylcholine receptors", "id": "716aee76-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-629587", "value": 0.9099295685519893, "ngenes": 7, "description": "Highly sodium permeable postsynaptic acetylcholine nicotinic receptors", "id": "716aee77-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-629594", "value": 0.5753981684607465, "ngenes": 18, "description": "Highly calcium permeable postsynaptic nicotinic acetylcholine receptors", "id": "716aee78-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-112310", "value": 0.8570493342571446, "ngenes": 79, "description": "Neurotransmitter release cycle", "id": "716aee79-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-181429", "value": 0.3577401359806463, "ngenes": 29, "description": "Serotonin Neurotransmitter Release Cycle", "id": "716aee7a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-181430", "value": 0.2013230289964383, "ngenes": 27, "description": "Norepinephrine Neurotransmitter Release Cycle", "id": "716aee7b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210500", "value": 0.6328301595040259, "ngenes": 31, "description": "Glutamate Neurotransmitter Release Cycle", "id": "716aee7c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-212676", "value": 0.32022994358517787, "ngenes": 36, "description": "Dopamine Neurotransmitter Release Cycle", "id": "716aee7d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-264642", "value": 0.15104600834235202, "ngenes": 27, "description": "Acetylcholine Neurotransmitter Release Cycle", "id": "716aee7e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-888590", "value": 0.9149171794384818, "ngenes": 31, "description": "GABA synthesis, release, reuptake and degradation", "id": "716aee7f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-888568", "value": 0.8101004685244003, "ngenes": 4, "description": "GABA synthesis", "id": "716aee80-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-888593", "value": 0.007469453550795344, "ngenes": 4, "description": "Reuptake of GABA", "id": "716aee81-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-916853", "value": 0.00011080059989708971, "ngenes": 5, "description": "Degradation of GABA", "id": "716aee82-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-112313", "value": 0.31695011655810135, "ngenes": 7, "description": "Neurotransmitter uptake and metabolism In glial cells", "id": "716aee83-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-210455", "value": 0.31695011655810135, "ngenes": 7, "description": "Astrocytic Glutamate-Glutamine Uptake And Metabolism", "id": "716aee84-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-112311", "value": 0.29099105574943185, "ngenes": 15, "description": "Neurotransmitter clearance", "id": "716aee85-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-379401", "value": 0.3286278429220936, "ngenes": 4, "description": "Dopamine clearance from the synaptic cleft", "id": "716aee86-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-379397", "value": 0.3286278429220936, "ngenes": 4, "description": "Enzymatic degradation of dopamine by COMT", "id": "716aee87-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-379398", "value": 0.468750042525909, "ngenes": 3, "description": "Enzymatic degradation of Dopamine by monoamine oxidase", "id": "716aee88-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-380615", "value": 0.5541124339543797, "ngenes": 4, "description": "Serotonin clearance from the synaptic cleft", "id": "716aee89-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1296071", "value": 0.7289396388774505, "ngenes": 181, "description": "Potassium Channels", "id": "716aee8a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1296065", "value": 0.7027433857399764, "ngenes": 53, "description": "Inwardly rectifying K+ channels", "id": "716aee8b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1296025", "value": 0.024075654878620376, "ngenes": 5, "description": "ATP sensitive Potassium channels", "id": "716aee8c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296059", "value": 0.41147580749515345, "ngenes": 42, "description": "G protein gated Potassium channels", "id": "716aee8d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1296041", "value": 0.41147580749515345, "ngenes": 42, "description": "Activation of G protein gated Potassium channels", "id": "716aee8e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1296053", "value": 0.3056236055452598, "ngenes": 7, "description": "Classical Kir channels", "id": "716aee8f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296067", "value": 0.9985759109710206, "ngenes": 6, "description": "Potassium transport channels", "id": "716aee90-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1296052", "value": 0.37549011001155547, "ngenes": 18, "description": "Ca2+ activated K+ channels", "id": "716aee91-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296061", "value": 0.32903342513790956, "ngenes": 5, "description": "HCN channels", "id": "716aee92-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296072", "value": 0.9774897473314653, "ngenes": 81, "description": "Voltage gated Potassium channels", "id": "716aee93-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296346", "value": 0.017698471296031835, "ngenes": 24, "description": "Tandem pore domain potassium channels", "id": "716aee94-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1299308", "value": 0.08161862671404954, "ngenes": 6, "description": "Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)", "id": "716aee95-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1299503", "value": 0.046199443510615404, "ngenes": 12, "description": "TWIK related potassium channel (TREK)", "id": "716aee96-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-6794362", "value": 0.01956592979592086, "ngenes": 159, "description": "Protein-protein interactions at synapses", "id": "716aee97-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-388844", "value": 0.31330737074318804, "ngenes": 38, "description": "Receptor-type tyrosine-protein phosphatases", "id": "716aee98-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6794361", "value": 0.042478668181941674, "ngenes": 103, "description": "Neurexins and neuroligins", "id": "716aee99-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849932", "value": 0.7884072105342698, "ngenes": 39, "description": "Synaptic adhesion-like molecules", "id": "716aee9a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-74160", "value": 0.08479275845836448, "ngenes": 2475, "description": "Gene expression (Transcription)", "id": "716aee9b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73857", "value": 0.09501863737308526, "ngenes": 2246, "description": "RNA Polymerase II Transcription", "id": "716aee9c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75955", "value": 0.11777218870458916, "ngenes": 88, "description": "RNA Polymerase II Transcription Elongation", "id": "716aee9d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112382", "value": 0.11777218870458916, "ngenes": 88, "description": "Formation of RNA Pol II elongation complex ", "id": "716aee9e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-113418", "value": 0.1423152533084256, "ngenes": 52, "description": "Formation of the Early Elongation Complex", "id": "716aee9f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-212436", "value": 0.09657838865417234, "ngenes": 2054, "description": "Generic Transcription Pathway", "id": "716aeea0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2032785", "value": 0.3669517997155557, "ngenes": 27, "description": "YAP1- and WWTR1 (TAZ)-stimulated gene expression", "id": "716aeea1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173793", "value": 0.09219611882665504, "ngenes": 83, "description": "Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer", "id": "716aeea2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173795", "value": 0.17385995892110886, "ngenes": 48, "description": "Downregulation of SMAD2/3:SMAD4 transcriptional activity", "id": "716aeea3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173796", "value": 0.06949697316721493, "ngenes": 59, "description": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription", "id": "716aeea4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-350054", "value": 0.37534576151653687, "ngenes": 46, "description": "Notch-HLH transcription pathway", "id": "716aeea5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-383280", "value": 0.7191844659971434, "ngenes": 107, "description": "Nuclear Receptor transcription pathway", "id": "716aeea6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3700989", "value": 0.04875125383778436, "ngenes": 652, "description": "Transcriptional Regulation by TP53", "id": "716aeea7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5628897", "value": 0.07324039944630467, "ngenes": 129, "description": "TP53 Regulates Metabolic Genes", "id": "716aeea8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6796648", "value": 0.04216998412170033, "ngenes": 107, "description": "TP53 Regulates Transcription of DNA Repair Genes", "id": "716aeea9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5633008", "value": 0.09219611882665504, "ngenes": 86, "description": "TP53 Regulates Transcription of Cell Death Genes", "id": "716aeeaa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6803204", "value": 0.30565426025203696, "ngenes": 39, "description": "TP53 Regulates Transcription of Genes Involved in Cytochrome C Release", "id": "716aeeab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803205", "value": 0.09480799100842513, "ngenes": 24, "description": "TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain", "id": "716aeeac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803207", "value": 0.14462859621967175, "ngenes": 25, "description": "TP53 Regulates Transcription of Caspase Activators and Caspases", "id": "716aeead-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803211", "value": 0.30565426025203696, "ngenes": 17, "description": "TP53 Regulates Transcription of Death Receptors and Ligands", "id": "716aeeae-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6791312", "value": 0.8019639163432887, "ngenes": 84, "description": "TP53 Regulates Transcription of Cell Cycle Genes", "id": "716aeeaf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6804114", "value": 0.7191844659971434, "ngenes": 31, "description": "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest", "id": "716aeeb0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804115", "value": 0.03622112250874287, "ngenes": 35, "description": "TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain", "id": "716aeeb1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804116", "value": 0.5186239378507668, "ngenes": 24, "description": "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest", "id": "716aeeb2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5633007", "value": 0.0594537139956224, "ngenes": 314, "description": "Regulation of TP53 Activity", "id": "716aeeb3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6806003", "value": 0.02888885624133474, "ngenes": 91, "description": "Regulation of TP53 Expression and Degradation", "id": "716aeeb4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6804754", "value": 0.8636052042095431, "ngenes": 5, "description": "Regulation of TP53 Expression", "id": "716aeeb5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804757", "value": 0.027433904885968752, "ngenes": 87, "description": "Regulation of TP53 Degradation", "id": "716aeeb6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6804756", "value": 0.2627261527178871, "ngenes": 171, "description": "Regulation of TP53 Activity through Phosphorylation", "id": "716aeeb7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804759", "value": 0.0025381240714288794, "ngenes": 23, "description": "Regulation of TP53 Activity through Association with Co-factors", "id": "716aeeb8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804760", "value": 0.10404356720284604, "ngenes": 40, "description": "Regulation of TP53 Activity through Methylation", "id": "716aeeb9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804758", "value": 0.047224016530099736, "ngenes": 58, "description": "Regulation of TP53 Activity through Acetylation", "id": "716aeeba-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6811555", "value": 0.2018312088141814, "ngenes": 13, "description": "PI5P Regulates TP53 Acetylation", "id": "716aeebb-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-8853884", "value": 0.15961833247705798, "ngenes": 77, "description": "Transcriptional Regulation by VENTX", "id": "716aeebc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8864260", "value": 0.10975423641214238, "ngenes": 71, "description": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors", "id": "716aeebd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866904", "value": 0.8978764811258031, "ngenes": 22, "description": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors", "id": "716aeebe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866906", "value": 0.6887378651198116, "ngenes": 11, "description": "TFAP2 (AP-2) family regulates transcription of other transcription factors", "id": "716aeebf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866907", "value": 0.8572185123996907, "ngenes": 21, "description": "Activation of the TFAP2 (AP-2) family of transcription factors", "id": "716aeec0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866910", "value": 0.49085015866978793, "ngenes": 29, "description": "TFAP2 (AP-2) family regulates transcription of growth factors and their receptors", "id": "716aeec1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866911", "value": 0.4232423495283154, "ngenes": 11, "description": "TFAP2 (AP-2) family regulates transcription of cell cycle factors", "id": "716aeec2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8869496", "value": 0.6336724938716827, "ngenes": 14, "description": "TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation", "id": "716aeec3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8878171", "value": 0.4278596927396901, "ngenes": 387, "description": "Transcriptional regulation by RUNX1", "id": "716aeec4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8877330", "value": 0.34923890893417403, "ngenes": 21, "description": "RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)", "id": "716aeec5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8931987", "value": 0.9327530006123662, "ngenes": 12, "description": "RUNX1 regulates estrogen receptor mediated transcription", "id": "716aeec6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8934593", "value": 0.2131081998422232, "ngenes": 38, "description": "Regulation of RUNX1 Expression and Activity", "id": "716aeec7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8935964", "value": 0.23726346596898132, "ngenes": 12, "description": "RUNX1 regulates expression of components of tight junctions", "id": "716aeec8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8936459", "value": 0.8618947340062005, "ngenes": 135, "description": "RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function", "id": "716aeec9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939236", "value": 0.6578225965184719, "ngenes": 182, "description": "RUNX1 regulates transcription of genes involved in differentiation of HSCs", "id": "716aeeca-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939242", "value": 0.9788666536950346, "ngenes": 15, "description": "RUNX1 regulates transcription of genes involved in differentiation of keratinocytes", "id": "716aeecb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939243", "value": 0.8656251799217087, "ngenes": 74, "description": "RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known", "id": "716aeecc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939245", "value": 0.4213112267409292, "ngenes": 11, "description": "RUNX1 regulates transcription of genes involved in BCR signaling", "id": "716aeecd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939246", "value": 0.42399869283281466, "ngenes": 16, "description": "RUNX1 regulates transcription of genes involved in differentiation of myeloid cells", "id": "716aeece-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939247", "value": 0.3496654163593763, "ngenes": 8, "description": "RUNX1 regulates transcription of genes involved in interleukin signaling", "id": "716aeecf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939256", "value": 0.8565922999008526, "ngenes": 10, "description": "RUNX1 regulates transcription of genes involved in WNT signaling", "id": "716aeed0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8878166", "value": 0.12721138533759097, "ngenes": 201, "description": "Transcriptional regulation by RUNX2", "id": "716aeed1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8939902", "value": 0.2499813394440606, "ngenes": 129, "description": "Regulation of RUNX2 expression and activity", "id": "716aeed2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941326", "value": 0.16019450751458392, "ngenes": 46, "description": "RUNX2 regulates bone development", "id": "716aeed3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8940973", "value": 0.1807243232561564, "ngenes": 38, "description": "RUNX2 regulates osteoblast differentiation", "id": "716aeed4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941284", "value": 0.7202442219959402, "ngenes": 8, "description": "RUNX2 regulates chondrocyte maturation", "id": "716aeed5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8941332", "value": 0.03167752340066155, "ngenes": 16, "description": "RUNX2 regulates genes involved in cell migration", "id": "716aeed6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941333", "value": 0.3930343960142252, "ngenes": 10, "description": "RUNX2 regulates genes involved in differentiation of myeloid cells", "id": "716aeed7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8878159", "value": 0.16827886272597348, "ngenes": 176, "description": "Transcriptional regulation by RUNX3", "id": "716aeed8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8941855", "value": 5.369021162270391e-05, "ngenes": 10, "description": "RUNX3 regulates CDKN1A transcription", "id": "716aeed9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941856", "value": 0.9010183567915067, "ngenes": 19, "description": "RUNX3 regulates NOTCH signaling", "id": "716aeeda-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941858", "value": 0.24760791804928345, "ngenes": 102, "description": "Regulation of RUNX3 expression and activity", "id": "716aeedb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8949275", "value": 0.7314404707984932, "ngenes": 12, "description": "RUNX3 Regulates Immune Response and Cell Migration", "id": "716aeedc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951430", "value": 0.07860580228445357, "ngenes": 21, "description": "RUNX3 regulates WNT signaling", "id": "716aeedd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951671", "value": 0.7319741838888478, "ngenes": 12, "description": "RUNX3 regulates YAP1-mediated transcription", "id": "716aeede-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951911", "value": 0.30719159924024425, "ngenes": 7, "description": "RUNX3 regulates RUNX1-mediated transcription", "id": "716aeedf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951936", "value": 0.042478668181941674, "ngenes": 17, "description": "RUNX3 regulates p14-ARF", "id": "716aeee0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8952158", "value": 0.1807243232561564, "ngenes": 11, "description": "RUNX3 regulates BCL2L11 (BIM) transcription", "id": "716aeee1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8953750", "value": 0.007684557736169694, "ngenes": 69, "description": "Transcriptional Regulation by E2F6", "id": "716aeee2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8986944", "value": 0.7222875745548956, "ngenes": 122, "description": "Transcriptional Regulation by MECP2", "id": "716aeee3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9022692", "value": 0.7747820596378019, "ngenes": 62, "description": "Regulation of MECP2 expression and activity", "id": "716aeee4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022699", "value": 0.11344440955684568, "ngenes": 30, "description": "MECP2 regulates neuronal receptors and channels", "id": "716aeee5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022702", "value": 0.10344965165026217, "ngenes": 18, "description": "MECP2 regulates transcription of neuronal ligands", "id": "716aeee6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022707", "value": 0.08670163058043681, "ngenes": 15, "description": "MECP2 regulates transcription factors", "id": "716aeee7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022927", "value": 0.7657138914490477, "ngenes": 6, "description": "MECP2 regulates transcription of genes involved in GABA signaling", "id": "716aeee8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9614085", "value": 0.07661561155969829, "ngenes": 110, "description": "FOXO-mediated transcription", "id": "716aeee9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9614399", "value": 0.055169294981411474, "ngenes": 22, "description": "Regulation of localization of FOXO transcription factors", "id": "716c12ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9614657", "value": 0.3780448701644226, "ngenes": 23, "description": "FOXO-mediated transcription of cell death genes", "id": "716c12ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9615017", "value": 0.23887090758705487, "ngenes": 52, "description": "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes", "id": "716c12ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9617629", "value": 0.705766976117149, "ngenes": 15, "description": "Regulation of FOXO transcriptional activity by acetylation", "id": "716c12af-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9617828", "value": 0.12721138533759097, "ngenes": 31, "description": "FOXO-mediated transcription of cell cycle genes", "id": "716c12b0-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-674695", "value": 0.12013537038193475, "ngenes": 117, "description": "RNA Polymerase II Pre-transcription Events", "id": "716c12b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807505", "value": 0.13271067227571115, "ngenes": 106, "description": "RNA polymerase II transcribes snRNA genes", "id": "716c12b2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76042", "value": 0.1655260481081655, "ngenes": 64, "description": "RNA Polymerase II Transcription Initiation And Promoter Clearance", "id": "716c12b3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73776", "value": 0.1655260481081655, "ngenes": 64, "description": "RNA Polymerase II Promoter Escape", "id": "716c12b4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75953", "value": 0.1655260481081655, "ngenes": 64, "description": "RNA Polymerase II Transcription Initiation", "id": "716c12b5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73779", "value": 0.1655260481081655, "ngenes": 64, "description": "RNA Polymerase II Transcription Pre-Initiation And Promoter Opening", "id": "716c12b6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73856", "value": 0.06525056324868748, "ngenes": 114, "description": "RNA Polymerase II Transcription Termination", "id": "716c12b7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77075", "value": 0.18905048243690628, "ngenes": 38, "description": "RNA Pol II CTD phosphorylation and interaction with CE", "id": "716c12b8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75944", "value": 0.06980941466577938, "ngenes": 6, "description": "Transcription from mitochondrial promoters", "id": "716c12b9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163282", "value": 0.07373709906444208, "ngenes": 4, "description": "Mitochondrial transcription initiation", "id": "716c12ba-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-211000", "value": 0.7143527140533982, "ngenes": 186, "description": "Gene Silencing by RNA", "id": "716c12bb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-203927", "value": 0.07342878394642192, "ngenes": 34, "description": "MicroRNA (miRNA) biogenesis", "id": "716c12bc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-426486", "value": 0.2397817177255525, "ngenes": 17, "description": "Small interfering RNA (siRNA) biogenesis", "id": "716c12bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-426496", "value": 0.9694129607641102, "ngenes": 16, "description": "Post-transcriptional silencing by small RNAs", "id": "716c12be-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5578749", "value": 0.9603055173148054, "ngenes": 135, "description": "Transcriptional regulation by small RNAs", "id": "716c12bf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5601884", "value": 0.1792094027655885, "ngenes": 39, "description": "PIWI-interacting RNA (piRNA) biogenesis", "id": "716c12c0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-212165", "value": 0.29862921047105073, "ngenes": 216, "description": "Epigenetic regulation of gene expression", "id": "716c12c1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-212300", "value": 0.7079614216129824, "ngenes": 93, "description": "PRC2 methylates histones and DNA", "id": "716c12c2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250941", "value": 0.9136134212427254, "ngenes": 151, "description": "Negative epigenetic regulation of rRNA expression", "id": "716c12c3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-427359", "value": 0.7314404707984932, "ngenes": 82, "description": "SIRT1 negatively regulates rRNA expression", "id": "716c12c4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-427413", "value": 0.9366905000603821, "ngenes": 148, "description": "NoRC negatively regulates rRNA expression", "id": "716c12c5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5250913", "value": 0.9204816451795196, "ngenes": 139, "description": "Positive epigenetic regulation of rRNA expression", "id": "716c12c6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-427389", "value": 0.745200724443715, "ngenes": 92, "description": "ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression", "id": "716c12c7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250924", "value": 0.9205519421979803, "ngenes": 116, "description": "B-WICH complex positively regulates rRNA expression", "id": "716c12c8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5221030", "value": 0.002799706126077655, "ngenes": 6, "description": "TET1,2,3 and TDG demethylate DNA", "id": "716c12c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5334118", "value": 0.6383269355901228, "ngenes": 79, "description": "DNA methylation", "id": "716c12ca-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73864", "value": 0.9221313222133508, "ngenes": 153, "description": "RNA Polymerase I Transcription", "id": "716c12cb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73854", "value": 0.9555411769511896, "ngenes": 152, "description": "RNA Polymerase I Promoter Clearance", "id": "716c12cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73728", "value": 0.6632014579925812, "ngenes": 77, "description": "RNA Polymerase I Promoter Opening", "id": "716c12cd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73762", "value": 0.1792094027655885, "ngenes": 76, "description": "RNA Polymerase I Transcription Initiation", "id": "716c12ce-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73772", "value": 0.8572185123996907, "ngenes": 122, "description": "RNA Polymerase I Promoter Escape", "id": "716c12cf-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73863", "value": 0.1797323723475155, "ngenes": 54, "description": "RNA Polymerase I Transcription Termination", "id": "716c12d0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-74158", "value": 0.035253484889292405, "ngenes": 61, "description": "RNA Polymerase III Transcription", "id": "716c12d1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73780", "value": 0.5530902022338174, "ngenes": 23, "description": "RNA Polymerase III Chain Elongation", "id": "716c12d2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73980", "value": 0.03333898376158171, "ngenes": 35, "description": "RNA Polymerase III Transcription Termination", "id": "716c12d3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-749476", "value": 0.035253484889292405, "ngenes": 61, "description": "RNA Polymerase III Abortive And Retractive Initiation", "id": "716c12d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76046", "value": 0.03353723961526887, "ngenes": 49, "description": "RNA Polymerase III Transcription Initiation", "id": "716c12d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-76061", "value": 0.8886511349556971, "ngenes": 38, "description": "RNA Polymerase III Transcription Initiation From Type 1 Promoter", "id": "716c12d6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76066", "value": 0.8354334697861959, "ngenes": 37, "description": "RNA Polymerase III Transcription Initiation From Type 2 Promoter", "id": "716c12d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76071", "value": 0.038533459227377984, "ngenes": 36, "description": "RNA Polymerase III Transcription Initiation From Type 3 Promoter", "id": "716c12d8-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-1640170", "value": 0.8724822540138668, "ngenes": 1161, "description": "Cell Cycle", "id": "716c12d9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69278", "value": 0.8395289871268451, "ngenes": 907, "description": "Cell Cycle, Mitotic", "id": "716c12da-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-453279", "value": 0.09219611882665504, "ngenes": 258, "description": "Mitotic G1 phase and G1/S transition", "id": "716c12db-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69206", "value": 0.1040506828516798, "ngenes": 222, "description": "G1/S Transition", "id": "716c12dc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-113510", "value": 0.05222886760524688, "ngenes": 39, "description": "E2F mediated regulation of DNA replication", "id": "716c12dd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-113501", "value": 0.08161862671404954, "ngenes": 24, "description": "Inhibition of replication initiation of damaged DNA by RB1/E2F1", "id": "716c12de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-113507", "value": 0.5186219464486044, "ngenes": 15, "description": "E2F-enabled inhibition of pre-replication complex formation", "id": "716c12df-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69202", "value": 0.10354851918892131, "ngenes": 146, "description": "Cyclin E associated events during G1/S transition ", "id": "716c12e0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187577", "value": 0.20049686874408543, "ngenes": 109, "description": "SCF(Skp2)-mediated degradation of p27/p21", "id": "716c12e1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69200", "value": 0.26748248334966235, "ngenes": 9, "description": "Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes", "id": "716c12e2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68962", "value": 0.322964685665524, "ngenes": 47, "description": "Activation of the pre-replicative complex", "id": "716c12e3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69205", "value": 0.46537101480891696, "ngenes": 43, "description": "G1/S-Specific Transcription", "id": "716c12e4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1538133", "value": 0.035253484889292405, "ngenes": 49, "description": "G0 and Early G1", "id": "716c12e5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1362277", "value": 0.015513662319995954, "ngenes": 30, "description": "Transcription of E2F targets under negative control by DREAM complex", "id": "716c12e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1362300", "value": 0.07072760875934536, "ngenes": 20, "description": "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1", "id": "716c12e7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69236", "value": 0.04341555259176416, "ngenes": 87, "description": "G1 Phase", "id": "716c12e8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69231", "value": 0.04341555259176416, "ngenes": 87, "description": "Cyclin D associated events in G1", "id": "716c12e9-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-453276", "value": 0.7484326852612023, "ngenes": 161, "description": "Regulation of mitotic cell cycle", "id": "716c12ea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174143", "value": 0.7484326852612023, "ngenes": 161, "description": "APC/C-mediated degradation of cell cycle proteins", "id": "716c12eb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176408", "value": 0.4211922441995311, "ngenes": 144, "description": "Regulation of APC/C activators between G1/S and early anaphase", "id": "716c12ec-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141405", "value": 0.38113247736459027, "ngenes": 41, "description": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components", "id": "716c12ed-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141430", "value": 0.38113247736459027, "ngenes": 41, "description": "Inactivation of APC/C via direct inhibition of the APC/C complex", "id": "716c12ee-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-174113", "value": 0.3123437336578039, "ngenes": 96, "description": "SCF-beta-TrCP mediated degradation of Emi1", "id": "716c12ef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-176417", "value": 0.06179051941079923, "ngenes": 8, "description": "Phosphorylation of Emi1", "id": "716c12f0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-176814", "value": 0.5672045315875678, "ngenes": 137, "description": "Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins", "id": "716c12f1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176409", "value": 0.5275723678547117, "ngenes": 136, "description": "APC/C:Cdc20 mediated degradation of mitotic proteins", "id": "716c12f2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174048", "value": 0.12721138533759097, "ngenes": 46, "description": "APC/C:Cdc20 mediated degradation of Cyclin B", "id": "716c12f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174154", "value": 0.37051080294822014, "ngenes": 122, "description": "APC/C:Cdc20 mediated degradation of Securin", "id": "716c12f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-179419", "value": 0.3868129729383569, "ngenes": 133, "description": "APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint", "id": "716c12f5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174184", "value": 0.37582395900431764, "ngenes": 131, "description": "Cdc20:Phospho-APC/C mediated degradation of Cyclin A", "id": "716c12f6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-179409", "value": 0.6903362689910377, "ngenes": 52, "description": "APC-Cdc20 mediated degradation of Nek2A", "id": "716c12f7-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-176412", "value": 0.08296202590391369, "ngenes": 37, "description": "Phosphorylation of the APC/C", "id": "716c12f8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-174084", "value": 0.30057555648381573, "ngenes": 117, "description": "Autodegradation of Cdh1 by Cdh1:APC/C", "id": "716c12f9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174178", "value": 0.5375225104698272, "ngenes": 131, "description": "APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1", "id": "716c12fa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-176407", "value": 0.0003226104894618999, "ngenes": 41, "description": "Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase", "id": "716c12fb-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-453274", "value": 0.18117816450617322, "ngenes": 317, "description": "Mitotic G2-G2/M phases", "id": "716c12fc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69275", "value": 0.18210113444586062, "ngenes": 315, "description": "G2/M Transition", "id": "716c12fd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156711", "value": 0.01956592979592086, "ngenes": 22, "description": "Polo-like kinase mediated events", "id": "716c12fe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69273", "value": 0.01956592979592086, "ngenes": 43, "description": "Cyclin A/B1/B2 associated events during G2/M transition", "id": "716c12ff-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170145", "value": 0.6762751219692819, "ngenes": 4, "description": "Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes", "id": "716c1300-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2565942", "value": 0.028678592139156807, "ngenes": 142, "description": "Regulation of PLK1 Activity at G2/M Transition", "id": "716c1301-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380287", "value": 0.06980941466577938, "ngenes": 130, "description": "Centrosome maturation", "id": "716c1302-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380284", "value": 0.037126356197780395, "ngenes": 109, "description": "Loss of proteins required for interphase microtubule organization from the centrosome", "id": "716c1303-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380259", "value": 0.037126356197780395, "ngenes": 109, "description": "Loss of Nlp from mitotic centrosomes", "id": "716c1304-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-380270", "value": 0.06980941466577938, "ngenes": 130, "description": "Recruitment of mitotic centrosome proteins and complexes", "id": "716c1305-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8852276", "value": 0.47144410367122225, "ngenes": 121, "description": "The role of GTSE1 in G2/M progression after G2 checkpoint", "id": "716c1306-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854050", "value": 0.3131828135641375, "ngenes": 94, "description": "FBXL7 down-regulates AURKA during mitotic entry and in early mitosis", "id": "716c1307-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854518", "value": 0.012056487379485342, "ngenes": 114, "description": "AURKA Activation by TPX2", "id": "716c1308-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854521", "value": 4.840344389421222e-05, "ngenes": 3, "description": "Interaction between PHLDA1 and AURKA", "id": "716c1309-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68911", "value": 0.41147580749515345, "ngenes": 6, "description": "G2 Phase", "id": "716c130a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68886", "value": 0.6719994439128143, "ngenes": 664, "description": "M Phase", "id": "716c130b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68875", "value": 0.5347233122540755, "ngenes": 203, "description": "Mitotic Prophase", "id": "716c130c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162658", "value": 0.913055343521628, "ngenes": 20, "description": "Golgi Cisternae Pericentriolar Stack Reorganization", "id": "716c130d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2299718", "value": 0.6396887297635051, "ngenes": 90, "description": "Condensation of Prophase Chromosomes", "id": "716c130e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2465910", "value": 0.09811407950169769, "ngenes": 22, "description": "MASTL Facilitates Mitotic Progression", "id": "716c130f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2980766", "value": 0.23726346596898132, "ngenes": 81, "description": "Nuclear Envelope Breakdown", "id": "716c1310-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2980767", "value": 0.15020671530343088, "ngenes": 9, "description": "Activation of NIMA Kinases NEK9, NEK6, NEK7", "id": "716c1311-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3301854", "value": 0.10338673641081263, "ngenes": 55, "description": "Nuclear Pore Complex (NPC) Disassembly", "id": "716c1312-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4419969", "value": 0.9255427833653975, "ngenes": 24, "description": "Depolymerisation of the Nuclear Lamina", "id": "716c1313-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2555396", "value": 0.8987241990955358, "ngenes": 396, "description": "Mitotic Metaphase and Anaphase", "id": "716c1314-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68882", "value": 0.9341260046487088, "ngenes": 394, "description": "Mitotic Anaphase", "id": "716c1315-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2467813", "value": 0.5018074816161089, "ngenes": 308, "description": "Separation of Sister Chromatids", "id": "716c1316-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2995410", "value": 0.16051528739706003, "ngenes": 128, "description": "Nuclear Envelope (NE) Reassembly", "id": "716c1317-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2995383", "value": 0.8526477727205065, "ngenes": 37, "description": "Initiation of Nuclear Envelope (NE) Reformation", "id": "716c1318-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9615933", "value": 0.058106145339246684, "ngenes": 49, "description": "Postmitotic nuclear pore complex (NPC) reformation", "id": "716c1319-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9668328", "value": 0.2744947037358761, "ngenes": 44, "description": "Sealing of the nuclear envelope (NE) by ESCRT-III", "id": "716c131a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-68881", "value": 0.04892218509660346, "ngenes": 3, "description": "Mitotic Metaphase/Anaphase Transition", "id": "716c131b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68884", "value": 0.9283131377503262, "ngenes": 22, "description": "Mitotic Telophase/Cytokinesis", "id": "716c131c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2470946", "value": 0.09219611882665504, "ngenes": 18, "description": "Cohesin Loading onto Chromatin", "id": "716c131d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68877", "value": 0.09961856503478693, "ngenes": 321, "description": "Mitotic Prometaphase", "id": "716c131e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2500257", "value": 0.08256565189037975, "ngenes": 190, "description": "Resolution of Sister Chromatid Cohesion", "id": "716c131f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2514853", "value": 0.10503612693605015, "ngenes": 20, "description": "Condensation of Prometaphase Chromosomes", "id": "716c1320-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380320", "value": 0.11475312669900828, "ngenes": 145, "description": "Recruitment of NuMA to mitotic centrosomes", "id": "716c1321-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9648025", "value": 0.06440264800765468, "ngenes": 175, "description": "EML4 and NUDC in mitotic spindle formation", "id": "716c1322-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-69242", "value": 0.10938598871557997, "ngenes": 273, "description": "S Phase", "id": "716c1323-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69239", "value": 0.23774361745488784, "ngenes": 206, "description": "Synthesis of DNA", "id": "716c1324-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69190", "value": 0.32291125960226097, "ngenes": 54, "description": "DNA strand elongation", "id": "716c1325-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176974", "value": 0.8320022427326571, "ngenes": 18, "description": "Unwinding of DNA", "id": "716c1326-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69109", "value": 0.035253484889292405, "ngenes": 28, "description": "Leading Strand Synthesis", "id": "716c1327-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.035253484889292405, "ngenes": 28, "description": "Polymerase switching", "id": "716c1328-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69186", "value": 0.07626043712953795, "ngenes": 36, "description": "Lagging Strand Synthesis", "id": "716c1329-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.035253484889292405, "ngenes": 28, "description": "Polymerase switching", "id": "716c132a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69183", "value": 0.36408899812871554, "ngenes": 24, "description": "Processive synthesis on the lagging strand", "id": "716c132b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69166", "value": 0.155870532999355, "ngenes": 23, "description": "Removal of the Flap Intermediate", "id": "716c132c-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-69052", "value": 0.3025000117972867, "ngenes": 161, "description": "Switching of origins to a post-replicative state", "id": "716c132d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68949", "value": 0.18452742839407488, "ngenes": 121, "description": "Orc1 removal from chromatin", "id": "716c132e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69017", "value": 0.32750948516334544, "ngenes": 131, "description": "CDK-mediated phosphorylation and removal of Cdc6", "id": "716c132f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68952", "value": 0.12223851496961394, "ngenes": 11, "description": "DNA replication initiation", "id": "716c1330-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69656", "value": 0.10404356720284604, "ngenes": 149, "description": "Cyclin A:Cdk2-associated events at S phase entry", "id": "716c1331-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187577", "value": 0.20049686874408543, "ngenes": 109, "description": "SCF(Skp2)-mediated degradation of p27/p21", "id": "716c1332-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2468052", "value": 0.091596951382805, "ngenes": 17, "description": "Establishment of Sister Chromatid Cohesion", "id": "716c1333-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75815", "value": 0.2432662517816353, "ngenes": 89, "description": "Ubiquitin-dependent degradation of Cyclin D", "id": "716c1334-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1500620", "value": 0.9267689217685907, "ngenes": 189, "description": "Meiosis", "id": "716c1335-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1221632", "value": 0.778548354761792, "ngenes": 117, "description": "Meiotic synapsis", "id": "716c1336-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912446", "value": 0.930540635367851, "ngenes": 126, "description": "Meiotic recombination", "id": "716c1337-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69620", "value": 0.786700270596591, "ngenes": 493, "description": "Cell Cycle Checkpoints", "id": "716c1338-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69618", "value": 0.04861235324053456, "ngenes": 181, "description": "Mitotic Spindle Checkpoint", "id": "716c1339-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141405", "value": 0.38113247736459027, "ngenes": 41, "description": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components", "id": "716c133a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141430", "value": 0.38113247736459027, "ngenes": 41, "description": "Inactivation of APC/C via direct inhibition of the APC/C complex", "id": "716c133b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-141424", "value": 0.08870499993854414, "ngenes": 148, "description": "Amplification of signal from the kinetochores", "id": "716c133c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141444", "value": 0.08870499993854414, "ngenes": 148, "description": "Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal", "id": "716c133d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-69481", "value": 0.2750176731055966, "ngenes": 283, "description": "G2/M Checkpoints", "id": "716c133e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176187", "value": 0.25560762321102537, "ngenes": 69, "description": "Activation of ATR in response to replication stress", "id": "716c133f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69478", "value": 0.02646815606877149, "ngenes": 7, "description": "G2/M DNA replication checkpoint", "id": "716c1340-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69473", "value": 0.335684275779116, "ngenes": 160, "description": "G2/M DNA damage checkpoint", "id": "716c1341-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75035", "value": 0.778548354761792, "ngenes": 22, "description": "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex", "id": "716c1342-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-69615", "value": 0.16019450751458392, "ngenes": 128, "description": "G1/S DNA Damage Checkpoints", "id": "716c1343-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69580", "value": 0.1651953716763447, "ngenes": 125, "description": "p53-Dependent G1/S DNA damage checkpoint", "id": "716c1344-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69563", "value": 0.1651953716763447, "ngenes": 125, "description": "p53-Dependent G1 DNA Damage Response", "id": "716c1345-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69541", "value": 0.18846217415371763, "ngenes": 106, "description": "Stabilization of p53", "id": "716c1346-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-349425", "value": 0.25945780556828607, "ngenes": 94, "description": "Autodegradation of the E3 ubiquitin ligase COP1", "id": "716c1347-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69560", "value": 0.07249273226070745, "ngenes": 8, "description": "Transcriptional activation of p53 responsive genes  ", "id": "716c1348-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69895", "value": 0.07249273226070745, "ngenes": 8, "description": "Transcriptional  activation of  cell cycle inhibitor p21 ", "id": "716c1349-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-69613", "value": 0.24671560242464718, "ngenes": 92, "description": "p53-Independent G1/S DNA damage checkpoint", "id": "716c134a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69610", "value": 0.24671560242464718, "ngenes": 92, "description": "p53-Independent DNA Damage Response", "id": "716c134b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69601", "value": 0.24671560242464718, "ngenes": 92, "description": "Ubiquitin Mediated Degradation of Phosphorylated Cdc25A", "id": "716c134c-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-73886", "value": 0.7259083233406297, "ngenes": 202, "description": "Chromosome Maintenance", "id": "716c134d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-157579", "value": 0.4488915425359903, "ngenes": 161, "description": "Telomere Maintenance", "id": "716c134e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-171306", "value": 0.705766976117149, "ngenes": 58, "description": "Packaging Of Telomere Ends", "id": "716c134f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180786", "value": 0.09480799100842513, "ngenes": 86, "description": "Extension of Telomeres", "id": "716c1350-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-171319", "value": 0.19165414355869898, "ngenes": 39, "description": "Telomere Extension By Telomerase", "id": "716c1351-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174417", "value": 0.07373709906444208, "ngenes": 55, "description": "Telomere C-strand (Lagging Strand) Synthesis", "id": "716c1352-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174411", "value": 0.04861235324053456, "ngenes": 45, "description": "Polymerase switching on the C-strand of the telomere", "id": "716c1353-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174430", "value": 0.30057555648381573, "ngenes": 19, "description": "Telomere C-strand synthesis initiation", "id": "716c1354-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174414", "value": 0.04216998412170033, "ngenes": 27, "description": "Processive synthesis on the C-strand of the telomere", "id": "716c1355-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174437", "value": 0.03333898376158171, "ngenes": 25, "description": "Removal of the Flap Intermediate from the C-strand", "id": "716c1356-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9670095", "value": 0.7771617468984144, "ngenes": 83, "description": "Inhibition of DNA recombination at telomere", "id": "716c1357-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-774815", "value": 0.661335104045452, "ngenes": 94, "description": "Nucleosome assembly", "id": "716c1358-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-606279", "value": 0.661335104045452, "ngenes": 94, "description": "Deposition of new CENPA-containing nucleosomes at the centromere", "id": "716c1359-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-109582", "value": 0.6152313630035718, "ngenes": 1025, "description": "Hemostasis", "id": "716c135a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-76002", "value": 0.5718376503493853, "ngenes": 441, "description": "Platelet activation, signaling and aggregation", "id": "716c135b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-76005", "value": 0.8978764811258031, "ngenes": 218, "description": "Response to elevated platelet cytosolic Ca2+", "id": "716c135c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-114516", "value": 0.42399869283281466, "ngenes": 7, "description": "Disinhibition of SNARE formation", "id": "716c135d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-114608", "value": 0.7917294943119937, "ngenes": 211, "description": "Platelet degranulation ", "id": "716c135e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-114604", "value": 1.0, "ngenes": 75, "description": "GPVI-mediated activation cascade", "id": "716c135f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76009", "value": 0.028678592139156807, "ngenes": 65, "description": "Platelet Aggregation (Plug Formation)", "id": "716c1360-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-354192", "value": 0.0009734218695103252, "ngenes": 55, "description": "Integrin signaling", "id": "716c1361-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-354194", "value": 0.007950428030311853, "ngenes": 29, "description": "GRB2:SOS provides linkage to MAPK signaling for Integrins ", "id": "716c1362-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-372708", "value": 0.0033249014799327436, "ngenes": 30, "description": "p130Cas linkage to MAPK signaling for integrins", "id": "716c1363-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392023", "value": 0.04662188404779444, "ngenes": 3, "description": "Adrenaline signalling through Alpha-2 adrenergic receptor", "id": "716c1364-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392518", "value": 0.2552869492378058, "ngenes": 48, "description": "Signal amplification", "id": "716c1365-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-392170", "value": 0.35265833466820323, "ngenes": 28, "description": "ADP signalling through P2Y purinoceptor 12", "id": "716c1366-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418592", "value": 0.2504539143527474, "ngenes": 36, "description": "ADP signalling through P2Y purinoceptor 1", "id": "716c1367-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428930", "value": 0.3220442773315056, "ngenes": 33, "description": "Thromboxane signalling through TP receptor", "id": "716c1368-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-114508", "value": 0.5856668610407034, "ngenes": 49, "description": "Effects of PIP2 hydrolysis", "id": "716c1369-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-426048", "value": 0.40071333678837345, "ngenes": 10, "description": "Arachidonate production from DAG", "id": "716c136a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-430116", "value": 0.037126356197780395, "ngenes": 19, "description": "GP1b-IX-V activation signalling", "id": "716c136b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-456926", "value": 0.2627261527178871, "ngenes": 49, "description": "Thrombin signalling through proteinase activated receptors (PARs)", "id": "716c136c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-418346", "value": 0.06364182080681376, "ngenes": 161, "description": "Platelet homeostasis", "id": "716c136d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-418360", "value": 0.09657838865417234, "ngenes": 53, "description": "Platelet calcium homeostasis", "id": "716c136e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-139853", "value": 0.4235858087437095, "ngenes": 21, "description": "Elevation of cytosolic Ca2+ levels", "id": "716c136f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418359", "value": 0.09939770088346835, "ngenes": 32, "description": "Reduction of cytosolic Ca++ levels", "id": "716c1370-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392851", "value": 0.25409736888038054, "ngenes": 26, "description": "Prostacyclin signalling through prostacyclin receptor", "id": "716c1371-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-392154", "value": 0.36458683492270577, "ngenes": 48, "description": "Nitric oxide stimulates guanylate cyclase", "id": "716c1372-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-418457", "value": 0.671405043535478, "ngenes": 38, "description": "cGMP effects", "id": "716c1373-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-432142", "value": 0.07571005029484179, "ngenes": 34, "description": "Platelet sensitization by LDL", "id": "716c1374-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-140877", "value": 0.7160670876802114, "ngenes": 54, "description": "Formation of Fibrin Clot (Clotting Cascade)", "id": "716c1375-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140834", "value": 0.40914664296745806, "ngenes": 9, "description": "Extrinsic Pathway of Fibrin Clot Formation", "id": "716c1376-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-140837", "value": 0.8332732680574292, "ngenes": 27, "description": "Intrinsic Pathway of Fibrin Clot Formation", "id": "716c1377-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-140875", "value": 0.003938258790431, "ngenes": 31, "description": "Common Pathway of Fibrin Clot Formation", "id": "716c1378-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-202733", "value": 0.8693787557146361, "ngenes": 245, "description": "Cell surface interactions at the vascular wall", "id": "716c1379-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-210990", "value": 0.7449226606453779, "ngenes": 22, "description": "PECAM1 interactions", "id": "716c137a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210991", "value": 0.3403527751880636, "ngenes": 50, "description": "Basigin interactions", "id": "716c137b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210993", "value": 0.02431646515081946, "ngenes": 35, "description": "Tie2 Signaling", "id": "716c137c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75205", "value": 0.42227802938598946, "ngenes": 23, "description": "Dissolution of Fibrin Clot", "id": "716c137d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75892", "value": 0.07571005029484179, "ngenes": 23, "description": "Platelet Adhesion to exposed collagen", "id": "716c137e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-983231", "value": 0.016738572589010625, "ngenes": 233, "description": "Factors involved in megakaryocyte development and platelet production", "id": "716c137f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-983189", "value": 0.00031721042564327915, "ngenes": 89, "description": "Kinesins", "id": "716c1380-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1474165", "value": 0.8287994702610315, "ngenes": 221, "description": "Reproduction", "id": "716c1381-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1500620", "value": 0.9267689217685907, "ngenes": 189, "description": "Meiosis", "id": "716c1382-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1221632", "value": 0.778548354761792, "ngenes": 117, "description": "Meiotic synapsis", "id": "716c1383-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912446", "value": 0.930540635367851, "ngenes": 126, "description": "Meiotic recombination", "id": "716c1384-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1187000", "value": 0.7225100776986413, "ngenes": 32, "description": "Fertilization", "id": "716c1385-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1300642", "value": 0.25412142993057474, "ngenes": 11, "description": "Sperm Motility And Taxes", "id": "716c1386-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1300645", "value": 0.4104577232688403, "ngenes": 7, "description": "Acrosome Reaction and Sperm:Oocyte Membrane Binding", "id": "716c1387-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2534343", "value": 0.3655735027986757, "ngenes": 14, "description": "Interaction With Cumulus Cells And The Zona Pellucida", "id": "716c1388-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8953897", "value": 0.10049563801011191, "ngenes": 1034, "description": "Cellular responses to external stimuli", "id": "716c1389-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2262752", "value": 0.09884167321281119, "ngenes": 1016, "description": "Cellular responses to stress", "id": "716c138a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1234174", "value": 0.1963525286626569, "ngenes": 140, "description": "Cellular response to hypoxia", "id": "716c138b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1234158", "value": 0.03704715733269709, "ngenes": 24, "description": "Regulation of gene expression by Hypoxia-inducible Factor", "id": "716c138c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1234176", "value": 0.2744947037358761, "ngenes": 125, "description": "Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha", "id": "716c138d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2559583", "value": 0.5332010701839299, "ngenes": 327, "description": "Cellular Senescence", "id": "716c138e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2559580", "value": 1.0, "ngenes": 199, "description": "Oxidative Stress Induced Senescence", "id": "716c138f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2559582", "value": 0.8491515933710332, "ngenes": 168, "description": "Senescence-Associated Secretory Phenotype (SASP)", "id": "716c1390-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2559586", "value": 0.8034719292557301, "ngenes": 108, "description": "DNA Damage/Telomere Stress Induced Senescence", "id": "716c1391-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2559584", "value": 0.37534576151653687, "ngenes": 23, "description": "Formation of Senescence-Associated Heterochromatin Foci (SAHF)", "id": "716c1392-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2559585", "value": 0.10631060765222129, "ngenes": 65, "description": "Oncogene Induced Senescence", "id": "716c1393-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3299685", "value": 0.2506530239039547, "ngenes": 59, "description": "Detoxification of Reactive Oxygen Species", "id": "716c1394-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3371556", "value": 0.14636450425981812, "ngenes": 171, "description": "Cellular response to heat stress", "id": "716c1395-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371453", "value": 0.06896937371942653, "ngenes": 139, "description": "Regulation of HSF1-mediated heat shock response", "id": "716c1396-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3371511", "value": 0.3111022257727626, "ngenes": 49, "description": "HSF1 activation", "id": "716c1397-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3371571", "value": 0.7748355879347011, "ngenes": 67, "description": "HSF1-dependent transactivation", "id": "716c1398-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371568", "value": 0.6324786572174614, "ngenes": 48, "description": "Attenuation phase", "id": "716c1399-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3371497", "value": 0.2750176731055966, "ngenes": 70, "description": "HSP90 chaperone cycle for steroid hormone receptors (SHR)", "id": "716c139a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9633012", "value": 0.14462859621967175, "ngenes": 213, "description": "Response of EIF2AK4 (GCN2) to amino acid deficiency", "id": "716c139b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9639288", "value": 0.155870532999355, "ngenes": 83, "description": "Amino acids regulate mTORC1", "id": "716c139c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9648895", "value": 0.32022994358517787, "ngenes": 23, "description": "Response of EIF2AK1 (HRI) to heme deficiency", "id": "716c139d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5660526", "value": 0.932297575391846, "ngenes": 18, "description": "Response to metal ions", "id": "716c139e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5660489", "value": 0.8636052042095431, "ngenes": 7, "description": "MTF1 activates gene expression", "id": "716c139f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5661231", "value": 0.9283131377503262, "ngenes": 11, "description": "Metallothioneins bind metals", "id": "716c13a0-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1643685", "value": 0.09939770088346835, "ngenes": 2643, "description": "Disease", "id": "716c13a1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5663202", "value": 0.12279976789558063, "ngenes": 698, "description": "Diseases of signal transduction by growth factor receptors and second messengers", "id": "716c13a2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1643713", "value": 0.8005117082109501, "ngenes": 48, "description": "Signaling by EGFR in Cancer", "id": "716c13a3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5637815", "value": 0.7066052020526674, "ngenes": 42, "description": "Signaling by Ligand-Responsive EGFR Variants in Cancer", "id": "716c13a4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1236382", "value": 0.7066052020526674, "ngenes": 42, "description": "Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants", "id": "716c13a5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5637812", "value": 0.7065351042023906, "ngenes": 33, "description": "Signaling by EGFRvIII in Cancer", "id": "716c13a6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5637810", "value": 0.7065351042023906, "ngenes": 33, "description": "Constitutive Signaling by EGFRvIII", "id": "716c13a7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5638302", "value": 0.3056236055452598, "ngenes": 11, "description": "Signaling by Overexpressed Wild-Type EGFR in Cancer", "id": "716c13a8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5638303", "value": 0.3056236055452598, "ngenes": 11, "description": "Inhibition of Signaling by Overexpressed EGFR", "id": "716c13a9-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1226099", "value": 0.7968205606631088, "ngenes": 117, "description": "Signaling by FGFR in disease", "id": "716c13aa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5655302", "value": 0.42714885815625286, "ngenes": 82, "description": "Signaling by FGFR1 in disease", "id": "716c13ab-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839124", "value": 0.5580452141042042, "ngenes": 67, "description": "FGFR1 mutant receptor activation", "id": "716c13ac-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839117", "value": 0.02694840780403818, "ngenes": 40, "description": "Signaling by cytosolic FGFR1 fusion mutants", "id": "716c13ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1839120", "value": 0.28009372044607456, "ngenes": 3, "description": "Signaling by FGFR1 amplification mutants", "id": "716c13ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1839122", "value": 0.1963525286626569, "ngenes": 22, "description": "Signaling by activated point mutants of FGFR1", "id": "716c13af-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8853336", "value": 0.8728246877076241, "ngenes": 8, "description": "Signaling by plasma membrane FGFR1 fusions", "id": "716c13b0-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5655291", "value": 0.07055742631022986, "ngenes": 27, "description": "Signaling by FGFR4 in disease", "id": "716c13b1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839128", "value": 0.00015894186110084675, "ngenes": 3, "description": "FGFR4 mutant receptor activation", "id": "716c13b2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5655332", "value": 0.29862921047105073, "ngenes": 46, "description": "Signaling by FGFR3 in disease", "id": "716c13b3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8853338", "value": 0.29862921047105073, "ngenes": 46, "description": "Signaling by FGFR3 point mutants in cancer", "id": "716c13b4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2033514", "value": 0.08716451175468608, "ngenes": 22, "description": "FGFR3 mutant receptor activation", "id": "716c13b5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839130", "value": 0.08716451175468608, "ngenes": 22, "description": "Signaling by activated point mutants of FGFR3", "id": "716c13b6-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8853334", "value": 0.7314404707984932, "ngenes": 24, "description": "Signaling by FGFR3 fusions in cancer", "id": "716c13b7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5655253", "value": 0.4047970176643241, "ngenes": 73, "description": "Signaling by FGFR2 in disease", "id": "716c13b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839126", "value": 0.4032689200958995, "ngenes": 49, "description": "FGFR2 mutant receptor activation", "id": "716c13b9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2033519", "value": 0.12680669311669948, "ngenes": 29, "description": "Activated point mutants of FGFR2", "id": "716c13ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851708", "value": 0.37371112554435026, "ngenes": 26, "description": "Signaling by FGFR2 IIIa TM", "id": "716c13bb-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-2219528", "value": 0.8636052042095431, "ngenes": 205, "description": "PI3K/AKT Signaling in Cancer", "id": "716c13bc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2219530", "value": 0.9875692517893132, "ngenes": 144, "description": "Constitutive Signaling by Aberrant PI3K in Cancer", "id": "716c13bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5674400", "value": 0.025223622457889457, "ngenes": 59, "description": "Constitutive Signaling by AKT1 E17K in Cancer", "id": "716c13be-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2644603", "value": 0.12223851496961394, "ngenes": 94, "description": "Signaling by NOTCH1 in Cancer", "id": "716c13bf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2644602", "value": 0.12223851496961394, "ngenes": 94, "description": "Signaling by NOTCH1 PEST Domain Mutants in Cancer", "id": "716c13c0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2644606", "value": 0.12223851496961394, "ngenes": 94, "description": "Constitutive Signaling by NOTCH1 PEST Domain Mutants", "id": "716c13c1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2644605", "value": 0.7386023065747235, "ngenes": 10, "description": "FBXW7 Mutants and NOTCH1 in Cancer", "id": "716c13c2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2644607", "value": 0.7386023065747235, "ngenes": 10, "description": "Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling", "id": "716c13c3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2660825", "value": 0.04216998412170033, "ngenes": 11, "description": "Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant", "id": "716c13c4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2660826", "value": 0.04216998412170033, "ngenes": 11, "description": "Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant", "id": "716c13c5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2691230", "value": 0.06962729134710448, "ngenes": 23, "description": "Signaling by NOTCH1 HD Domain Mutants in Cancer", "id": "716c13c6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2691232", "value": 0.06962729134710448, "ngenes": 23, "description": "Constitutive Signaling by NOTCH1 HD Domain Mutants", "id": "716c13c7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2894858", "value": 0.12223851496961394, "ngenes": 94, "description": "Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer", "id": "716c13c8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2894862", "value": 0.12223851496961394, "ngenes": 94, "description": "Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants", "id": "716c13c9-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3304351", "value": 0.8409571111058959, "ngenes": 18, "description": "Signaling by TGF-beta Receptor Complex in Cancer", "id": "716c13ca-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3304349", "value": 0.5284004715863589, "ngenes": 14, "description": "Loss of Function of SMAD2/3 in Cancer", "id": "716c13cb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3304356", "value": 0.8304729964422268, "ngenes": 13, "description": "SMAD2/3 Phosphorylation Motif Mutants in Cancer", "id": "716c13cc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3315487", "value": 0.8978764811258031, "ngenes": 5, "description": "SMAD2/3 MH2 Domain Mutants in Cancer", "id": "716c13cd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3304347", "value": 0.8978764811258031, "ngenes": 5, "description": "Loss of Function of SMAD4 in Cancer", "id": "716c13ce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3311021", "value": 0.8978764811258031, "ngenes": 5, "description": "SMAD4 MH2 Domain Mutants in Cancer", "id": "716c13cf-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3642278", "value": 1.0, "ngenes": 5, "description": "Loss of Function of TGFBR2 in Cancer", "id": "716c13d0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3642279", "value": 0.9763328968314454, "ngenes": 4, "description": "TGFBR2 MSI Frameshift Mutants in Cancer", "id": "716c13d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3645790", "value": 1.0, "ngenes": 5, "description": "TGFBR2 Kinase Domain Mutants in Cancer", "id": "716c13d2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3656534", "value": 0.6258486624625424, "ngenes": 17, "description": "Loss of Function of TGFBR1 in Cancer", "id": "716c13d3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3656532", "value": 0.8304729964422268, "ngenes": 13, "description": "TGFBR1 KD Mutants in Cancer", "id": "716c13d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656535", "value": 0.45960338022176866, "ngenes": 9, "description": "TGFBR1 LBD Mutants in Cancer", "id": "716c13d5-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-4791275", "value": 0.09480799100842513, "ngenes": 63, "description": "Signaling by WNT in cancer", "id": "716c13d6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5339700", "value": 0.8820723704887731, "ngenes": 5, "description": "Signaling by TCF7L2 mutants", "id": "716c13d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5339716", "value": 0.09219611882665504, "ngenes": 34, "description": "Signaling by GSK3beta mutants", "id": "716c13d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5339717", "value": 1.0, "ngenes": 14, "description": "Signaling by LRP5 mutants ", "id": "716c13d9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5340588", "value": 0.4543335448357411, "ngenes": 9, "description": "Signaling by RNF43 mutants", "id": "716c13da-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4839743", "value": 0.09219611882665504, "ngenes": 34, "description": "Signaling by CTNNB1 phospho-site mutants", "id": "716c13db-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5358747", "value": 0.09219611882665504, "ngenes": 34, "description": "S33 mutants of beta-catenin aren't phosphorylated", "id": "716c13dc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358749", "value": 0.09219611882665504, "ngenes": 34, "description": "S37 mutants of beta-catenin aren't phosphorylated", "id": "716c13dd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358751", "value": 0.09219611882665504, "ngenes": 34, "description": "S45 mutants of beta-catenin aren't phosphorylated", "id": "716c13de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358752", "value": 0.09219611882665504, "ngenes": 34, "description": "T41 mutants of beta-catenin aren't phosphorylated", "id": "716c13df-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4839744", "value": 0.06980941466577938, "ngenes": 27, "description": "Signaling by APC mutants", "id": "716c13e0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5467337", "value": 0.06980941466577938, "ngenes": 27, "description": "APC truncation mutants have impaired AXIN binding", "id": "716c13e1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4839735", "value": 0.06980941466577938, "ngenes": 27, "description": "Signaling by AXIN mutants", "id": "716c13e2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5467340", "value": 0.06980941466577938, "ngenes": 27, "description": "AXIN missense mutants destabilize the destruction complex", "id": "716c13e3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4839748", "value": 0.06980941466577938, "ngenes": 27, "description": "Signaling by AMER1 mutants", "id": "716c13e4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5467348", "value": 0.06980941466577938, "ngenes": 27, "description": "Truncations of AMER1 destabilize the destruction complex", "id": "716c13e5-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5387390", "value": 0.2779660341383081, "ngenes": 98, "description": "Hh mutants abrogate ligand secretion", "id": "716c13e6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5362768", "value": 0.2711181688553764, "ngenes": 95, "description": "Hh mutants are degraded by ERAD", "id": "716c13e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5658034", "value": 0.8204720978587338, "ngenes": 4, "description": "HHAT G278V doesn't palmitoylate Hh-Np", "id": "716c13e8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6802957", "value": 0.6903362689910377, "ngenes": 145, "description": "Oncogenic MAPK signaling", "id": "716c13e9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6802946", "value": 0.5644922054187091, "ngenes": 78, "description": "Signaling by moderate kinase activity BRAF mutants", "id": "716c13ea-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802948", "value": 0.7619670378829622, "ngenes": 62, "description": "Signaling by high-kinase activity BRAF mutants", "id": "716c13eb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802952", "value": 0.9818641008006582, "ngenes": 122, "description": "Signaling by BRAF and RAF fusions", "id": "716c13ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802953", "value": 0.14389869630949848, "ngenes": 11, "description": "RAS signaling downstream of NF1 loss-of-function variants", "id": "716c13ed-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802955", "value": 0.5644922054187091, "ngenes": 78, "description": "Paradoxical activation of RAF signaling by kinase inactive BRAF", "id": "716c13ee-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802949", "value": 0.5644922054187091, "ngenes": 78, "description": "Signaling by RAS mutants", "id": "716c13ef-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9649913", "value": 0.5225090917618829, "ngenes": 5, "description": "RAS GTPase cycle mutants", "id": "716c13f0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9649948", "value": 0.5644922054187091, "ngenes": 78, "description": "Signaling downstream of RAS mutants", "id": "716c13f1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9652169", "value": 0.39556458831374086, "ngenes": 7, "description": "Signaling by MAP2K mutants", "id": "716c13f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9652817", "value": 0.4110790114593146, "ngenes": 13, "description": "Signaling by MAPK mutants", "id": "716c13f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9656223", "value": 0.4885796347215152, "ngenes": 75, "description": "Signaling by RAF1 mutants", "id": "716c13f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9660537", "value": 0.06100298779926902, "ngenes": 10, "description": "Signaling by MRAS-complex mutants", "id": "716c13f5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1227990", "value": 0.7343283884525103, "ngenes": 54, "description": "Signaling by ERBB2 in Cancer", "id": "716c13f6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9634285", "value": 0.914477150567899, "ngenes": 21, "description": "Constitutive Signaling by Overexpressed ERBB2", "id": "716c13f7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664565", "value": 0.6471639228871243, "ngenes": 52, "description": "Signaling by ERBB2 KD Mutants", "id": "716c13f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665230", "value": 0.04216998412170033, "ngenes": 8, "description": "Drug resistance in ERBB2 KD mutants", "id": "716c13f9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9665233", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to trastuzumab", "id": "716c13fa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665244", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to sapitinib", "id": "716c13fb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665245", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to tesevatinib", "id": "716c13fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665246", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to neratinib", "id": "716c13fd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665247", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to osimertinib", "id": "716c13fe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665249", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to afatinib", "id": "716c13ff-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665250", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to AEE788", "id": "716c1400-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665251", "value": 0.04216998412170033, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to lapatinib", "id": "716c1401-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9665348", "value": 0.9563804245280768, "ngenes": 36, "description": "Signaling by ERBB2 ECD mutants", "id": "716c1402-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665686", "value": 0.5789004881165319, "ngenes": 42, "description": "Signaling by ERBB2 TMD/JMD mutants", "id": "716c1403-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665737", "value": 0.04216998412170033, "ngenes": 8, "description": "Drug resistance in ERBB2 TMD/JMD mutants", "id": "716c1404-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9669938", "value": 0.7744344394572328, "ngenes": 39, "description": "Signaling by KIT in disease", "id": "716c1405-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9670439", "value": 0.7744344394572328, "ngenes": 39, "description": "Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants", "id": "716c1406-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9671555", "value": 0.24897477630011242, "ngenes": 37, "description": "Signaling by PDGFR in disease", "id": "716c1407-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9673766", "value": 0.3131828135641375, "ngenes": 5, "description": "Signaling by cytosolic PDGFRA and PDGFRB fusion proteins", "id": "716c1408-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673767", "value": 0.6095580619164416, "ngenes": 25, "description": "Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants", "id": "716c1409-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673768", "value": 0.20904170909162118, "ngenes": 7, "description": "Signaling by membrane-tethered fusions of PDGFRA or PDGFRB", "id": "716c140a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673770", "value": 0.6095580619164416, "ngenes": 25, "description": "Signaling by PDGFRA extracellular domain mutants", "id": "716c140b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5663205", "value": 0.11187345293196137, "ngenes": 1418, "description": "Infectious disease", "id": "716c140c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162906", "value": 0.10115100214101994, "ngenes": 380, "description": "HIV Infection", "id": "716c140d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162587", "value": 0.08605892477993908, "ngenes": 232, "description": "HIV Life Cycle", "id": "716c140e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162599", "value": 0.085222472536829, "ngenes": 208, "description": "Late Phase of HIV Life Cycle", "id": "716c140f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162588", "value": 0.091596951382805, "ngenes": 46, "description": "Budding and maturation of HIV virion", "id": "716c1410-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-165054", "value": 0.06048874616558646, "ngenes": 55, "description": "Rev-mediated nuclear export of HIV RNA", "id": "716c1411-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167172", "value": 0.10491342665060116, "ngenes": 104, "description": "Transcription of the HIV genome", "id": "716c1412-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167152", "value": 0.10004710404590958, "ngenes": 73, "description": "Formation of HIV elongation complex in the absence of HIV Tat", "id": "716c1413-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167169", "value": 0.10531870587940882, "ngenes": 69, "description": "HIV Transcription Elongation", "id": "716c1414-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167158", "value": 0.1423152533084256, "ngenes": 52, "description": "Formation of the HIV-1 Early Elongation Complex", "id": "716c1415-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167246", "value": 0.10531870587940882, "ngenes": 69, "description": "Tat-mediated elongation of the HIV-1 transcript", "id": "716c1416-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167200", "value": 0.10531870587940882, "ngenes": 69, "description": "Formation of HIV-1 elongation complex containing HIV-1 Tat", "id": "716c1417-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-167242", "value": 0.09685748772901173, "ngenes": 33, "description": "Abortive elongation of HIV-1 transcript in the absence of Tat", "id": "716c1418-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-167160", "value": 0.18905048243690628, "ngenes": 38, "description": "RNA Pol II CTD phosphorylation and interaction with CE during HIV infection", "id": "716c1419-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167161", "value": 0.1655260481081655, "ngenes": 64, "description": "HIV Transcription Initiation", "id": "716c141a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167162", "value": 0.1655260481081655, "ngenes": 64, "description": "RNA Polymerase II HIV Promoter Escape", "id": "716c141b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167238", "value": 0.07661561155969829, "ngenes": 46, "description": "Pausing and recovery of Tat-mediated HIV elongation", "id": "716c141c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167243", "value": 0.07661561155969829, "ngenes": 46, "description": "Tat-mediated HIV elongation arrest and recovery", "id": "716c141d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167287", "value": 0.0707229434916646, "ngenes": 50, "description": "HIV elongation arrest and recovery", "id": "716c141e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167290", "value": 0.0707229434916646, "ngenes": 50, "description": "Pausing and recovery of HIV elongation", "id": "716c141f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-175474", "value": 0.028678592139156807, "ngenes": 26, "description": "Assembly Of The HIV Virion", "id": "716c1420-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174495", "value": 0.027435303323596314, "ngenes": 24, "description": "Synthesis And Processing Of GAG, GAGPOL Polyproteins", "id": "716c1421-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174490", "value": 0.027435303323596314, "ngenes": 24, "description": "Membrane binding and targetting of GAG proteins", "id": "716c1422-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-162594", "value": 0.8695417430113445, "ngenes": 25, "description": "Early Phase of HIV Life Cycle", "id": "716c1423-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162592", "value": 0.11180304639132696, "ngenes": 16, "description": "Integration of provirus", "id": "716c1424-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164843", "value": 0.11949455892167062, "ngenes": 14, "description": "2-LTR circle formation", "id": "716c1425-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-175567", "value": 0.4852276436582596, "ngenes": 7, "description": "Integration of viral DNA into host genomic DNA", "id": "716c1426-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-177539", "value": 0.4852276436582596, "ngenes": 7, "description": "Autointegration results in viral DNA circles", "id": "716c1427-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-173107", "value": 0.6484451624744836, "ngenes": 7, "description": "Binding and entry of HIV virion", "id": "716c1428-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-162909", "value": 0.11777218870458916, "ngenes": 229, "description": "Host Interactions of HIV factors", "id": "716c1429-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164952", "value": 0.8747412795997429, "ngenes": 56, "description": "The role of Nef in HIV-1 replication and disease pathogenesis", "id": "716c142a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164938", "value": 0.1655260481081655, "ngenes": 40, "description": "Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters", "id": "716c142b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164939", "value": 0.02729478778815131, "ngenes": 3, "description": "Nef mediated downregulation of CD28 cell surface expression", "id": "716c142c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-164940", "value": 0.1804597374699515, "ngenes": 17, "description": "Nef mediated downregulation of MHC class I complex cell surface expression", "id": "716c142d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167590", "value": 0.0463470603268933, "ngenes": 19, "description": "Nef Mediated CD4 Down-regulation", "id": "716c142e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-182218", "value": 0.07249273226070745, "ngenes": 15, "description": "Nef Mediated CD8 Down-regulation", "id": "716c142f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-164944", "value": 0.9255427833653975, "ngenes": 19, "description": "Nef and signal transduction", "id": "716c1430-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-177243", "value": 0.04894347050477222, "ngenes": 58, "description": "Interactions of Rev with host cellular proteins", "id": "716c1431-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165054", "value": 0.06048874616558646, "ngenes": 55, "description": "Rev-mediated nuclear export of HIV RNA", "id": "716c1432-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180746", "value": 0.045059012461690105, "ngenes": 54, "description": "Nuclear import of Rev protein", "id": "716c1433-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-176034", "value": 0.06804060364047887, "ngenes": 3, "description": "Interactions of Tat with host cellular proteins", "id": "716c1434-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180534", "value": 0.29229851762321585, "ngenes": 92, "description": "Vpu mediated degradation of CD4", "id": "716c1435-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180585", "value": 0.2431141977626884, "ngenes": 95, "description": "Vif-mediated degradation of APOBEC3G", "id": "716c1436-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180689", "value": 0.13701252908631628, "ngenes": 11, "description": "APOBEC3G mediated resistance to HIV-1 infection", "id": "716c1437-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-176033", "value": 0.1040506828516798, "ngenes": 58, "description": "Interactions of Vpr with host cellular proteins", "id": "716c1438-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-180897", "value": 0.5339767331305375, "ngenes": 3, "description": "Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization", "id": "716c1439-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180910", "value": 0.0741623946062189, "ngenes": 55, "description": "Vpr-mediated nuclear import of PICs", "id": "716c143a-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-168255", "value": 0.12527119187622013, "ngenes": 286, "description": "Influenza Infection", "id": "716c143b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168271", "value": 0.047224016530099736, "ngenes": 49, "description": "Transport of Ribonucleoproteins into the Host Nucleus", "id": "716c143c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168275", "value": 0.9694129607641102, "ngenes": 4, "description": "Entry of Influenza Virion into Host Cell via Endocytosis", "id": "716c143d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168276", "value": 0.07571005029484179, "ngenes": 63, "description": "NS1 Mediated Effects on Host Pathways", "id": "716c143e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168315", "value": 0.09657838865417234, "ngenes": 3, "description": "Inhibition of Host mRNA Processing and RNA Silencing", "id": "716c143f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168273", "value": 0.12721138533759097, "ngenes": 261, "description": "Influenza Viral RNA Transcription and Replication", "id": "716c1440-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168325", "value": 0.06880400292056259, "ngenes": 63, "description": "Viral Messenger RNA Synthesis", "id": "716c1441-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192823", "value": 0.1556900711186517, "ngenes": 195, "description": "Viral mRNA Translation", "id": "716c1442-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192905", "value": 0.5141884258747684, "ngenes": 3, "description": "vRNP Assembly", "id": "716c1443-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168274", "value": 0.06525056324868748, "ngenes": 50, "description": "Export of Viral Ribonucleoproteins from Nucleus", "id": "716c1444-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168333", "value": 0.06450044587440303, "ngenes": 49, "description": "NEP/NS2 Interacts with the Cellular Export Machinery", "id": "716c1445-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5339562", "value": 0.4631052768001092, "ngenes": 45, "description": "Uptake and actions of bacterial toxins", "id": "716c1446-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5210891", "value": 0.12497777752038124, "ngenes": 21, "description": "Uptake and function of anthrax toxins", "id": "716c1447-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168799", "value": 0.29862921047105073, "ngenes": 14, "description": "Neurotoxicity of clostridium toxins", "id": "716c1448-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5250955", "value": 0.29862921047105073, "ngenes": 7, "description": "Toxicity of botulinum toxin type D (botD)", "id": "716c1449-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250958", "value": 0.4811057692150324, "ngenes": 4, "description": "Toxicity of botulinum toxin type B (botB)", "id": "716c144a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250968", "value": 0.7233280572327202, "ngenes": 5, "description": "Toxicity of botulinum toxin type A (botA)", "id": "716c144b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250971", "value": 0.13375822907700052, "ngenes": 4, "description": "Toxicity of botulinum toxin type C (botC)", "id": "716c144c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250981", "value": 0.29862921047105073, "ngenes": 7, "description": "Toxicity of botulinum toxin type F (botF)", "id": "716c144d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250989", "value": 0.2684524629523711, "ngenes": 6, "description": "Toxicity of botulinum toxin type G (botG)", "id": "716c144e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250992", "value": 0.7093160686465013, "ngenes": 4, "description": "Toxicity of botulinum toxin type E (botE)", "id": "716c144f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5336415", "value": 0.037126356197780395, "ngenes": 8, "description": "Uptake and function of diphtheria toxin", "id": "716c1450-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8876384", "value": 0.10170185653107983, "ngenes": 41, "description": "Listeria monocytogenes entry into host cells", "id": "716c1451-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8875360", "value": 0.4648763566451699, "ngenes": 24, "description": "InlB-mediated entry of Listeria monocytogenes into host cell", "id": "716c1452-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8876493", "value": 0.12721138533759097, "ngenes": 26, "description": "InlA-mediated entry of Listeria monocytogenes into host cells", "id": "716c1453-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9609646", "value": 0.2552869492378058, "ngenes": 220, "description": "HCMV Infection", "id": "716c1454-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9609690", "value": 0.705766976117149, "ngenes": 183, "description": "HCMV Early Events", "id": "716c1455-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9610379", "value": 0.671405043535478, "ngenes": 146, "description": "HCMV Late Events", "id": "716c1456-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9635486", "value": 0.09939196395857756, "ngenes": 46, "description": "Infection with Mycobacterium tuberculosis", "id": "716c1457-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9637690", "value": 0.06896937371942653, "ngenes": 40, "description": "Response of Mtb to phagocytosis", "id": "716c1458-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9635465", "value": 0.09480799100842513, "ngenes": 13, "description": "Suppression of apoptosis", "id": "716c1459-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9637687", "value": 0.0565561344420959, "ngenes": 23, "description": "Suppression of phagosomal maturation", "id": "716c145a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9636249", "value": 0.02694840780403818, "ngenes": 5, "description": "Inhibition of nitric oxide production", "id": "716c145b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9636383", "value": 0.39556458831374086, "ngenes": 16, "description": "Prevention of phagosomal-lysosomal fusion", "id": "716c145c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9636667", "value": 0.03717060655419382, "ngenes": 3, "description": "Manipulation of host energy metabolism", "id": "716c145d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9637628", "value": 0.5879587686259897, "ngenes": 13, "description": "Modulation by Mtb of host immune system", "id": "716c145e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9658195", "value": 0.6058355101467456, "ngenes": 411, "description": "Leishmania infection", "id": "716c145f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9664433", "value": 0.7822039303659291, "ngenes": 256, "description": "Leishmania parasite growth and survival", "id": "716c1460-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9662851", "value": 0.7822039303659291, "ngenes": 256, "description": "Anti-inflammatory response favouring Leishmania parasite infection", "id": "716c1461-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9660821", "value": 0.2744947037358761, "ngenes": 178, "description": "ADORA2B mediated anti-inflammatory cytokines production", "id": "716c1462-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9662834", "value": 0.4014812309679882, "ngenes": 18, "description": "CD163 mediating an anti-inflammatory response", "id": "716c1463-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664323", "value": 0.8696264530591605, "ngenes": 79, "description": "FCGR3A-mediated IL10 synthesis", "id": "716c1464-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664535", "value": 0.1545419583346894, "ngenes": 15, "description": "LTC4-CYSLTR mediated IL4 production", "id": "716c1465-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9664424", "value": 0.3131828135641375, "ngenes": 37, "description": "Cell recruitment (pro-inflammatory response)", "id": "716c1466-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9660826", "value": 0.3131828135641375, "ngenes": 37, "description": "Purinergic signaling in leishmaniasis infection", "id": "716c1467-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9664407", "value": 0.9973015730164824, "ngenes": 129, "description": "Parasite infection", "id": "716c1468-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9664417", "value": 0.9973015730164824, "ngenes": 129, "description": "Leishmania phagocytosis", "id": "716c1469-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9664422", "value": 0.9973015730164824, "ngenes": 129, "description": "FCGR3A-mediated phagocytosis", "id": "716c146a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9664420", "value": 0.39556458831374086, "ngenes": 25, "description": "Killing mechanisms", "id": "716c146b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9673324", "value": 0.39556458831374086, "ngenes": 25, "description": "WNT5:FZD7-mediated leishmania damping", "id": "716c146c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9679506", "value": 0.14672266941821546, "ngenes": 245, "description": "SARS-CoV Infections", "id": "716c146d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9678108", "value": 0.10404356720284604, "ngenes": 83, "description": "SARS-CoV-1 Infection", "id": "716c146e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9678110", "value": 0.3061831522264598, "ngenes": 6, "description": "Attachment and Entry", "id": "716c146f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9679504", "value": 0.1285384417993569, "ngenes": 19, "description": "Translation of Replicase and Assembly of the Replication Transcription Complex", "id": "716c1470-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9679514", "value": 0.08256565189037975, "ngenes": 8, "description": "SARS-CoV-1 Genome Replication and Transcription", "id": "716c1471-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9682706", "value": 0.08256565189037975, "ngenes": 8, "description": "Replication of the SARS-CoV-1 genome", "id": "716c1472-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9683701", "value": 0.05183685153303107, "ngenes": 51, "description": "Translation of structural proteins", "id": "716c1473-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9683610", "value": 0.18117816450617322, "ngenes": 20, "description": "Maturation of nucleoprotein", "id": "716c1474-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9683673", "value": 0.07571005029484179, "ngenes": 15, "description": "Maturation of protein 3a", "id": "716c1475-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9683683", "value": 0.6187202233388981, "ngenes": 9, "description": "Maturation of protein E", "id": "716c1476-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9683686", "value": 0.12509918756053942, "ngenes": 7, "description": "Maturation of spike protein", "id": "716c1477-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9679191", "value": 0.16861054733354136, "ngenes": 140, "description": "Potential therapeutics for SARS", "id": "716c1478-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694516", "value": 0.12187139342920543, "ngenes": 107, "description": "SARS-CoV-2 Infection", "id": "716c1479-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9694635", "value": 0.07571005029484179, "ngenes": 74, "description": "Translation of structural proteins", "id": "716c147a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9694493", "value": 0.6187202233388981, "ngenes": 9, "description": "Maturation of protein E", "id": "716c147b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694548", "value": 0.10531870587940882, "ngenes": 44, "description": "Maturation of spike protein", "id": "716c147c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694631", "value": 0.18117816450617322, "ngenes": 20, "description": "Maturation of nucleoprotein", "id": "716c147d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694719", "value": 0.07571005029484179, "ngenes": 15, "description": "Maturation of protein 3a", "id": "716c147e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9694614", "value": 0.34399370661333695, "ngenes": 7, "description": "Attachment and Entry", "id": "716c147f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694676", "value": 0.1285384417993569, "ngenes": 19, "description": "Translation of Replicase and Assembly of the Replication Transcription Complex", "id": "716c1480-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694682", "value": 0.08256565189037975, "ngenes": 8, "description": "SARS-CoV-2 Genome Replication and Transcription", "id": "716c1481-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9694686", "value": 0.08256565189037975, "ngenes": 8, "description": "Replication of the SARS-CoV-2 genome", "id": "716c1482-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-5668914", "value": 0.21890520777250846, "ngenes": 406, "description": "Diseases of metabolism", "id": "716c1483-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2160456", "value": 0.822293066330286, "ngenes": 3, "description": "Phenylketonuria", "id": "716c1484-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5663084", "value": 0.2742221794339797, "ngenes": 61, "description": "Diseases of carbohydrate metabolism", "id": "716c1485-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2206281", "value": 0.8978764811258031, "ngenes": 22, "description": "Mucopolysaccharidoses", "id": "716c1486-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2206280", "value": 0.9460710961334489, "ngenes": 4, "description": "MPS IX - Natowicz syndrome", "id": "716c1487-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2206285", "value": 0.3131828135641375, "ngenes": 3, "description": "MPS VI - Maroteaux-Lamy syndrome", "id": "716c1488-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2206296", "value": 0.7223250060454642, "ngenes": 4, "description": "MPS II - Hunter syndrome", "id": "716c1489-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2206308", "value": 0.7449226606453779, "ngenes": 3, "description": "MPS IV - Morquio syndrome B", "id": "716c148a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3229121", "value": 0.3613363292213869, "ngenes": 25, "description": "Glycogen storage diseases", "id": "716c148b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3785653", "value": 0.5826828883728375, "ngenes": 15, "description": "Myoclonic epilepsy of Lafora", "id": "716c148c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3858516", "value": 0.5107862430249993, "ngenes": 4, "description": "Glycogen storage disease type 0 (liver GYS2)", "id": "716c148d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3878781", "value": 0.5103983556716288, "ngenes": 5, "description": "Glycogen storage disease type IV (GBE1)", "id": "716c148e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5357609", "value": 0.25840813618539643, "ngenes": 3, "description": "Glycogen storage disease type II (GAA)", "id": "716c148f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5657562", "value": 0.045059012461690105, "ngenes": 4, "description": "Essential fructosuria", "id": "716c1490-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5659898", "value": 0.22955347979871693, "ngenes": 4, "description": "Intestinal saccharidase deficiencies", "id": "716c1491-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6791465", "value": 0.6029333190939079, "ngenes": 3, "description": "Pentose phosphate pathway disease", "id": "716c1492-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3296482", "value": 0.4032689200958995, "ngenes": 34, "description": "Defects in vitamin and cofactor metabolism", "id": "716c1493-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3296469", "value": 0.3056236055452598, "ngenes": 22, "description": "Defects in cobalamin (B12) metabolism", "id": "716c1494-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3359462", "value": 0.2253272691770601, "ngenes": 3, "description": "Defective AMN causes hereditary megaloblastic anemia 1", "id": "716c1495-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359463", "value": 0.2253272691770601, "ngenes": 3, "description": "Defective CUBN causes hereditary megaloblastic anemia 1", "id": "716c1496-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359467", "value": 0.3916805803435901, "ngenes": 5, "description": "Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE", "id": "716c1497-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359469", "value": 0.3916805803435901, "ngenes": 5, "description": "Defective MTR causes methylmalonic aciduria and homocystinuria type cblG", "id": "716c1498-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359473", "value": 0.2761352854891404, "ngenes": 3, "description": "Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD", "id": "716c1499-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5683329", "value": 0.37036798568308305, "ngenes": 4, "description": "Defective ABCD4 causes MAHCJ", "id": "716c149a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3323169", "value": 0.41971485431683964, "ngenes": 12, "description": "Defects in biotin (Btn) metabolism", "id": "716c149b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371599", "value": 0.479490779870015, "ngenes": 11, "description": "Defective HLCS causes multiple carboxylase deficiency", "id": "716c149c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3781865", "value": 0.3073311686011069, "ngenes": 237, "description": "Diseases of glycosylation", "id": "716c149d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3560782", "value": 0.9211583862945798, "ngenes": 62, "description": "Diseases associated with glycosaminoglycan metabolism", "id": "716c149e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3560783", "value": 0.5332010701839299, "ngenes": 32, "description": "Defective B4GALT7 causes EDS, progeroid type", "id": "716c149f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3560801", "value": 0.6617717777092356, "ngenes": 32, "description": "Defective B3GAT3 causes JDSSDHD", "id": "716c14a0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3595172", "value": 0.38739830145063364, "ngenes": 13, "description": "Defective CHST3 causes SEDCJD", "id": "716c14a1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3595174", "value": 0.36357662339597824, "ngenes": 13, "description": "Defective CHST14 causes EDS, musculocontractural type", "id": "716c14a2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3595177", "value": 0.4170535566748565, "ngenes": 13, "description": "Defective CHSY1 causes TPBS", "id": "716c14a3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656225", "value": 0.415498225999247, "ngenes": 15, "description": "Defective CHST6 causes MCDC1", "id": "716c14a4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656237", "value": 0.5826828883728375, "ngenes": 23, "description": "Defective EXT2 causes exostoses 2", "id": "716c14a5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656243", "value": 0.4168745502958328, "ngenes": 16, "description": "Defective ST3GAL3 causes MCT12 and EIEE15", "id": "716c14a6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656244", "value": 0.4115688359443714, "ngenes": 14, "description": "Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)", "id": "716c14a7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656253", "value": 0.5826828883728375, "ngenes": 23, "description": "Defective EXT1 causes exostoses 1, TRPS2 and CHDS", "id": "716c14a8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4420332", "value": 0.5178870791208532, "ngenes": 32, "description": "Defective B3GALT6 causes EDSP2 and SEMDJL1", "id": "716c14a9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5609975", "value": 0.07051331953672088, "ngenes": 35, "description": "Diseases associated with glycosylation precursor biosynthesis", "id": "716c14aa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4341670", "value": 0.6187202233388981, "ngenes": 8, "description": "Defective NEU1 causes sialidosis", "id": "716c14ab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4717374", "value": 0.009554036908535702, "ngenes": 6, "description": "Defective DPM1 causes DPM1-CDG (CDG-1e)", "id": "716c14ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4719360", "value": 0.009554036908535702, "ngenes": 6, "description": "Defective DPM3 causes DPM3-CDG (CDG-1o)", "id": "716c14ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4719377", "value": 0.009554036908535702, "ngenes": 6, "description": "Defective DPM2 causes DPM2-CDG (CDG-1u)", "id": "716c14ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4755609", "value": 0.12245856943712485, "ngenes": 6, "description": "Defective DHDDS causes retinitis pigmentosa 59", "id": "716c14af-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5609977", "value": 0.06526744680577472, "ngenes": 3, "description": "Defective GALE can cause Epimerase-deficiency galactosemia (EDG)", "id": "716c14b0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5609978", "value": 0.14203452555572924, "ngenes": 3, "description": "Defective GALT can cause Galactosemia", "id": "716c14b1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3781860", "value": 0.07860580228445357, "ngenes": 27, "description": "Diseases associated with N-glycosylation of proteins", "id": "716c14b2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4724325", "value": 0.42227802938598946, "ngenes": 3, "description": "Defective ALG8 causes ALG8-CDG (CDG-1h)", "id": "716c14b3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4793952", "value": 0.2661397242360793, "ngenes": 3, "description": "Defective MGAT2 causes MGAT2-CDG (CDG-2a)", "id": "716c14b4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5633231", "value": 0.12749798477878355, "ngenes": 5, "description": "Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)", "id": "716c14b5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3906995", "value": 0.07940660854331556, "ngenes": 113, "description": "Diseases associated with O-glycosylation of proteins", "id": "716c14b6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5083625", "value": 0.1622032439144783, "ngenes": 31, "description": "Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)", "id": "716c14b7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083627", "value": 0.6503973310854135, "ngenes": 4, "description": "Defective LARGE causes MDDGA6 and MDDGB6", "id": "716c14b8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083628", "value": 0.23461869955346384, "ngenes": 4, "description": "Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3", "id": "716c14b9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083629", "value": 0.572743741174598, "ngenes": 4, "description": "Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2", "id": "716c14ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083630", "value": 0.04613472897525862, "ngenes": 12, "description": "Defective LFNG causes SCDO3", "id": "716c14bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083632", "value": 0.14626428488663543, "ngenes": 34, "description": "Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)", "id": "716c14bc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083633", "value": 0.572743741174598, "ngenes": 4, "description": "Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1", "id": "716c14bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083635", "value": 0.044688814326312096, "ngenes": 56, "description": "Defective B3GALTL causes Peters-plus syndrome (PpS)", "id": "716c14be-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083636", "value": 0.23320711189221485, "ngenes": 32, "description": "Defective GALNT12 causes colorectal cancer 1 (CRCS1)", "id": "716c14bf-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5579029", "value": 0.39556458831374086, "ngenes": 56, "description": "Metabolic disorders of biological oxidation enzymes", "id": "716c14c0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5578999", "value": 0.06337184300136485, "ngenes": 4, "description": "Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)", "id": "716c14c1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579022", "value": 0.16496181132176466, "ngenes": 9, "description": "Defective GGT1 causes Glutathionuria (GLUTH)", "id": "716c14c2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579026", "value": 0.32803657005902925, "ngenes": 6, "description": "Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)", "id": "716c14c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579030", "value": 0.5420872748008373, "ngenes": 4, "description": "Defective CYP19A1 causes Aromatase excess syndrome (AEXS)", "id": "716c14c4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579031", "value": 0.29862921047105073, "ngenes": 3, "description": "Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)", "id": "716c14c5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9035968", "value": 0.16496181132176466, "ngenes": 9, "description": "Defective GGT1 causes Glutathionuria (GLUTH)", "id": "716c14c6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5687613", "value": 0.08161862671404954, "ngenes": 16, "description": "Diseases associated with surfactant metabolism", "id": "716c14c7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5687868", "value": 0.755199877369378, "ngenes": 3, "description": "Defective SFTPA2 causes IPF", "id": "716c14c8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5688849", "value": 0.03353723961526887, "ngenes": 14, "description": "Defective CSF2RB causes SMDP5", "id": "716c14c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5688890", "value": 0.03353723961526887, "ngenes": 14, "description": "Defective CSF2RA causes SMDP4", "id": "716c14ca-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9675143", "value": 0.5225090917618829, "ngenes": 13, "description": "Diseases of the neuronal system", "id": "716c14cb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2474795", "value": 0.5225090917618829, "ngenes": 13, "description": "Diseases associated with visual transduction", "id": "716c14cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2453864", "value": 0.5225090917618829, "ngenes": 13, "description": "Retinoid cycle disease events", "id": "716c14cd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9675135", "value": 0.05718407630343125, "ngenes": 25, "description": "Diseases of DNA repair", "id": "716c14ce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5423599", "value": 0.03844715584941761, "ngenes": 11, "description": "Diseases of Mismatch Repair (MMR)", "id": "716c14cf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5545483", "value": 0.002698769811069904, "ngenes": 6, "description": "Defective Mismatch Repair Associated With MLH1", "id": "716c14d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632927", "value": 0.2873636204741825, "ngenes": 3, "description": "Defective Mismatch Repair Associated With MSH3", "id": "716c14d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632928", "value": 0.2632856956588323, "ngenes": 5, "description": "Defective Mismatch Repair Associated With MSH2", "id": "716c14d2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632968", "value": 0.30057555648381573, "ngenes": 4, "description": "Defective Mismatch Repair Associated With MSH6", "id": "716c14d3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632987", "value": 0.002698769811069904, "ngenes": 6, "description": "Defective Mismatch Repair Associated With PMS2", "id": "716c14d4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9605308", "value": 0.10404356720284604, "ngenes": 9, "description": "Diseases of Base Excision Repair", "id": "716c14d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9605310", "value": 0.34479819805435974, "ngenes": 3, "description": "Defective Base Excision Repair Associated with MUTYH", "id": "716c14d6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9608287", "value": 0.34479819805435974, "ngenes": 3, "description": "Defective MUTYH substrate binding", "id": "716c14d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9608290", "value": 0.34479819805435974, "ngenes": 3, "description": "Defective MUTYH substrate processing", "id": "716c14d8-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-5260271", "value": 0.5644922054187091, "ngenes": 39, "description": "Diseases of Immune System", "id": "716c14d9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5602358", "value": 0.5644922054187091, "ngenes": 39, "description": "Diseases associated with the TLR signaling cascade", "id": "716c14da-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5602415", "value": 0.1882219742881029, "ngenes": 4, "description": "UNC93B1 deficiency - HSE", "id": "716c14db-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602498", "value": 0.6503973310854135, "ngenes": 17, "description": "MyD88 deficiency (TLR2/4)", "id": "716c14dc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602566", "value": 0.2662499268378284, "ngenes": 4, "description": "TICAM1 deficiency - HSE", "id": "716c14dd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602571", "value": 0.18307060469890377, "ngenes": 5, "description": "TRAF3 deficiency - HSE", "id": "716c14de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602636", "value": 0.7656635943411512, "ngenes": 4, "description": "IKBKB deficiency causes SCID", "id": "716c14df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603027", "value": 0.7656635943411512, "ngenes": 4, "description": "IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)", "id": "716c14e0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603029", "value": 0.6577702906896362, "ngenes": 10, "description": "IkBA variant leads to EDA-ID", "id": "716c14e1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603037", "value": 0.24939722269694672, "ngenes": 6, "description": "IRAK4 deficiency (TLR5)", "id": "716c14e2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603041", "value": 0.6328301595040259, "ngenes": 18, "description": "IRAK4 deficiency (TLR2/4)", "id": "716c14e3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5619115", "value": 0.16019450751458392, "ngenes": 276, "description": "Disorders of transmembrane transporters", "id": "716c14e4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5619102", "value": 0.06980941466577938, "ngenes": 146, "description": "SLC transporter disorders", "id": "716c14e5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5619047", "value": 0.713680458759928, "ngenes": 4, "description": "Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)", "id": "716c14e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619049", "value": 0.33371619310763434, "ngenes": 3, "description": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)", "id": "716c14e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619055", "value": 0.8572185123996907, "ngenes": 3, "description": "Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)", "id": "716c14e8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619056", "value": 0.745200724443715, "ngenes": 3, "description": "Defective HK1 causes hexokinase deficiency (HK deficiency)", "id": "716c14e9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619060", "value": 0.33371619310763434, "ngenes": 3, "description": "Defective CP causes aceruloplasminemia (ACERULOP)", "id": "716c14ea-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619066", "value": 0.9588255298330869, "ngenes": 3, "description": "Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)", "id": "716c14eb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619070", "value": 0.43207995013501255, "ngenes": 3, "description": "Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)", "id": "716c14ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619071", "value": 0.9614897711480838, "ngenes": 3, "description": "Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)", "id": "716c14ed-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619072", "value": 0.557370798462006, "ngenes": 4, "description": "Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)", "id": "716c14ee-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619073", "value": 0.5635225138846839, "ngenes": 3, "description": "Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)", "id": "716c14ef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619092", "value": 0.9694129607641102, "ngenes": 4, "description": "Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)", "id": "716c14f0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619099", "value": 0.880271785476252, "ngenes": 4, "description": "Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)", "id": "716c14f1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619101", "value": 0.4105242292090234, "ngenes": 3, "description": "Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)", "id": "716c14f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619107", "value": 0.05508234659751904, "ngenes": 51, "description": "Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)", "id": "716c14f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5655799", "value": 0.37803787382830495, "ngenes": 4, "description": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)", "id": "716c14f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5660686", "value": 0.4105242292090234, "ngenes": 3, "description": "Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)", "id": "716c14f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5660862", "value": 1.0, "ngenes": 4, "description": "Defective SLC7A7 causes lysinuric protein intolerance (LPI)", "id": "716c14f6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5619084", "value": 0.2720809480828609, "ngenes": 130, "description": "ABC transporter disorders", "id": "716c14f7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5678420", "value": 0.09811407950169769, "ngenes": 3, "description": "Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome", "id": "716c14f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5678895", "value": 0.262990817549514, "ngenes": 103, "description": "Defective CFTR causes cystic fibrosis", "id": "716c14f9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5679090", "value": 0.5779695659223154, "ngenes": 3, "description": "Defective ABCG8 causes GBD4 and sitosterolemia", "id": "716c14fa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5679096", "value": 0.5779695659223154, "ngenes": 3, "description": "Defective ABCG5 causes sitosterolemia", "id": "716c14fb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5683329", "value": 0.37036798568308305, "ngenes": 4, "description": "Defective ABCD4 causes MAHCJ", "id": "716c14fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5690338", "value": 0.7314404707984932, "ngenes": 6, "description": "Defective ABCC6 causes PXE", "id": "716c14fd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9645723", "value": 0.17046347877174978, "ngenes": 63, "description": "Diseases of programmed cell death", "id": "716c14fe-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8863678", "value": 1.0, "ngenes": 48, "description": "Neurodegenerative Diseases", "id": "716c14ff-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8862803", "value": 1.0, "ngenes": 48, "description": "Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models", "id": "716c1500-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9645722", "value": 0.008266147785476085, "ngenes": 4, "description": "Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function", "id": "716c1501-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9693928", "value": 0.029834752282636216, "ngenes": 11, "description": "Defective RIPK1-mediated regulated necrosis", "id": "716c1502-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9675151", "value": 0.597610338839184, "ngenes": 25, "description": "Disorders of Developmental Biology", "id": "716c1503-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9697154", "value": 0.597610338839184, "ngenes": 25, "description": "Disorders of Nervous System Development", "id": "716c1504-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9005895", "value": 0.597610338839184, "ngenes": 25, "description": "Pervasive developmental disorders", "id": "716c1505-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9005891", "value": 0.597610338839184, "ngenes": 25, "description": "Loss of function of MECP2 in Rett syndrome", "id": "716c1506-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9022535", "value": 0.047224016530099736, "ngenes": 7, "description": "Loss of phosphorylation of MECP2 at T308", "id": "716c1507-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022537", "value": 0.5864457084035299, "ngenes": 11, "description": "Loss of MECP2 binding ability to the NCoR/SMRT complex", "id": "716c1508-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022538", "value": 0.9018904461315899, "ngenes": 11, "description": "Loss of MECP2 binding ability to 5mC-DNA", "id": "716c1509-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-9675132", "value": 0.02259031855457533, "ngenes": 5, "description": "Diseases of cellular response to stress", "id": "716c150a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9630747", "value": 0.02259031855457533, "ngenes": 5, "description": "Diseases of Cellular Senescence", "id": "716c150b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9630750", "value": 0.02259031855457533, "ngenes": 5, "description": "Evasion of Oncogene Induced Senescence Due to p16INK4A Defects", "id": "716c150c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9630791", "value": 0.009554036908535702, "ngenes": 4, "description": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4", "id": "716c150d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9630794", "value": 0.02259031855457533, "ngenes": 5, "description": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "id": "716c150e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9632693", "value": 0.02259031855457533, "ngenes": 5, "description": "Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects", "id": "716c150f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9632697", "value": 0.009554036908535702, "ngenes": 4, "description": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4", "id": "716c1510-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9632700", "value": 0.02259031855457533, "ngenes": 5, "description": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "id": "716c1511-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9646303", "value": 0.02646815606877149, "ngenes": 3, "description": "Evasion of Oncogene Induced Senescence Due to p14ARF Defects", "id": "716c1512-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9646304", "value": 0.02646815606877149, "ngenes": 3, "description": "Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects", "id": "716c1513-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9671793", "value": 0.3056236055452598, "ngenes": 21, "description": "Diseases of hemostasis", "id": "716c1514-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9651496", "value": 0.3056236055452598, "ngenes": 21, "description": "Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)", "id": "716c1515-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9657689", "value": 0.16019450751458392, "ngenes": 4, "description": "Defective SERPING1 causes hereditary angioedema", "id": "716c1516-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672383", "value": 4.840344389421222e-05, "ngenes": 6, "description": "Defective factor IX causes thrombophilia", "id": "716c1517-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9662001", "value": 0.05752315783098558, "ngenes": 11, "description": "Defective factor VIII causes hemophilia A", "id": "716c1518-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9672387", "value": 4.840344389421222e-05, "ngenes": 4, "description": "Defective F8 accelerates dissociation of the A2 domain", "id": "716c1519-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672391", "value": 4.840344389421222e-05, "ngenes": 5, "description": "Defective F8 cleavage by thrombin", "id": "716c151a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672393", "value": 4.840344389421222e-05, "ngenes": 5, "description": "Defective F8 binding to von Willebrand factor", "id": "716c151b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672395", "value": 4.840344389421222e-05, "ngenes": 4, "description": "Defective F8 binding to the cell membrane", "id": "716c151c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672396", "value": 4.840344389421222e-05, "ngenes": 6, "description": "Defective cofactor function of FVIIIa variant", "id": "716c151d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672397", "value": 4.840344389421222e-05, "ngenes": 4, "description": "Defective F8 secretion", "id": "716c151e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9674519", "value": 0.037126356197780395, "ngenes": 8, "description": "Defective F8 sulfation at Y1699", "id": "716c151f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9668250", "value": 0.00016225071776398208, "ngenes": 12, "description": "Defective factor IX causes hemophilia B", "id": "716c1520-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9673202", "value": 4.840344389421222e-05, "ngenes": 6, "description": "Defective F9 variant does not activate FX", "id": "716c1521-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673221", "value": 0.5859484494885234, "ngenes": 6, "description": "Defective F9 activation", "id": "716c1522-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9675126", "value": 1.0, "ngenes": 68, "description": "Diseases of mitotic cell cycle", "id": "716c1523-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9687139", "value": 0.6267975282896396, "ngenes": 63, "description": "Aberrant regulation of mitotic cell cycle due to RB1 defects", "id": "716c1524-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9659787", "value": 0.02646815606877149, "ngenes": 26, "description": "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects", "id": "716c1525-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9661069", "value": 0.02646815606877149, "ngenes": 26, "description": "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)", "id": "716c1526-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9687136", "value": 0.04613472897525862, "ngenes": 38, "description": "Aberrant regulation of mitotic exit in cancer due to RB1 defects", "id": "716c1527-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-382551", "value": 0.13288998227813706, "ngenes": 1163, "description": "Transport of small molecules", "id": "716c1528-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1480926", "value": 0.5477992656529245, "ngenes": 16, "description": "O2/CO2 exchange in erythrocytes", "id": "716c1529-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1237044", "value": 0.5477992656529245, "ngenes": 16, "description": "Erythrocytes take up carbon dioxide and release oxygen", "id": "716c152a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1247673", "value": 0.7449226606453779, "ngenes": 10, "description": "Erythrocytes take up oxygen and release carbon dioxide", "id": "716c152b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-382556", "value": 0.15301022014952828, "ngenes": 179, "description": "ABC-family proteins mediated transport", "id": "716c152c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1369007", "value": 0.06179051941079923, "ngenes": 5, "description": "Mitochondrial ABC transporters", "id": "716c152d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1369062", "value": 0.10072586345955742, "ngenes": 34, "description": "ABC transporters in lipid homeostasis", "id": "716c152e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-425407", "value": 0.7824251417180138, "ngenes": 370, "description": "SLC-mediated transmembrane transport", "id": "716c152f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-189200", "value": 0.32968063215624954, "ngenes": 33, "description": "Cellular hexose transport", "id": "716c1530-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425393", "value": 0.3236577123021815, "ngenes": 156, "description": "Transport of inorganic cations/anions and amino acids/oligopeptides", "id": "716c1531-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-352230", "value": 0.3985480570855666, "ngenes": 48, "description": "Amino acid transport across the plasma membrane", "id": "716c1532-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425381", "value": 4.840344389421222e-05, "ngenes": 16, "description": "Bicarbonate transporters", "id": "716c1533-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425561", "value": 0.15027176446972595, "ngenes": 20, "description": "Sodium/Calcium exchangers", "id": "716c1534-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425986", "value": 0.5979885835539753, "ngenes": 14, "description": "Sodium/Proton exchangers", "id": "716c1535-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-426117", "value": 0.1890184887059646, "ngenes": 9, "description": "Cation-coupled Chloride cotransporters", "id": "716c1536-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-427652", "value": 0.05183685153303107, "ngenes": 6, "description": "Sodium-coupled phosphate cotransporters", "id": "716c1537-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-427589", "value": 0.7035598236382133, "ngenes": 4, "description": "Type II Na+/Pi cotransporters", "id": "716c1538-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-427601", "value": 0.08256565189037975, "ngenes": 20, "description": "Multifunctional anion exchangers", "id": "716c1539-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-427975", "value": 0.10404356720284604, "ngenes": 3, "description": "Proton/oligopeptide cotransporters", "id": "716c153a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428643", "value": 0.989794880331431, "ngenes": 9, "description": "Organic anion transporters", "id": "716c153b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-425366", "value": 0.29647556691096916, "ngenes": 127, "description": "Transport of bile salts and organic acids, metal ions and amine compounds", "id": "716c153c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-429593", "value": 0.08729205361465606, "ngenes": 3, "description": "Inositol transporters", "id": "716c153d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-433137", "value": 0.819591572978342, "ngenes": 8, "description": "Sodium-coupled sulphate, di- and tri-carboxylate transporters", "id": "716c153e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-433692", "value": 0.07239518012501328, "ngenes": 9, "description": "Proton-coupled monocarboxylate transport", "id": "716c153f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425410", "value": 0.035253484889292405, "ngenes": 42, "description": "Metal ion SLC transporters", "id": "716c1540-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-435354", "value": 0.03870375445735832, "ngenes": 30, "description": "Zinc transporters", "id": "716c1541-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-435368", "value": 0.1454035285371808, "ngenes": 13, "description": "Zinc efflux and compartmentalization by the SLC30 family", "id": "716c1542-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-442380", "value": 0.02729478778815131, "ngenes": 17, "description": "Zinc influx into cells by the SLC39 gene family", "id": "716c1543-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-442660", "value": 1.0, "ngenes": 26, "description": "Na+/Cl- dependent neurotransmitter transporters", "id": "716c1544-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444411", "value": 0.3506260567546662, "ngenes": 3, "description": "Rhesus glycoproteins mediate ammonium transport.", "id": "716c1545-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-549132", "value": 0.8360679767079591, "ngenes": 26, "description": "Organic cation/anion/zwitterion transport", "id": "716c1546-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-549127", "value": 0.8974988901194242, "ngenes": 16, "description": "Organic cation transport", "id": "716c1547-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-561048", "value": 0.5988255701043269, "ngenes": 10, "description": "Organic anion transport", "id": "716c1548-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-425397", "value": 0.8827867308816563, "ngenes": 64, "description": "Transport of vitamins, nucleosides, and related molecules", "id": "716c1549-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-727802", "value": 0.9102657587055601, "ngenes": 13, "description": "Transport of nucleotide sugars", "id": "716c154a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-804914", "value": 0.044688814326312096, "ngenes": 10, "description": "Transport of fatty acids", "id": "716c154b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-83936", "value": 0.6029333190939079, "ngenes": 14, "description": "Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane", "id": "716c154c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-879518", "value": 0.5928827675165083, "ngenes": 25, "description": "Transport of organic anions", "id": "716c154d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-983712", "value": 0.27701795295653275, "ngenes": 320, "description": "Ion channel transport", "id": "716c154e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2672351", "value": 0.16544214703985513, "ngenes": 175, "description": "Stimuli-sensing channels", "id": "716c154f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3295583", "value": 0.43153649892179025, "ngenes": 43, "description": "TRP channels", "id": "716c1550-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-936837", "value": 0.7347562045131799, "ngenes": 110, "description": "Ion transport by P-type ATPases", "id": "716c1551-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445717", "value": 0.2146483416664331, "ngenes": 74, "description": "Aquaporin-mediated transport", "id": "716c1552-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-432030", "value": 0.631362444295074, "ngenes": 3, "description": "Transport of glycerol from adipocytes to the liver by Aquaporins", "id": "716c1553-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-432040", "value": 0.18929752415174866, "ngenes": 64, "description": "Vasopressin regulates renal water homeostasis via Aquaporins", "id": "716c1554-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-432047", "value": 0.5864457084035299, "ngenes": 16, "description": "Passive transport by Aquaporins", "id": "716c1555-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5223345", "value": 0.8588258771641076, "ngenes": 45, "description": "Miscellaneous transport and binding events", "id": "716c1556-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174824", "value": 0.42122859688197495, "ngenes": 127, "description": "Plasma lipoprotein assembly, remodeling, and clearance", "id": "716c1557-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8963898", "value": 0.5235198228942736, "ngenes": 31, "description": "Plasma lipoprotein assembly", "id": "716c1558-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866423", "value": 0.13177655784366718, "ngenes": 5, "description": "VLDL assembly", "id": "716c1559-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963888", "value": 0.46942751164804625, "ngenes": 12, "description": "Chylomicron assembly", "id": "716c155a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963896", "value": 0.1732754134046908, "ngenes": 18, "description": "HDL assembly", "id": "716c155b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8964043", "value": 0.2382680074746527, "ngenes": 49, "description": "Plasma lipoprotein clearance", "id": "716c155c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866427", "value": 0.16392587730721794, "ngenes": 21, "description": "VLDLR internalisation and degradation", "id": "716c155d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964011", "value": 1.0, "ngenes": 7, "description": "HDL clearance", "id": "716c155e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964026", "value": 0.06100298779926902, "ngenes": 6, "description": "Chylomicron clearance", "id": "716c155f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964038", "value": 0.15133061696093103, "ngenes": 30, "description": "LDL clearance", "id": "716c1560-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964046", "value": 0.025116695354688363, "ngenes": 9, "description": "VLDL clearance", "id": "716c1561-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8963899", "value": 0.6578225965184719, "ngenes": 61, "description": "Plasma lipoprotein remodeling", "id": "716c1562-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8963889", "value": 0.9203021068739293, "ngenes": 36, "description": "Assembly of active LPL and LIPC lipase complexes", "id": "716c1563-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963901", "value": 0.47778786183803407, "ngenes": 12, "description": "Chylomicron remodeling", "id": "716c1564-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964041", "value": 0.18034293740950935, "ngenes": 8, "description": "LDL remodeling", "id": "716c1565-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964058", "value": 0.7386023065747235, "ngenes": 19, "description": "HDL remodeling", "id": "716c1566-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8949215", "value": 0.023657916076338107, "ngenes": 33, "description": "Mitochondrial calcium ion transport", "id": "716c1567-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8949664", "value": 0.016738572589010625, "ngenes": 23, "description": "Processing of SMDT1", "id": "716c1568-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8981607", "value": 0.5541477302483739, "ngenes": 6, "description": "Intracellular oxygen transport", "id": "716c1569-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-917937", "value": 0.33757711061765966, "ngenes": 95, "description": "Iron uptake and transport", "id": "716c156a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-917977", "value": 0.5262985964664606, "ngenes": 54, "description": "Transferrin endocytosis and recycling", "id": "716c156b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1430728", "value": 0.09219611882665504, "ngenes": 3335, "description": "Metabolism", "id": "716c156c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-71291", "value": 0.07999861398585909, "ngenes": 627, "description": "Metabolism of amino acids and derivatives", "id": "716c156d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1614635", "value": 0.16652823963871297, "ngenes": 44, "description": "Sulfur amino acid metabolism", "id": "716c156e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1237112", "value": 0.8263249123262675, "ngenes": 10, "description": "Methionine salvage pathway", "id": "716c156f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1614558", "value": 0.23320711189221485, "ngenes": 23, "description": "Degradation of cysteine and homocysteine", "id": "716c1570-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1614517", "value": 0.6367751822298636, "ngenes": 9, "description": "Sulfide oxidation to sulfate", "id": "716c1571-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1614603", "value": 0.2506530239039547, "ngenes": 4, "description": "Cysteine formation from homocysteine", "id": "716c1572-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-209776", "value": 0.047386078152789314, "ngenes": 23, "description": "Metabolism of amine-derived hormones", "id": "716c1573-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-209905", "value": 0.03333898376158171, "ngenes": 5, "description": "Catecholamine biosynthesis", "id": "716c1574-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209931", "value": 0.7979872507036092, "ngenes": 5, "description": "Serotonin and melatonin biosynthesis", "id": "716c1575-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209968", "value": 0.14462859621967175, "ngenes": 14, "description": "Thyroxine biosynthesis", "id": "716c1576-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-350864", "value": 0.1245317765865038, "ngenes": 6, "description": "Regulation of thyroid hormone activity", "id": "716c1577-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2408522", "value": 0.13855348391525474, "ngenes": 235, "description": "Selenoamino acid metabolism", "id": "716c1578-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2408508", "value": 0.15810672079576676, "ngenes": 14, "description": "Metabolism of ingested SeMet, Sec, MeSec into H2Se", "id": "716c1579-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2408550", "value": 0.05693528045723856, "ngenes": 7, "description": "Metabolism of ingested H2SeO4 and H2SeO3 into H2Se", "id": "716c157a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2408557", "value": 0.15020671530343088, "ngenes": 200, "description": "Selenocysteine synthesis", "id": "716c157b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-351202", "value": 0.2767727737172947, "ngenes": 99, "description": "Metabolism of polyamines", "id": "716c157c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-350562", "value": 0.30316412360147216, "ngenes": 85, "description": "Regulation of ornithine decarboxylase (ODC)", "id": "716c157d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-351200", "value": 0.09479157878146452, "ngenes": 7, "description": "Interconversion of polyamines", "id": "716c157e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5662702", "value": 0.27776153001374615, "ngenes": 8, "description": "Melanin biosynthesis", "id": "716c157f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389661", "value": 0.002698769811069904, "ngenes": 51, "description": "Glyoxylate metabolism and glycine degradation", "id": "716c1580-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6783984", "value": 0.14051276440445443, "ngenes": 7, "description": "Glycine degradation", "id": "716c1581-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6798163", "value": 0.12357001580529121, "ngenes": 9, "description": "Choline catabolism", "id": "716c1582-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70635", "value": 0.9873342089929794, "ngenes": 13, "description": "Urea cycle", "id": "716c1583-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70688", "value": 0.5644922054187091, "ngenes": 6, "description": "Proline catabolism", "id": "716c1584-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70895", "value": 0.0008552920800305216, "ngenes": 27, "description": "Branched-chain amino acid catabolism", "id": "716c1585-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70921", "value": 0.13375822907700052, "ngenes": 15, "description": "Histidine catabolism", "id": "716c1586-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71064", "value": 0.5492030712260563, "ngenes": 23, "description": "Lysine catabolism", "id": "716c1587-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71240", "value": 0.09657838865417234, "ngenes": 24, "description": "Tryptophan catabolism", "id": "716c1588-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71262", "value": 0.00201328401590426, "ngenes": 9, "description": "Carnitine synthesis", "id": "716c1589-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71288", "value": 0.46537101480891696, "ngenes": 13, "description": "Creatine metabolism", "id": "716c158a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849175", "value": 0.18905048243690628, "ngenes": 6, "description": "Threonine catabolism", "id": "716c158b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963691", "value": 0.9689625471354482, "ngenes": 19, "description": "Phenylalanine and tyrosine metabolism", "id": "716c158c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8963684", "value": 0.6324786572174614, "ngenes": 10, "description": "Tyrosine catabolism", "id": "716c158d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964208", "value": 0.8572185123996907, "ngenes": 9, "description": "Phenylalanine metabolism", "id": "716c158e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8963693", "value": 0.29304228207449035, "ngenes": 11, "description": "Aspartate and asparagine metabolism", "id": "716c158f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964539", "value": 0.6073209069103005, "ngenes": 22, "description": "Glutamate and glutamine metabolism", "id": "716c1590-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-977347", "value": 0.7361748543815269, "ngenes": 12, "description": "Serine biosynthesis", "id": "716c1591-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-211859", "value": 0.3504572955282555, "ngenes": 340, "description": "Biological oxidations", "id": "716c1592-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211945", "value": 0.6276916077290325, "ngenes": 142, "description": "Phase I - Functionalization of compounds", "id": "716c1593-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140179", "value": 0.07342878394642192, "ngenes": 8, "description": "Amine Oxidase reactions", "id": "716c1594-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141334", "value": 0.10049563801011191, "ngenes": 6, "description": "PAOs oxidise polyamines to amines", "id": "716c1595-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-211897", "value": 0.9474089154377879, "ngenes": 84, "description": "Cytochrome P450 - arranged by substrate type", "id": "716c1596-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211916", "value": 0.8156494226170143, "ngenes": 8, "description": "Vitamins", "id": "716c1597-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211935", "value": 0.16174887717724898, "ngenes": 21, "description": "Fatty acids", "id": "716c1598-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211958", "value": 0.3682845431575101, "ngenes": 17, "description": "Miscellaneous substrates", "id": "716c1599-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211976", "value": 0.24424018962773714, "ngenes": 37, "description": "Endogenous sterols", "id": "716c159a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211979", "value": 0.4681017771025311, "ngenes": 13, "description": "Eicosanoids", "id": "716c159b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211981", "value": 0.12398964310425166, "ngenes": 29, "description": "Xenobiotics", "id": "716c159c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211999", "value": 0.21079354458763944, "ngenes": 17, "description": "CYP2E1 reactions", "id": "716c159d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-217271", "value": 0.7723008365550326, "ngenes": 3, "description": "FMO oxidises nucleophiles", "id": "716c159e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71384", "value": 0.24993662444792122, "ngenes": 19, "description": "Ethanol oxidation", "id": "716c159f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8937144", "value": 0.06525056324868748, "ngenes": 7, "description": "Aryl hydrocarbon receptor signalling", "id": "716c15a0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156580", "value": 0.2082835662953309, "ngenes": 189, "description": "Phase II - Conjugation of compounds", "id": "716c15a1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156581", "value": 0.18662285113082658, "ngenes": 22, "description": "Methylation", "id": "716c15a2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-156582", "value": 0.0786459426782135, "ngenes": 4, "description": "Acetylation", "id": "716c15a3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-156588", "value": 0.24793598721250526, "ngenes": 39, "description": "Glucuronidation", "id": "716c15a4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-173599", "value": 0.41784076030391865, "ngenes": 7, "description": "Formation of the active cofactor, UDP-glucuronate", "id": "716c15a5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156584", "value": 0.597513586010148, "ngenes": 45, "description": "Cytosolic sulfonation of small molecules", "id": "716c15a6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174362", "value": 0.10531870587940882, "ngenes": 11, "description": "Transport and synthesis of PAPS", "id": "716c15a7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156590", "value": 0.5103759583981674, "ngenes": 65, "description": "Glutathione conjugation", "id": "716c15a8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174403", "value": 0.1949641884470656, "ngenes": 24, "description": "Glutathione synthesis and recycling", "id": "716c15a9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156587", "value": 0.4058135272353899, "ngenes": 16, "description": "Amino Acid conjugation", "id": "716c15aa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159424", "value": 0.4058135272353899, "ngenes": 16, "description": "Conjugation of carboxylic acids", "id": "716c15ab-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-177128", "value": 0.405876168262995, "ngenes": 15, "description": "Conjugation of salicylate with glycine", "id": "716c15ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-177135", "value": 0.23031307864038617, "ngenes": 10, "description": "Conjugation of benzoate with glycine", "id": "716c15ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-177162", "value": 0.8148059847621457, "ngenes": 5, "description": "Conjugation of phenylacetate with glutamine", "id": "716c15ae-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-5423646", "value": 0.26748248334966235, "ngenes": 32, "description": "Aflatoxin activation and detoxification", "id": "716c15af-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196854", "value": 0.3056236055452598, "ngenes": 285, "description": "Metabolism of vitamins and cofactors", "id": "716c15b0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8978934", "value": 0.6169419135077292, "ngenes": 31, "description": "Metabolism of cofactors", "id": "716c15b1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1474151", "value": 0.3123437336578039, "ngenes": 18, "description": "Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation", "id": "716c15b2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142789", "value": 0.8636052042095431, "ngenes": 11, "description": "Ubiquinol biosynthesis", "id": "716c15b3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196849", "value": 0.42733022428698086, "ngenes": 193, "description": "Metabolism of water-soluble vitamins and cofactors", "id": "716c15b4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196741", "value": 0.30042120890306223, "ngenes": 32, "description": "Cobalamin (Cbl, vitamin B12) transport and metabolism", "id": "716c15b5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196757", "value": 0.14852614033917946, "ngenes": 26, "description": "Metabolism of folate and pterines", "id": "716c15b6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196780", "value": 0.40501418406326883, "ngenes": 14, "description": "Biotin transport and metabolism", "id": "716c15b7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-199220", "value": 0.3056236055452598, "ngenes": 27, "description": "Vitamin B5 (pantothenate) metabolism", "id": "716c15b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196783", "value": 0.5978108937784699, "ngenes": 15, "description": "Coenzyme A biosynthesis", "id": "716c15b9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196819", "value": 0.493014100163527, "ngenes": 6, "description": "Vitamin B1 (thiamin) metabolism", "id": "716c15ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196836", "value": 0.6653074803916362, "ngenes": 14, "description": "Vitamin C (ascorbate) metabolism", "id": "716c15bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196843", "value": 0.7986285572570058, "ngenes": 10, "description": "Vitamin B2 (riboflavin) metabolism", "id": "716c15bc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196807", "value": 0.4651142896043178, "ngenes": 49, "description": "Nicotinate metabolism", "id": "716c15bd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-197264", "value": 0.26227632447937427, "ngenes": 32, "description": "Nicotinamide salvaging", "id": "716c15be-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-947581", "value": 0.6719994439128143, "ngenes": 13, "description": "Molybdenum cofactor biosynthesis", "id": "716c15bf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-964975", "value": 0.5356637997569935, "ngenes": 4, "description": "Vitamins B6 activation to pyridoxal phosphate", "id": "716c15c0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6806667", "value": 0.3423454324469691, "ngenes": 64, "description": "Metabolism of fat-soluble vitamins", "id": "716c15c1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6806664", "value": 0.30042120890306223, "ngenes": 4, "description": "Metabolism of vitamin K", "id": "716c15c2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8877627", "value": 0.7936599036367434, "ngenes": 3, "description": "Vitamin E", "id": "716c15c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975634", "value": 0.3346263399090412, "ngenes": 57, "description": "Retinoid metabolism and transport", "id": "716c15c4-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1475029", "value": 0.6324786572174614, "ngenes": 16, "description": "Reversible hydration of carbon dioxide", "id": "716c15c5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-556833", "value": 0.08256565189037975, "ngenes": 1171, "description": "Metabolism of lipids", "id": "716c15c6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1483257", "value": 0.022715740129102557, "ngenes": 340, "description": "Phospholipid metabolism", "id": "716c15c7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1483206", "value": 0.022715740129102557, "ngenes": 200, "description": "Glycerophospholipid biosynthesis", "id": "716c15c8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1482788", "value": 0.0594537139956224, "ngenes": 34, "description": "Acyl chain remodelling of PC", "id": "716c15c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482798", "value": 0.6536064953066831, "ngenes": 10, "description": "Acyl chain remodeling of CL", "id": "716c15ca-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482801", "value": 0.03333898376158171, "ngenes": 28, "description": "Acyl chain remodelling of PS", "id": "716c15cb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482839", "value": 0.0707229434916646, "ngenes": 36, "description": "Acyl chain remodelling of PE", "id": "716c15cc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482883", "value": 0.238513440962836, "ngenes": 9, "description": "Acyl chain remodeling of DAG and TAG", "id": "716c15cd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482922", "value": 0.6173208834826669, "ngenes": 21, "description": "Acyl chain remodelling of PI", "id": "716c15ce-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482925", "value": 0.21105502285266028, "ngenes": 22, "description": "Acyl chain remodelling of PG", "id": "716c15cf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483115", "value": 0.9438466463533149, "ngenes": 11, "description": "Hydrolysis of LPC", "id": "716c15d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483148", "value": 0.584928104934674, "ngenes": 10, "description": "Synthesis of PG", "id": "716c15d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483166", "value": 0.05969835406066545, "ngenes": 57, "description": "Synthesis of PA", "id": "716c15d2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483191", "value": 0.04861235324053456, "ngenes": 58, "description": "Synthesis of PC", "id": "716c15d3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483213", "value": 0.20291399313977876, "ngenes": 29, "description": "Synthesis of PE", "id": "716c15d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483226", "value": 0.7365013553282641, "ngenes": 6, "description": "Synthesis of PI", "id": "716c15d5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1483255", "value": 0.035253484889292405, "ngenes": 141, "description": "PI Metabolism", "id": "716c15d6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1483248", "value": 0.09101768554082425, "ngenes": 10, "description": "Synthesis of PIPs at the ER membrane", "id": "716c15d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660499", "value": 0.04216998412170033, "ngenes": 91, "description": "Synthesis of PIPs at the plasma membrane", "id": "716c15d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660514", "value": 0.017064400272771757, "ngenes": 32, "description": "Synthesis of PIPs at the Golgi membrane", "id": "716c15d9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660516", "value": 0.10082275618848612, "ngenes": 25, "description": "Synthesis of PIPs at the early endosome membrane", "id": "716c15da-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660517", "value": 0.4156271098311624, "ngenes": 15, "description": "Synthesis of PIPs at the late endosome membrane", "id": "716c15db-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6814848", "value": 0.12721138533759097, "ngenes": 12, "description": "Glycerophospholipid catabolism", "id": "716c15dc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8847453", "value": 0.698386134013551, "ngenes": 6, "description": "Synthesis of PIPs in the nucleus", "id": "716c15dd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8957322", "value": 0.25049405525448054, "ngenes": 241, "description": "Metabolism of steroids", "id": "716c15de-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-194068", "value": 0.8978764811258031, "ngenes": 70, "description": "Bile acid and bile salt metabolism", "id": "716c15df-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159418", "value": 0.39357828143693746, "ngenes": 25, "description": "Recycling of bile acids and salts", "id": "716c15e0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192105", "value": 0.18910078156248342, "ngenes": 54, "description": "Synthesis of bile acids and bile salts", "id": "716c15e1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193368", "value": 0.4610878081154705, "ngenes": 33, "description": "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol", "id": "716c15e2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193775", "value": 0.9683096548724827, "ngenes": 21, "description": "Synthesis of bile acids and bile salts via 24-hydroxycholesterol", "id": "716c15e3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193807", "value": 0.989794880331431, "ngenes": 21, "description": "Synthesis of bile acids and bile salts via 27-hydroxycholesterol", "id": "716c15e4-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-196071", "value": 0.2013230289964383, "ngenes": 51, "description": "Metabolism of steroid hormones", "id": "716c15e5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193048", "value": 0.451938419352849, "ngenes": 13, "description": "Androgen biosynthesis", "id": "716c15e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193144", "value": 0.9600152909120198, "ngenes": 11, "description": "Estrogen biosynthesis", "id": "716c15e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193993", "value": 0.7667819689795599, "ngenes": 6, "description": "Mineralocorticoid biosynthesis", "id": "716c15e8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-194002", "value": 0.14091670755703514, "ngenes": 14, "description": "Glucocorticoid biosynthesis", "id": "716c15e9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196108", "value": 0.1728509579334862, "ngenes": 18, "description": "Pregnenolone biosynthesis", "id": "716c15ea-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196791", "value": 0.6578399784332993, "ngenes": 18, "description": "Vitamin D (calciferol) metabolism", "id": "716c15eb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1655829", "value": 0.2566692368358437, "ngenes": 89, "description": "Regulation of cholesterol biosynthesis by SREBP (SREBF)", "id": "716c15ec-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2426168", "value": 0.06980941466577938, "ngenes": 64, "description": "Activation of gene expression by SREBF (SREBP)", "id": "716c15ed-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-191273", "value": 0.15810672079576676, "ngenes": 41, "description": "Cholesterol biosynthesis", "id": "716c15ee-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6807047", "value": 0.15492797003311004, "ngenes": 7, "description": "Cholesterol biosynthesis via desmosterol", "id": "716c15ef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807062", "value": 0.15492797003311004, "ngenes": 7, "description": "Cholesterol biosynthesis via lathosterol", "id": "716c15f0-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8979227", "value": 0.1792094027655885, "ngenes": 56, "description": "Triglyceride metabolism", "id": "716c15f1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163560", "value": 0.22474226053220678, "ngenes": 40, "description": "Triglyceride catabolism", "id": "716c15f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75109", "value": 0.3399079956568508, "ngenes": 16, "description": "Triglyceride biosynthesis", "id": "716c15f3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-428157", "value": 0.47981069277432625, "ngenes": 151, "description": "Sphingolipid metabolism", "id": "716c15f4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1660661", "value": 0.7289396388774505, "ngenes": 74, "description": "Sphingolipid de novo biosynthesis", "id": "716c15f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660662", "value": 0.1952071231639489, "ngenes": 77, "description": "Glycosphingolipid metabolism", "id": "716c15f6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-400206", "value": 0.14672266941821546, "ngenes": 184, "description": "Regulation of lipid metabolism by PPARalpha", "id": "716c15f7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1989781", "value": 0.1454035285371808, "ngenes": 182, "description": "PPARA activates gene expression", "id": "716c15f8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8978868", "value": 0.03353723961526887, "ngenes": 266, "description": "Fatty acid metabolism", "id": "716c15f9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-200425", "value": 0.026691474897908248, "ngenes": 25, "description": "Carnitine metabolism", "id": "716c15fa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2046104", "value": 0.001836721552893203, "ngenes": 16, "description": "alpha-linolenic (omega3) and linoleic (omega6) acid metabolism", "id": "716c15fb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2046105", "value": 0.04231790465308578, "ngenes": 8, "description": "Linoleic acid (LA) metabolism", "id": "716c15fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2046106", "value": 0.001836721552893203, "ngenes": 16, "description": "alpha-linolenic acid (ALA) metabolism", "id": "716c15fd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2142753", "value": 0.19126158659763745, "ngenes": 84, "description": "Arachidonic acid metabolism", "id": "716c15fe-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2142670", "value": 0.1651953716763447, "ngenes": 6, "description": "Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)", "id": "716c15ff-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142688", "value": 0.04379993650861246, "ngenes": 15, "description": "Synthesis of 5-eicosatetraenoic acids", "id": "716c1600-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142691", "value": 0.08102908424039212, "ngenes": 38, "description": "Synthesis of Leukotrienes (LT) and Eoxins (EX)", "id": "716c1601-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142712", "value": 0.9849750692500847, "ngenes": 11, "description": "Synthesis of 12-eicosatetraenoic acid derivatives", "id": "716c1602-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142770", "value": 0.09218528826601044, "ngenes": 13, "description": "Synthesis of 15-eicosatetraenoic acid derivatives", "id": "716c1603-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142816", "value": 0.6693101490581971, "ngenes": 7, "description": "Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)", "id": "716c1604-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2162123", "value": 0.16652823963871297, "ngenes": 19, "description": "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)", "id": "716c1605-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-390918", "value": 0.015675339003482468, "ngenes": 41, "description": "Peroxisomal lipid metabolism", "id": "716c1606-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389599", "value": 0.00015894186110084675, "ngenes": 10, "description": "Alpha-oxidation of phytanate", "id": "716c1607-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389887", "value": 0.9568878774515732, "ngenes": 12, "description": "Beta-oxidation of pristanoyl-CoA", "id": "716c1608-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390247", "value": 0.057324099763536106, "ngenes": 15, "description": "Beta-oxidation of very long chain fatty acids", "id": "716c1609-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-77289", "value": 0.04757934316888559, "ngenes": 52, "description": "Mitochondrial Fatty Acid Beta-Oxidation", "id": "716c160a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-71032", "value": 0.07930124169465091, "ngenes": 5, "description": "Propionyl-CoA catabolism", "id": "716c160b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77286", "value": 0.0017214713101527607, "ngenes": 17, "description": "mitochondrial fatty acid beta-oxidation of saturated fatty acids", "id": "716c160c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-77285", "value": 0.6079910434458088, "ngenes": 3, "description": "Beta oxidation of myristoyl-CoA to lauroyl-CoA", "id": "716c160d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77305", "value": 0.168798340892524, "ngenes": 5, "description": "Beta oxidation of palmitoyl-CoA to myristoyl-CoA", "id": "716c160e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77310", "value": 0.5107862430249993, "ngenes": 5, "description": "Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA", "id": "716c160f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77346", "value": 0.00022740360434773702, "ngenes": 8, "description": "Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA", "id": "716c1610-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77348", "value": 0.00037711697949228685, "ngenes": 6, "description": "Beta oxidation of octanoyl-CoA to hexanoyl-CoA", "id": "716c1611-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77350", "value": 0.47981069277432625, "ngenes": 4, "description": "Beta oxidation of hexanoyl-CoA to butanoyl-CoA", "id": "716c1612-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77352", "value": 0.15609774319060718, "ngenes": 7, "description": "Beta oxidation of butanoyl-CoA to acetyl-CoA", "id": "716c1613-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-77288", "value": 0.000754535607733383, "ngenes": 7, "description": "mitochondrial fatty acid beta-oxidation of unsaturated fatty acids", "id": "716c1614-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75105", "value": 0.256683910934971, "ngenes": 65, "description": "Fatty acyl-CoA biosynthesis", "id": "716c1615-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75876", "value": 0.3056236055452598, "ngenes": 44, "description": "Synthesis of very long-chain fatty acyl-CoAs", "id": "716c1616-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9018678", "value": 0.008323586841700318, "ngenes": 29, "description": "Biosynthesis of specialized proresolving mediators (SPMs)", "id": "716c1617-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2142700", "value": 0.1804597374699515, "ngenes": 10, "description": "Synthesis of Lipoxins (LX)", "id": "716c1618-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9018677", "value": 0.01720774194713181, "ngenes": 26, "description": "Biosynthesis of DHA-derived SPMs", "id": "716c1619-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9018676", "value": 0.5225090917618829, "ngenes": 7, "description": "Biosynthesis of D-series resolvins", "id": "716c161a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9018681", "value": 0.6491257092345148, "ngenes": 4, "description": "Biosynthesis of protectins", "id": "716c161b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020265", "value": 0.4786510760851275, "ngenes": 6, "description": "Biosynthesis of aspirin-triggered D-series resolvins", "id": "716c161c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026395", "value": 0.0030764313378110926, "ngenes": 6, "description": "Biosynthesis of DHA-derived sulfido conjugates", "id": "716c161d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9026762", "value": 0.0030764313378110926, "ngenes": 6, "description": "Biosynthesis of maresin conjugates in tissue regeneration (MCTR)", "id": "716c161e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9018682", "value": 0.7043248661103585, "ngenes": 10, "description": "Biosynthesis of maresins", "id": "716c161f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9027307", "value": 0.11342725109869617, "ngenes": 6, "description": "Biosynthesis of maresin-like SPMs", "id": "716c1620-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9018679", "value": 0.1963525286626569, "ngenes": 12, "description": "Biosynthesis of EPA-derived SPMs", "id": "716c1621-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9018896", "value": 0.5235198228942736, "ngenes": 10, "description": "Biosynthesis of E-series 18(S)-resolvins", "id": "716c1622-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9023661", "value": 0.4765635639358844, "ngenes": 9, "description": "Biosynthesis of E-series 18(R)-resolvins", "id": "716c1623-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9018683", "value": 0.12721138533759097, "ngenes": 9, "description": "Biosynthesis of DPA-derived SPMs", "id": "716c1624-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9025106", "value": 0.8900873185580673, "ngenes": 4, "description": "Biosynthesis of DPAn-6 SPMs", "id": "716c1625-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9025094", "value": 0.12721138533759097, "ngenes": 9, "description": "Biosynthesis of DPAn-3 SPMs", "id": "716c1626-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9026286", "value": 0.18307060469890377, "ngenes": 6, "description": "Biosynthesis of DPAn-3-derived protectins and resolvins", "id": "716c1627-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026290", "value": 0.1922723541020987, "ngenes": 4, "description": "Biosynthesis of DPAn-3-derived maresins", "id": "716c1628-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026403", "value": 0.19416474033792055, "ngenes": 3, "description": "Biosynthesis of DPAn-3-derived 13-series resolvins", "id": "716c1629-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9027604", "value": 0.12022548846798739, "ngenes": 5, "description": "Biosynthesis of electrophilic \u03c9-3 PUFA oxo-derivatives", "id": "716c162a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8848584", "value": 0.3506260567546662, "ngenes": 8, "description": "Wax and plasmalogen biosynthesis", "id": "716c162b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75896", "value": 0.15020671530343088, "ngenes": 3, "description": "Plasmalogen biosynthesis", "id": "716c162c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9640463", "value": 0.2382680074746527, "ngenes": 5, "description": "Wax biosynthesis", "id": "716c162d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-74182", "value": 0.04341555259176416, "ngenes": 13, "description": "Ketone body metabolism", "id": "716c162e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-77108", "value": 0.009554036908535702, "ngenes": 6, "description": "Utilization of Ketone Bodies", "id": "716c162f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77111", "value": 0.06980941466577938, "ngenes": 11, "description": "Synthesis of Ketone Bodies", "id": "716c1630-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8964572", "value": 0.2180853565935762, "ngenes": 11, "description": "Lipid particle organization", "id": "716c1631-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1428517", "value": 0.09939770088346835, "ngenes": 239, "description": "The citric acid (TCA) cycle and respiratory electron transport", "id": "716c1632-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163200", "value": 0.13502730330498747, "ngenes": 161, "description": "Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.", "id": "716c1633-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163210", "value": 0.06896937371942653, "ngenes": 32, "description": "Formation of ATP by chemiosmotic coupling", "id": "716c1634-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166187", "value": 0.091596951382805, "ngenes": 13, "description": "Mitochondrial Uncoupling", "id": "716c1635-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167826", "value": 0.09657838865417234, "ngenes": 8, "description": "The fatty acid cycling model", "id": "716c1636-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167827", "value": 0.09657838865417234, "ngenes": 8, "description": "The proton buffering model", "id": "716c1637-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673163", "value": 0.9683096548724827, "ngenes": 5, "description": "Oleoyl-phe metabolism", "id": "716c1638-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-611105", "value": 0.20583003029438632, "ngenes": 116, "description": "Respiratory electron transport", "id": "716c1639-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6799198", "value": 0.20830723578032395, "ngenes": 63, "description": "Complex I biogenesis", "id": "716c163a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-71406", "value": 0.0416147690885917, "ngenes": 85, "description": "Pyruvate metabolism and Citric Acid (TCA) cycle", "id": "716c163b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-70268", "value": 0.035253484889292405, "ngenes": 44, "description": "Pyruvate metabolism", "id": "716c163c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-204174", "value": 0.01926270775832281, "ngenes": 23, "description": "Regulation of pyruvate dehydrogenase (PDH) complex", "id": "716c163d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-71403", "value": 0.02822576810029488, "ngenes": 39, "description": "Citric acid cycle (TCA cycle)", "id": "716c163e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-880009", "value": 0.026691474897908248, "ngenes": 3, "description": "Interconversion of 2-oxoglutarate and 2-hydroxyglutarate", "id": "716c163f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-163685", "value": 0.23103431986956088, "ngenes": 178, "description": "Integration of energy metabolism", "id": "716c1640-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163358", "value": 0.8756110438803343, "ngenes": 11, "description": "PKA-mediated phosphorylation of key metabolic factors", "id": "716c1641-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163680", "value": 0.016738572589010625, "ngenes": 13, "description": "AMPK inhibits chREBP transcriptional activation activity", "id": "716c1642-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163754", "value": 0.5633367769572261, "ngenes": 3, "description": "Insulin effects increased synthesis of Xylulose-5-Phosphate", "id": "716c1643-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163765", "value": 0.9518708468083799, "ngenes": 20, "description": "ChREBP activates metabolic gene expression", "id": "716c1644-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163767", "value": 0.047224016530099736, "ngenes": 15, "description": "PP2A-mediated dephosphorylation of key metabolic factors", "id": "716c1645-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163359", "value": 0.2082835662953309, "ngenes": 47, "description": "Glucagon signaling in metabolic regulation", "id": "716c1646-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164378", "value": 0.9267901644852048, "ngenes": 28, "description": "PKA activation in glucagon signalling", "id": "716c1647-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-422356", "value": 0.3239995655104988, "ngenes": 123, "description": "Regulation of insulin secretion", "id": "716c1648-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381676", "value": 0.11777218870458916, "ngenes": 62, "description": "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion", "id": "716c1649-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399997", "value": 0.36469532920469283, "ngenes": 14, "description": "Acetylcholine regulates insulin secretion", "id": "716c164a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400042", "value": 0.3332285457392508, "ngenes": 42, "description": "Adrenaline,noradrenaline inhibits insulin secretion", "id": "716c164b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400451", "value": 0.881750611076199, "ngenes": 21, "description": "Free fatty acids regulate insulin secretion", "id": "716c164c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-434313", "value": 1.0, "ngenes": 11, "description": "Intracellular metabolism of fatty acids regulates insulin secretion", "id": "716c164d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-434316", "value": 0.5307998888774476, "ngenes": 10, "description": "Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion", "id": "716c164e-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-71387", "value": 0.17293277209696895, "ngenes": 479, "description": "Metabolism of carbohydrates", "id": "716c164f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-70326", "value": 0.17051089002980763, "ngenes": 162, "description": "Glucose metabolism", "id": "716c1650-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-70171", "value": 0.1859967007385008, "ngenes": 134, "description": "Glycolysis", "id": "716c1651-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170822", "value": 0.05508234659751904, "ngenes": 51, "description": "Regulation of Glucokinase by Glucokinase Regulatory Protein", "id": "716c1652-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9634600", "value": 0.057226079260128966, "ngenes": 28, "description": "Regulation of glycolysis by fructose 2,6-bisphosphate metabolism", "id": "716c1653-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-70263", "value": 0.5221112751308605, "ngenes": 54, "description": "Gluconeogenesis", "id": "716c1654-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1630316", "value": 0.8166729563989763, "ngenes": 193, "description": "Glycosaminoglycan metabolism", "id": "716c1655-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174362", "value": 0.10531870587940882, "ngenes": 11, "description": "Transport and synthesis of PAPS", "id": "716c1656-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1638091", "value": 0.9880327694252751, "ngenes": 83, "description": "Heparan sulfate/heparin (HS-GAG) metabolism", "id": "716c1657-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1971475", "value": 0.8820816237155895, "ngenes": 43, "description": "A tetrasaccharide linker sequence is required for GAG synthesis", "id": "716c1658-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022928", "value": 0.5235198228942736, "ngenes": 42, "description": "HS-GAG biosynthesis", "id": "716c1659-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2024096", "value": 0.5366879580585562, "ngenes": 36, "description": "HS-GAG degradation", "id": "716c165a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1793185", "value": 0.745200724443715, "ngenes": 78, "description": "Chondroitin sulfate/dermatan sulfate metabolism", "id": "716c165b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1971475", "value": 0.8820816237155895, "ngenes": 43, "description": "A tetrasaccharide linker sequence is required for GAG synthesis", "id": "716c165c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022870", "value": 0.23014161508210415, "ngenes": 25, "description": "Chondroitin sulfate biosynthesis", "id": "716c165d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022923", "value": 0.5531410090729686, "ngenes": 19, "description": "Dermatan sulfate biosynthesis", "id": "716c165e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2024101", "value": 0.43207995013501255, "ngenes": 27, "description": "CS/DS degradation", "id": "716c165f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1638074", "value": 0.33965651324216495, "ngenes": 52, "description": "Keratan sulfate/keratin metabolism", "id": "716c1660-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2022854", "value": 0.1923234607623144, "ngenes": 44, "description": "Keratan sulfate biosynthesis", "id": "716c1661-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022857", "value": 0.5980906590461648, "ngenes": 22, "description": "Keratan sulfate degradation", "id": "716c1662-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2142845", "value": 0.0859372043822212, "ngenes": 32, "description": "Hyaluronan metabolism", "id": "716c1663-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2142850", "value": 0.03942446780434165, "ngenes": 12, "description": "Hyaluronan biosynthesis and export", "id": "716c1664-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2160916", "value": 0.745200724443715, "ngenes": 20, "description": "Hyaluronan uptake and degradation", "id": "716c1665-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8982491", "value": 0.2843250860451167, "ngenes": 49, "description": "Glycogen metabolism", "id": "716c1666-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3322077", "value": 0.13797412326459937, "ngenes": 28, "description": "Glycogen synthesis", "id": "716c1667-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70221", "value": 0.7976729997657158, "ngenes": 27, "description": "Glycogen breakdown (glycogenolysis)", "id": "716c1668-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5652084", "value": 0.8636052042095431, "ngenes": 15, "description": "Fructose metabolism", "id": "716c1669-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5652227", "value": 0.8351704802460743, "ngenes": 5, "description": "Fructose biosynthesis", "id": "716c166a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70350", "value": 0.6185247994525451, "ngenes": 10, "description": "Fructose catabolism", "id": "716c166b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5661270", "value": 0.9924305734222377, "ngenes": 10, "description": "Formation of xylulose-5-phosphate", "id": "716c166c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70370", "value": 0.14275890071318711, "ngenes": 9, "description": "Galactose catabolism", "id": "716c166d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71336", "value": 0.03286010627271804, "ngenes": 20, "description": "Pentose phosphate pathway", "id": "716c166e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73843", "value": 0.018125679217150362, "ngenes": 5, "description": "5-Phosphoribose 1-diphosphate biosynthesis", "id": "716c166f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8853383", "value": 0.18846217415371763, "ngenes": 4, "description": "Lysosomal oligosaccharide catabolism", "id": "716c1670-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9033658", "value": 0.2257968622775206, "ngenes": 29, "description": "Blood group systems biosynthesis", "id": "716c1671-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9037628", "value": 0.6100471412773094, "ngenes": 3, "description": "Rhesus blood group biosynthesis", "id": "716c1672-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9037629", "value": 0.2506530239039547, "ngenes": 25, "description": "Lewis blood group biosynthesis", "id": "716c1673-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1483249", "value": 0.9205519421979803, "ngenes": 74, "description": "Inositol phosphate metabolism", "id": "716c1674-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1855167", "value": 0.7935943752500556, "ngenes": 22, "description": "Synthesis of pyrophosphates in the cytosol", "id": "716c1675-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1855183", "value": 0.04894347050477222, "ngenes": 21, "description": "Synthesis of IP2, IP, and Ins in the cytosol", "id": "716c1676-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1855191", "value": 0.05508234659751904, "ngenes": 7, "description": "Synthesis of IPs in the nucleus", "id": "716c1677-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1855204", "value": 0.7314404707984932, "ngenes": 36, "description": "Synthesis of IP3 and IP4 in the cytosol", "id": "716c1678-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-189445", "value": 0.9255427833653975, "ngenes": 41, "description": "Metabolism of porphyrins", "id": "716c1679-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-189451", "value": 0.018125679217150362, "ngenes": 24, "description": "Heme biosynthesis", "id": "716c167a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-189483", "value": 0.8636052042095431, "ngenes": 20, "description": "Heme degradation", "id": "716c167b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-202131", "value": 0.04790306572826659, "ngenes": 22, "description": "Metabolism of nitric oxide: NOS3 activation and regulation", "id": "716c167c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-203615", "value": 0.35831768208713666, "ngenes": 17, "description": "eNOS activation", "id": "716c167d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-203641", "value": 0.2552869492378058, "ngenes": 7, "description": "NOSTRIN mediated eNOS trafficking", "id": "716c167e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2161522", "value": 0.23031307864038617, "ngenes": 13, "description": "Abacavir transport and metabolism", "id": "716c167f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2161517", "value": 0.4543335448357411, "ngenes": 7, "description": "Abacavir transmembrane transport", "id": "716c1680-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2161541", "value": 0.07571005029484179, "ngenes": 6, "description": "Abacavir metabolism", "id": "716c1681-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-15869", "value": 0.37385879578412473, "ngenes": 178, "description": "Metabolism of nucleotides", "id": "716c1682-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8956319", "value": 0.908775444069779, "ngenes": 57, "description": "Nucleobase catabolism", "id": "716c1683-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-74259", "value": 0.1804597374699515, "ngenes": 27, "description": "Purine catabolism", "id": "716c1684-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2393930", "value": 0.7412330679417806, "ngenes": 11, "description": "Phosphate bond hydrolysis by NUDT proteins", "id": "716c1685-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73621", "value": 0.775098387971574, "ngenes": 17, "description": "Pyrimidine catabolism", "id": "716c1686-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8850843", "value": 0.19709009262112914, "ngenes": 14, "description": "Phosphate bond hydrolysis by NTPDase proteins", "id": "716c1687-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-499943", "value": 0.6029333190939079, "ngenes": 58, "description": "Interconversion of nucleotide di- and triphosphates", "id": "716c1688-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8956320", "value": 0.13502730330498747, "ngenes": 26, "description": "Nucleobase biosynthesis", "id": "716c1689-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-500753", "value": 0.8572185123996907, "ngenes": 4, "description": "Pyrimidine biosynthesis", "id": "716c168a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73817", "value": 0.09242946417072014, "ngenes": 22, "description": "Purine ribonucleoside monophosphate biosynthesis", "id": "716c168b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8956321", "value": 0.946774182988149, "ngenes": 45, "description": "Nucleotide salvage", "id": "716c168c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73614", "value": 0.04861235324053456, "ngenes": 17, "description": "Pyrimidine salvage", "id": "716c168d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-74217", "value": 0.3648966931905261, "ngenes": 30, "description": "Purine salvage", "id": "716c168e-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1362409", "value": 0.044688814326312096, "ngenes": 25, "description": "Mitochondrial iron-sulfur cluster biogenesis", "id": "716c168f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2395516", "value": 0.39357828143693746, "ngenes": 5, "description": "Electron transport from NADPH to Ferredoxin", "id": "716c1690-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2564830", "value": 0.8263249123262675, "ngenes": 19, "description": "Cytosolic iron-sulfur cluster assembly", "id": "716c1691-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71737", "value": 0.13375822907700052, "ngenes": 4, "description": "Pyrophosphate hydrolysis", "id": "716c1692-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9609507", "value": 0.04826032229081501, "ngenes": 260, "description": "Protein localization", "id": "716c1693-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1268020", "value": 0.091596951382805, "ngenes": 90, "description": "Mitochondrial protein import", "id": "716d30ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9033241", "value": 0.05508234659751904, "ngenes": 102, "description": "Peroxisomal protein import", "id": "716d30bb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9033500", "value": 0.0013920821953304302, "ngenes": 14, "description": "TYSND1 cleaves peroxisomal proteins", "id": "716d30bc-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9603798", "value": 0.00037711697949228685, "ngenes": 34, "description": "Class I peroxisomal membrane protein import", "id": "716d30bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9609523", "value": 0.12989934432233236, "ngenes": 44, "description": "Insertion of tail-anchored proteins into the endoplasmic reticulum membrane", "id": "716d30be-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-400253", "value": 0.18117816450617322, "ngenes": 124, "description": "Circadian Clock", "id": "716d30bf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1368071", "value": 0.43849935957512653, "ngenes": 4, "description": "NR1D1 (REV-ERBA) represses gene expression", "id": "716d30c0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1368082", "value": 0.41649173219748287, "ngenes": 35, "description": "RORA activates gene expression", "id": "716d30c1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1368108", "value": 0.2052794809876083, "ngenes": 41, "description": "BMAL1:CLOCK,NPAS2 activates circadian gene expression", "id": "716d30c2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1266738", "value": 0.08870499993854414, "ngenes": 1869, "description": "Developmental Biology", "id": "716d30c3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1181150", "value": 0.9204816451795196, "ngenes": 44, "description": "Signaling by NODAL", "id": "716d30c4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1433617", "value": 0.7558325801093805, "ngenes": 23, "description": "Regulation of signaling by NODAL", "id": "716d30c5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-186712", "value": 0.09855815827986986, "ngenes": 70, "description": "Regulation of beta-cell development", "id": "716d30c6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-210744", "value": 0.5845774467976105, "ngenes": 24, "description": "Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells", "id": "716d30c7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210746", "value": 0.15810672079576676, "ngenes": 5, "description": "Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells", "id": "716d30c8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210747", "value": 0.0859372043822212, "ngenes": 15, "description": "Regulation of gene expression in early pancreatic precursor cells", "id": "716d30c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210745", "value": 0.006751876720623643, "ngenes": 39, "description": "Regulation of gene expression in beta cells", "id": "716d30ca-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211163", "value": 0.0008342128124254597, "ngenes": 9, "description": "AKT-mediated inactivation of FOXO1A", "id": "716d30cb-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-452723", "value": 0.10294573529936397, "ngenes": 56, "description": "Transcriptional regulation of pluripotent stem cells", "id": "716d30cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2892245", "value": 0.9119902884065593, "ngenes": 18, "description": "POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation", "id": "716d30cd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2892247", "value": 0.02259031855457533, "ngenes": 22, "description": "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation", "id": "716d30ce-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9675108", "value": 0.09480799100842513, "ngenes": 1076, "description": "Nervous system development", "id": "716d30cf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-422475", "value": 0.09233152408106514, "ngenes": 1040, "description": "Axon guidance", "id": "716d30d0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373752", "value": 0.39101923243033243, "ngenes": 85, "description": "Netrin-1 signaling", "id": "716d30d1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-376172", "value": 0.10115100214101994, "ngenes": 22, "description": "DSCAM interactions", "id": "716d30d2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418885", "value": 0.34839593834831734, "ngenes": 29, "description": "DCC mediated attractive signaling", "id": "716d30d3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418886", "value": 0.008552019852522779, "ngenes": 11, "description": "Netrin mediated repulsion signals", "id": "716d30d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418890", "value": 0.8164397944063196, "ngenes": 12, "description": "Role of second messengers in netrin-1 signaling", "id": "716d30d5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2682334", "value": 0.5736252063959639, "ngenes": 176, "description": "EPH-Ephrin signaling", "id": "716d30d6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3928662", "value": 0.8218156012588609, "ngenes": 82, "description": "EPHB-mediated forward signaling", "id": "716d30d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3928663", "value": 0.5105763486703357, "ngenes": 56, "description": "EPHA-mediated growth cone collapse", "id": "716d30d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3928664", "value": 0.7443227005656078, "ngenes": 34, "description": "Ephrin signaling", "id": "716d30d9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3928665", "value": 0.10404356720284604, "ngenes": 93, "description": "EPH-ephrin mediated repulsion of cells", "id": "716d30da-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-373755", "value": 0.9694129607641102, "ngenes": 112, "description": "Semaphorin interactions", "id": "716d30db-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-399954", "value": 0.4786510760851275, "ngenes": 27, "description": "Sema3A PAK dependent Axon repulsion", "id": "716d30dc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399955", "value": 0.2873636204741825, "ngenes": 21, "description": "SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion", "id": "716d30dd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399956", "value": 0.324123303694925, "ngenes": 24, "description": "CRMPs in Sema3A signaling", "id": "716d30de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400685", "value": 0.7885350045720521, "ngenes": 48, "description": "Sema4D in semaphorin signaling", "id": "716d30df-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-416550", "value": 0.6693101490581971, "ngenes": 13, "description": "Sema4D mediated inhibition of cell attachment and migration", "id": "716d30e0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-416572", "value": 0.9563804245280768, "ngenes": 40, "description": "Sema4D induced cell migration and growth-cone collapse", "id": "716d30e1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-416700", "value": 0.9899449009012773, "ngenes": 34, "description": "Other semaphorin interactions", "id": "716d30e2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-375165", "value": 0.8820816237155895, "ngenes": 136, "description": "NCAM signaling for neurite out-growth", "id": "716d30e3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-419037", "value": 0.03353723961526887, "ngenes": 86, "description": "NCAM1 interactions", "id": "716d30e4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-376176", "value": 0.10404356720284604, "ngenes": 432, "description": "Signaling by ROBO receptors", "id": "716d30e5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-428540", "value": 0.07162617907589916, "ngenes": 23, "description": "Activation of RAC1", "id": "716d30e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428542", "value": 0.1040718892098891, "ngenes": 17, "description": "Regulation of commissural axon pathfinding by SLIT and ROBO", "id": "716d30e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428543", "value": 0.04216998412170033, "ngenes": 26, "description": "Inactivation of CDC42 and RAC1", "id": "716d30e8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428890", "value": 0.0073203905170892095, "ngenes": 14, "description": "Role of ABL in ROBO-SLIT signaling", "id": "716d30e9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8985586", "value": 0.6691567371995883, "ngenes": 6, "description": "SLIT2:ROBO1 increases RHOA activity", "id": "716d30ea-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8985801", "value": 0.8304729964422268, "ngenes": 8, "description": "Regulation of cortical dendrite branching", "id": "716d30eb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9010553", "value": 0.1298088881737574, "ngenes": 340, "description": "Regulation of expression of SLITs and ROBOs", "id": "716d30ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9010642", "value": 0.5547094808466699, "ngenes": 15, "description": "ROBO receptors bind AKAP5", "id": "716d30ed-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-373760", "value": 0.5873547449207005, "ngenes": 209, "description": "L1CAM interactions", "id": "716d30ee-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-437239", "value": 0.3916805803435901, "ngenes": 75, "description": "Recycling pathway of L1", "id": "716d30ef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445095", "value": 0.26748248334966235, "ngenes": 63, "description": "Interaction between L1 and Ankyrins", "id": "716d30f0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445144", "value": 0.6693101490581971, "ngenes": 42, "description": "Signal transduction by L1", "id": "716d30f1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447038", "value": 0.4884578760745695, "ngenes": 14, "description": "NrCAM interactions", "id": "716d30f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447041", "value": 0.3936951931944725, "ngenes": 19, "description": "CHL1 interactions", "id": "716d30f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447043", "value": 0.5307958638542406, "ngenes": 15, "description": "Neurofascin interactions", "id": "716d30f4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8853659", "value": 0.40849522621170387, "ngenes": 86, "description": "RET signaling", "id": "716d30f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866376", "value": 0.8434322245429606, "ngenes": 13, "description": "Reelin signalling pathway", "id": "716d30f6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9619665", "value": 0.745200724443715, "ngenes": 40, "description": "EGR2 and SOX10-mediated initiation of Schwann cell myelination", "id": "716d30f7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381340", "value": 0.1266934110301937, "ngenes": 124, "description": "Transcriptional regulation of white adipocyte differentiation", "id": "716d30f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-525793", "value": 0.3880249300262277, "ngenes": 52, "description": "Myogenesis", "id": "716d30f9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619507", "value": 1.0, "ngenes": 163, "description": "Activation of HOX genes during differentiation", "id": "716d30fa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5617472", "value": 1.0, "ngenes": 163, "description": "Activation of anterior HOX genes in hindbrain development during early embryogenesis", "id": "716d30fb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5682910", "value": 0.8372825362868461, "ngenes": 18, "description": "LGI-ADAM interactions", "id": "716d30fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6805567", "value": 0.6029333190939079, "ngenes": 263, "description": "Keratinization", "id": "716d30fd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6809371", "value": 0.7066052020526674, "ngenes": 173, "description": "Formation of the cornified envelope", "id": "716d30fe-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9616222", "value": 0.8263249123262675, "ngenes": 121, "description": "Transcriptional regulation of granulopoiesis", "id": "716d30ff-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1474244", "value": 0.10354851918892131, "ngenes": 516, "description": "Extracellular matrix organization", "id": "716d3100-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1474228", "value": 0.08891862078422103, "ngenes": 242, "description": "Degradation of the extracellular matrix", "id": "716d3101-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1442490", "value": 0.042455472816984106, "ngenes": 100, "description": "Collagen degradation", "id": "716d3102-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1592389", "value": 0.42701340036677726, "ngenes": 49, "description": "Activation of Matrix Metalloproteinases", "id": "716d3103-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1566977", "value": 0.08891862078422103, "ngenes": 15, "description": "Fibronectin matrix formation", "id": "716d3104-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1566948", "value": 0.2163014722751683, "ngenes": 71, "description": "Elastic fibre formation", "id": "716d3105-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2129379", "value": 0.30057555648381573, "ngenes": 64, "description": "Molecules associated with elastic fibres", "id": "716d3106-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-216083", "value": 0.014899827032134105, "ngenes": 141, "description": "Integrin cell surface interactions", "id": "716d3107-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1474290", "value": 0.037126356197780395, "ngenes": 164, "description": "Collagen formation", "id": "716d3108-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2022090", "value": 0.038089170479462246, "ngenes": 124, "description": "Assembly of collagen fibrils and other multimeric structures", "id": "716d3109-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2214320", "value": 0.12721138533759097, "ngenes": 33, "description": "Anchoring fibril formation", "id": "716d310a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2243919", "value": 0.025116695354688363, "ngenes": 28, "description": "Crosslinking of collagen fibrils", "id": "716d310b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1650814", "value": 0.02729478778815131, "ngenes": 109, "description": "Collagen biosynthesis and modifying enzymes", "id": "716d310c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8948216", "value": 0.02729478778815131, "ngenes": 72, "description": "Collagen chain trimerization", "id": "716d310d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3000157", "value": 0.08420618191760897, "ngenes": 53, "description": "Laminin interactions", "id": "716d310e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000171", "value": 0.03333898376158171, "ngenes": 114, "description": "Non-integrin membrane-ECM interactions", "id": "716d310f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3000170", "value": 0.03333898376158171, "ngenes": 47, "description": "Syndecan interactions", "id": "716d3110-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3000178", "value": 0.06101644759460556, "ngenes": 129, "description": "ECM proteoglycans", "id": "716d3111-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941237", "value": 0.7590275694917322, "ngenes": 11, "description": "Invadopodia formation", "id": "716d3112-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5653656", "value": 0.10957749269883645, "ngenes": 1076, "description": "Vesicle-mediated transport", "id": "716d3113-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199991", "value": 0.09480799100842513, "ngenes": 1004, "description": "Membrane Trafficking", "id": "716d3114-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1445148", "value": 0.3346263399090412, "ngenes": 109, "description": "Translocation of SLC2A4 (GLUT4) to the plasma membrane", "id": "716d3115-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-157858", "value": 0.8900873185580673, "ngenes": 72, "description": "Gap junction trafficking and regulation", "id": "716d3116-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190828", "value": 0.8304729964422268, "ngenes": 67, "description": "Gap junction trafficking", "id": "716d3117-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190861", "value": 0.6328301595040259, "ngenes": 46, "description": "Gap junction assembly", "id": "716d3118-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190704", "value": 0.40501418406326883, "ngenes": 3, "description": "Oligomerization of connexins into connexons", "id": "716d3119-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190827", "value": 0.40501418406326883, "ngenes": 3, "description": "Transport of connexins along the secretory pathway", "id": "716d311a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190872", "value": 0.11165738403774256, "ngenes": 24, "description": "Transport of connexons to the plasma membrane", "id": "716d311b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190840", "value": 0.06980941466577938, "ngenes": 23, "description": "Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane", "id": "716d311c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-190873", "value": 0.014126471708495804, "ngenes": 22, "description": "Gap junction degradation", "id": "716d311d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196025", "value": 0.016283685409915236, "ngenes": 21, "description": "Formation of annular gap junctions", "id": "716d311e-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-191650", "value": 0.8771554116693717, "ngenes": 6, "description": "Regulation of gap junction activity", "id": "716d311f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-199977", "value": 0.0707229434916646, "ngenes": 245, "description": "ER to Golgi Anterograde Transport", "id": "716d3120-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-204005", "value": 0.04892218509660346, "ngenes": 122, "description": "COPII-mediated vesicle transport", "id": "716d3121-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5694530", "value": 0.09219611882665504, "ngenes": 73, "description": "Cargo concentration in the ER", "id": "716d3122-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807878", "value": 0.09714496436057612, "ngenes": 144, "description": "COPI-mediated anterograde transport", "id": "716d3123-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-199992", "value": 0.22195357555611497, "ngenes": 125, "description": "trans-Golgi Network Vesicle Budding", "id": "716d3124-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-432720", "value": 0.2708738057154165, "ngenes": 61, "description": "Lysosome Vesicle Biogenesis", "id": "716d3125-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-432722", "value": 0.24760791804928345, "ngenes": 99, "description": "Golgi Associated Vesicle Biogenesis", "id": "716d3126-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6811442", "value": 0.10138094917227693, "ngenes": 287, "description": "Intra-Golgi and retrograde Golgi-to-ER traffic", "id": "716d3127-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8856688", "value": 0.11165738403774256, "ngenes": 185, "description": "Golgi-to-ER retrograde transport", "id": "716d3128-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6811434", "value": 0.002799706126077655, "ngenes": 142, "description": "COPI-dependent Golgi-to-ER retrograde traffic", "id": "716d3129-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6811436", "value": 0.07571005029484179, "ngenes": 65, "description": "COPI-independent Golgi-to-ER retrograde traffic", "id": "716d312a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6811438", "value": 0.18369607493987292, "ngenes": 70, "description": "Intra-Golgi traffic", "id": "716d312b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6811440", "value": 0.08296202590391369, "ngenes": 72, "description": "Retrograde transport at the Trans-Golgi-Network", "id": "716d312c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9007101", "value": 0.049064369921667315, "ngenes": 205, "description": "Rab regulation of trafficking", "id": "716d312d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8854214", "value": 0.049013339914585875, "ngenes": 65, "description": "TBC/RABGAPs", "id": "716d312e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8876198", "value": 0.053599186373397646, "ngenes": 157, "description": "RAB GEFs exchange GTP for GDP on RABs", "id": "716d312f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8856828", "value": 0.09368873145870828, "ngenes": 232, "description": "Clathrin-mediated endocytosis", "id": "716d3130-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8856825", "value": 0.2966129799925685, "ngenes": 162, "description": "Cargo recognition for clathrin-mediated endocytosis", "id": "716d3131-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-917729", "value": 0.091596951382805, "ngenes": 49, "description": "Endosomal Sorting Complex Required For Transport (ESCRT)", "id": "716d3132-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2173782", "value": 0.4536409641040282, "ngenes": 76, "description": "Binding and Uptake of Ligands by Scavenger Receptors", "id": "716d3133-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2168880", "value": 0.8948992163866106, "ngenes": 27, "description": "Scavenging of heme from plasma", "id": "716d3134-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000471", "value": 1.0, "ngenes": 11, "description": "Scavenging by Class B Receptors", "id": "716d3135-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000480", "value": 0.025223622457889457, "ngenes": 31, "description": "Scavenging by Class A Receptors", "id": "716d3136-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000484", "value": 0.8611839158976119, "ngenes": 9, "description": "Scavenging by Class F Receptors", "id": "716d3137-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000497", "value": 0.09242946417072014, "ngenes": 4, "description": "Scavenging by Class H Receptors", "id": "716d3138-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-392499", "value": 0.11165738403774256, "ngenes": 3271, "description": "Metabolism of proteins", "id": "716d3139-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72766", "value": 0.09855815827986986, "ngenes": 505, "description": "Translation", "id": "716d313a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72613", "value": 0.12810076497154332, "ngenes": 248, "description": "Eukaryotic Translation Initiation", "id": "716d313b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156827", "value": 0.13288998227813706, "ngenes": 236, "description": "L13a-mediated translational silencing of Ceruloplasmin expression", "id": "716d313c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72737", "value": 0.12810076497154332, "ngenes": 248, "description": "Cap-dependent Translation Initiation", "id": "716d313d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72662", "value": 0.09855815827986986, "ngenes": 120, "description": "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S", "id": "716d313e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72649", "value": 0.09884167321281119, "ngenes": 119, "description": "Translation initiation complex formation", "id": "716d313f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72689", "value": 0.14013386213914883, "ngenes": 217, "description": "Formation of a pool of free 40S subunits", "id": "716d3140-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72695", "value": 0.10291960734873193, "ngenes": 103, "description": "Formation of the ternary complex, and subsequently, the 43S complex", "id": "716d3141-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72702", "value": 0.09425214542764854, "ngenes": 121, "description": "Ribosomal scanning and start codon recognition", "id": "716d3142-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72706", "value": 0.12818989810302303, "ngenes": 239, "description": "GTP hydrolysis and joining of the 60S ribosomal subunit", "id": "716d3143-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72731", "value": 0.05508234659751904, "ngenes": 9, "description": "Recycling of eIF2:GDP", "id": "716d3144-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-156842", "value": 0.14874966298348638, "ngenes": 208, "description": "Eukaryotic Translation Elongation", "id": "716d3145-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156902", "value": 0.15219369269585056, "ngenes": 197, "description": "Peptide chain elongation", "id": "716d3146-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1799339", "value": 0.13375822907700052, "ngenes": 228, "description": "SRP-dependent cotranslational protein targeting to membrane", "id": "716d3147-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-379724", "value": 0.091596951382805, "ngenes": 55, "description": "tRNA Aminoacylation", "id": "716d3148-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-379716", "value": 0.10531870587940882, "ngenes": 32, "description": "Cytosolic tRNA aminoacylation", "id": "716d3149-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-379726", "value": 0.2146483416664331, "ngenes": 26, "description": "Mitochondrial tRNA aminoacylation", "id": "716d314a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5368287", "value": 0.16645519673075324, "ngenes": 145, "description": "Mitochondrial translation", "id": "716d314b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5368286", "value": 0.1894900125452224, "ngenes": 133, "description": "Mitochondrial translation initiation", "id": "716d314c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5389840", "value": 0.19162367646007247, "ngenes": 132, "description": "Mitochondrial translation elongation", "id": "716d314d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5419276", "value": 0.19354901632736132, "ngenes": 136, "description": "Mitochondrial translation termination", "id": "716d314e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72764", "value": 0.15466987552876504, "ngenes": 200, "description": "Eukaryotic Translation Termination", "id": "716d314f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-597592", "value": 0.11180304639132696, "ngenes": 2279, "description": "Post-translational protein modification", "id": "716d3150-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163841", "value": 0.7160938808340862, "ngenes": 68, "description": "Gamma carboxylation, hypusine formation and arylsulfatase activation", "id": "716d3151-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159854", "value": 0.5742997757175232, "ngenes": 15, "description": "Gamma-carboxylation, transport, and amino-terminal cleavage of proteins", "id": "716d3152-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159740", "value": 0.5811560333136986, "ngenes": 14, "description": "Gamma-carboxylation of protein precursors", "id": "716d3153-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159763", "value": 0.6328301595040259, "ngenes": 13, "description": "Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus", "id": "716d3154-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159782", "value": 0.6238540684833126, "ngenes": 14, "description": "Removal of aminoterminal propeptides from gamma-carboxylated proteins", "id": "716d3155-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1663150", "value": 0.03622112250874287, "ngenes": 20, "description": "The activation of arylsulfatases", "id": "716d3156-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-204626", "value": 0.6736672551575683, "ngenes": 7, "description": "Hypusine synthesis from eIF5A-lysine", "id": "716d3157-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358493", "value": 0.3698290327508932, "ngenes": 14, "description": "Synthesis of diphthamide-EEF2", "id": "716d3158-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-163125", "value": 0.09746877555807236, "ngenes": 140, "description": "Post-translational modification: synthesis of GPI-anchored proteins", "id": "716d3159-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162699", "value": 0.009554036908535702, "ngenes": 6, "description": "Synthesis of dolichyl-phosphate mannose", "id": "716d315a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-162710", "value": 0.07373709906444208, "ngenes": 29, "description": "Synthesis of glycosylphosphatidylinositol (GPI)", "id": "716d315b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-162791", "value": 0.1882219742881029, "ngenes": 9, "description": "Attachment of GPI anchor to uPAR", "id": "716d315c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-446203", "value": 0.07571005029484179, "ngenes": 485, "description": "Asparagine N-linked glycosylation", "id": "716d315d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-446193", "value": 0.10656915761067158, "ngenes": 126, "description": "Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein", "id": "716d315e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-446219", "value": 0.3043728635371638, "ngenes": 102, "description": "Synthesis of substrates in N-glycan biosythesis", "id": "716d315f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162699", "value": 0.009554036908535702, "ngenes": 6, "description": "Synthesis of dolichyl-phosphate mannose", "id": "716d3160-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4085001", "value": 0.31139023686199435, "ngenes": 54, "description": "Sialic acid metabolism", "id": "716d3161-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446199", "value": 0.047469763523936774, "ngenes": 10, "description": "Synthesis of Dolichyl-phosphate", "id": "716d3162-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446205", "value": 0.13600904106624143, "ngenes": 11, "description": "Synthesis of GDP-mannose", "id": "716d3163-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446210", "value": 0.9752488710477298, "ngenes": 13, "description": "Synthesis of UDP-N-acetyl-glucosamine", "id": "716d3164-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6787639", "value": 0.01926270775832281, "ngenes": 6, "description": "GDP-fucose biosynthesis", "id": "716d3165-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-948021", "value": 0.08469741916285516, "ngenes": 297, "description": "Transport to the Golgi and subsequent modification", "id": "716d3166-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199977", "value": 0.0707229434916646, "ngenes": 245, "description": "ER to Golgi Anterograde Transport", "id": "716d3167-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-204005", "value": 0.04892218509660346, "ngenes": 122, "description": "COPII-mediated vesicle transport", "id": "716d3168-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5694530", "value": 0.09219611882665504, "ngenes": 73, "description": "Cargo concentration in the ER", "id": "716d3169-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807878", "value": 0.09714496436057612, "ngenes": 144, "description": "COPI-mediated anterograde transport", "id": "716d316a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-964739", "value": 0.15133061696093103, "ngenes": 10, "description": "N-glycan trimming and elongation in the cis-Golgi", "id": "716d316b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-964827", "value": 0.586752116750227, "ngenes": 4, "description": "Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2", "id": "716d316c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975576", "value": 0.9162699788361499, "ngenes": 42, "description": "N-glycan antennae elongation in the medial/trans-Golgi", "id": "716d316d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975577", "value": 0.5109605275666315, "ngenes": 25, "description": "N-Glycan antennae elongation", "id": "716d316e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975578", "value": 0.3551733330522627, "ngenes": 15, "description": "Reactions specific to the complex N-glycan synthesis pathway", "id": "716d316f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-532668", "value": 0.07249273226070745, "ngenes": 56, "description": "N-glycan trimming in the ER and Calnexin/Calreticulin cycle", "id": "716d3170-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-901042", "value": 0.06863521613689515, "ngenes": 45, "description": "Calnexin/calreticulin cycle", "id": "716d3171-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-901032", "value": 0.047224016530099736, "ngenes": 39, "description": "ER Quality Control Compartment (ERQC)", "id": "716d3172-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-2990846", "value": 0.06540911383312764, "ngenes": 325, "description": "SUMOylation", "id": "716d3173-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3215018", "value": 0.15043543902668774, "ngenes": 15, "description": "Processing and activation of SUMO", "id": "716d3174-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3065676", "value": 0.1037509564187798, "ngenes": 7, "description": "SUMO is conjugated to E1 (UBA2:SAE1)", "id": "716d3175-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3065678", "value": 0.06980941466577938, "ngenes": 12, "description": "SUMO is transferred from E1 to E2 (UBE2I, UBC9)", "id": "716d3176-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3065679", "value": 0.7520626397259877, "ngenes": 8, "description": "SUMO is proteolytically processed", "id": "716d3177-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3108232", "value": 0.06962729134710448, "ngenes": 319, "description": "SUMO E3 ligases SUMOylate target proteins", "id": "716d3178-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3108214", "value": 0.043142616039961904, "ngenes": 134, "description": "SUMOylation of DNA damage response and repair proteins", "id": "716d3179-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3232118", "value": 0.018125679217150362, "ngenes": 46, "description": "SUMOylation of transcription factors", "id": "716d317a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3232142", "value": 0.050955201772694206, "ngenes": 75, "description": "SUMOylation of ubiquitinylation proteins", "id": "716d317b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3899300", "value": 0.590330123961429, "ngenes": 81, "description": "SUMOylation of transcription cofactors", "id": "716d317c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4085377", "value": 0.04973106574028432, "ngenes": 58, "description": "SUMOylation of SUMOylation proteins", "id": "716d317d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4090294", "value": 0.034352739314483405, "ngenes": 68, "description": "SUMOylation of intracellular receptors", "id": "716d317e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4551638", "value": 0.10354851918892131, "ngenes": 108, "description": "SUMOylation of chromatin organization proteins", "id": "716d317f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4570464", "value": 0.05391401094414201, "ngenes": 79, "description": "SUMOylation of RNA binding proteins", "id": "716d3180-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4615885", "value": 0.4264543148937853, "ngenes": 73, "description": "SUMOylation of DNA replication proteins", "id": "716d3181-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4655427", "value": 0.1681166020808964, "ngenes": 34, "description": "SUMOylation of DNA methylation proteins", "id": "716d3182-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4755510", "value": 0.4193807860716992, "ngenes": 18, "description": "SUMOylation of immune response proteins", "id": "716d3183-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5173105", "value": 0.9796941259575827, "ngenes": 165, "description": "O-linked glycosylation", "id": "716d3184-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5173214", "value": 0.03494963771631864, "ngenes": 59, "description": "O-glycosylation of TSR domain-containing proteins", "id": "716d3185-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-913709", "value": 0.13375822907700052, "ngenes": 92, "description": "O-linked glycosylation of mucins", "id": "716d3186-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-977068", "value": 0.46185263221736383, "ngenes": 45, "description": "Termination of O-glycan biosynthesis", "id": "716d3187-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5688426", "value": 0.11949455892167062, "ngenes": 444, "description": "Deubiquitination", "id": "716d3188-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5689603", "value": 0.19162367646007247, "ngenes": 165, "description": "UCH proteinases", "id": "716d3189-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689877", "value": 0.05893028982384436, "ngenes": 20, "description": "Josephin domain DUBs", "id": "716d318a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689880", "value": 0.16645519673075324, "ngenes": 322, "description": "Ub-specific processing proteases", "id": "716d318b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689896", "value": 0.06980941466577938, "ngenes": 61, "description": "Ovarian tumor domain proteases", "id": "716d318c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689901", "value": 0.678248497735386, "ngenes": 53, "description": "Metalloprotease DUBs", "id": "716d318d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8852135", "value": 0.18268610902008883, "ngenes": 131, "description": "Protein ubiquitination", "id": "716d318e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866652", "value": 0.053565012963375146, "ngenes": 55, "description": "Synthesis of active ubiquitin: roles of E1 and E2 enzymes", "id": "716d318f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866654", "value": 0.2873636204741825, "ngenes": 94, "description": "E3 ubiquitin ligases ubiquitinate target proteins", "id": "716d3190-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8873719", "value": 0.06724729072005585, "ngenes": 99, "description": "RAB geranylgeranylation", "id": "716d3191-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8876725", "value": 0.3332285457392508, "ngenes": 34, "description": "Protein methylation", "id": "716d3192-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951664", "value": 0.15827721604977818, "ngenes": 414, "description": "Neddylation", "id": "716d3193-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8955332", "value": 0.8614988870353867, "ngenes": 62, "description": "Carboxyterminal post-translational modifications of tubulin", "id": "716d3194-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8957275", "value": 0.6736672551575683, "ngenes": 165, "description": "Post-translational protein phosphorylation", "id": "716d3195-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2980736", "value": 0.2425360414305281, "ngenes": 136, "description": "Peptide hormone metabolism", "id": "716d3196-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2022377", "value": 0.601581652168745, "ngenes": 25, "description": "Metabolism of Angiotensinogen to Angiotensins", "id": "716d3197-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209952", "value": 0.415498225999247, "ngenes": 16, "description": "Peptide hormone biosynthesis", "id": "716d3198-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-209822", "value": 0.7191610478186655, "ngenes": 12, "description": "Glycoprotein hormones", "id": "716d3199-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-264876", "value": 0.4091870497349478, "ngenes": 47, "description": "Insulin processing", "id": "716d319a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400508", "value": 0.15771340923861052, "ngenes": 37, "description": "Incretin synthesis, secretion, and inactivation", "id": "716d319b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381771", "value": 0.16174887717724898, "ngenes": 34, "description": "Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)", "id": "716d319c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400511", "value": 0.16652823963871297, "ngenes": 18, "description": "Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)", "id": "716d319d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-422085", "value": 0.22764400882015662, "ngenes": 29, "description": "Synthesis, secretion, and deacylation of Ghrelin", "id": "716d319e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381119", "value": 0.21849931609707826, "ngenes": 150, "description": "Unfolded Protein Response (UPR)", "id": "716d319f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381042", "value": 0.37534576151653687, "ngenes": 46, "description": "PERK regulates gene expression", "id": "716d31a0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380994", "value": 0.7191844659971434, "ngenes": 41, "description": "ATF4 activates genes in response to endoplasmic reticulum  stress", "id": "716d31a1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381070", "value": 0.20917472737124368, "ngenes": 90, "description": "IRE1alpha activates chaperones", "id": "716d31a2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381038", "value": 0.21041539853771177, "ngenes": 87, "description": "XBP1(S) activates chaperone genes", "id": "716d31a3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381033", "value": 0.31069814429457154, "ngenes": 19, "description": "ATF6 (ATF6-alpha) activates chaperones", "id": "716d31a4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381183", "value": 0.5628796925509781, "ngenes": 14, "description": "ATF6 (ATF6-alpha) activates chaperone genes", "id": "716d31a5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8874211", "value": 0.7358876309289297, "ngenes": 13, "description": "CREB3 factors activate genes", "id": "716d31a6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381426", "value": 0.7822640962366303, "ngenes": 191, "description": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)", "id": "716d31a7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-391251", "value": 0.30719159924024425, "ngenes": 159, "description": "Protein folding", "id": "716d31a8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-390466", "value": 0.3244432286227629, "ngenes": 151, "description": "Chaperonin-mediated protein folding", "id": "716d31a9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389958", "value": 0.8172827396622016, "ngenes": 47, "description": "Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding", "id": "716d31aa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389957", "value": 0.6233121376118631, "ngenes": 42, "description": "Prefoldin mediated transfer of substrate  to CCT/TriC", "id": "716d31ab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389960", "value": 0.8618947340062005, "ngenes": 36, "description": "Formation of tubulin folding intermediates by CCT/TriC", "id": "716d31ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390450", "value": 1.0, "ngenes": 18, "description": "Folding of actin by CCT/TriC", "id": "716d31ad-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-390471", "value": 0.7679485790922168, "ngenes": 72, "description": "Association of TriC/CCT with target proteins during biosynthesis", "id": "716d31ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6814122", "value": 0.698386134013551, "ngenes": 62, "description": "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding", "id": "716d31af-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-389977", "value": 0.30929660160862277, "ngenes": 29, "description": "Post-chaperonin tubulin folding pathway", "id": "716d31b0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5676934", "value": 0.782461543738104, "ngenes": 9, "description": "Protein repair", "id": "716d31b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5683826", "value": 0.23887090758705487, "ngenes": 52, "description": "Surfactant metabolism", "id": "716d31b2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-977225", "value": 0.8028845808747818, "ngenes": 155, "description": "Amyloid fiber formation", "id": "716d31b3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69306", "value": 0.28009372044607456, "ngenes": 215, "description": "DNA Replication", "id": "716d31b4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69239", "value": 0.23774361745488784, "ngenes": 206, "description": "Synthesis of DNA", "id": "716d31b5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69190", "value": 0.32291125960226097, "ngenes": 54, "description": "DNA strand elongation", "id": "716d31b6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176974", "value": 0.8320022427326571, "ngenes": 18, "description": "Unwinding of DNA", "id": "716d31b7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69109", "value": 0.035253484889292405, "ngenes": 28, "description": "Leading Strand Synthesis", "id": "716d31b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.035253484889292405, "ngenes": 28, "description": "Polymerase switching", "id": "716d31b9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69186", "value": 0.07626043712953795, "ngenes": 36, "description": "Lagging Strand Synthesis", "id": "716d31ba-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.035253484889292405, "ngenes": 28, "description": "Polymerase switching", "id": "716d31bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69183", "value": 0.36408899812871554, "ngenes": 24, "description": "Processive synthesis on the lagging strand", "id": "716d31bc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69166", "value": 0.155870532999355, "ngenes": 23, "description": "Removal of the Flap Intermediate", "id": "716d31bd-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-69052", "value": 0.3025000117972867, "ngenes": 161, "description": "Switching of origins to a post-replicative state", "id": "716d31be-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68949", "value": 0.18452742839407488, "ngenes": 121, "description": "Orc1 removal from chromatin", "id": "716d31bf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69017", "value": 0.32750948516334544, "ngenes": 131, "description": "CDK-mediated phosphorylation and removal of Cdc6", "id": "716d31c0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68952", "value": 0.12223851496961394, "ngenes": 11, "description": "DNA replication initiation", "id": "716d31c1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69002", "value": 0.1747195608928016, "ngenes": 136, "description": "DNA Replication Pre-Initiation", "id": "716d31c2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68867", "value": 0.23986222107213964, "ngenes": 114, "description": "Assembly of the pre-replicative complex", "id": "716d31c3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68616", "value": 0.705766976117149, "ngenes": 9, "description": "Assembly of the ORC complex at the origin of replication", "id": "716d31c4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-68689", "value": 0.10082275618848612, "ngenes": 16, "description": "CDC6 association with the ORC:origin complex", "id": "716d31c5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-68827", "value": 0.24760791804928345, "ngenes": 101, "description": "CDT1 association with the CDC6:ORC:origin complex", "id": "716d31c6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68962", "value": 0.322964685665524, "ngenes": 47, "description": "Activation of the pre-replicative complex", "id": "716d31c7-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8963743", "value": 0.3131828135641375, "ngenes": 40, "description": "Digestion and absorption", "id": "716d31c8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8935690", "value": 0.2987330602038509, "ngenes": 35, "description": "Digestion", "id": "716d31c9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-189085", "value": 0.32968063215624954, "ngenes": 22, "description": "Digestion of dietary carbohydrate", "id": "716d31ca-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192456", "value": 0.06896937371942653, "ngenes": 7, "description": "Digestion of dietary lipid", "id": "716d31cb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8963676", "value": 0.8060721070976409, "ngenes": 5, "description": "Intestinal absorption", "id": "716d31cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8981373", "value": 0.4651142896043178, "ngenes": 4, "description": "Intestinal hexose absorption", "id": "716d31cd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1852241", "value": 0.07112727931051015, "ngenes": 471, "description": "Organelle biogenesis and maintenance", "id": "716d31ce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1592230", "value": 0.04500162695226774, "ngenes": 151, "description": "Mitochondrial biogenesis", "id": "716d31cf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2151201", "value": 0.06980941466577938, "ngenes": 83, "description": "Transcriptional activation of mitochondrial biogenesis", "id": "716d31d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2151209", "value": 0.02729478778815131, "ngenes": 19, "description": "Activation of PPARGC1A (PGC-1alpha) by phosphorylation", "id": "716d31d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8949613", "value": 0.0594537139956224, "ngenes": 52, "description": "Cristae formation", "id": "716d31d2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5617833", "value": 0.10082275618848612, "ngenes": 320, "description": "Cilium Assembly", "id": "716d31d3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5620912", "value": 0.048554100566718, "ngenes": 153, "description": "Anchoring of the basal body to the plasma membrane", "id": "716d31d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5620920", "value": 0.39315908066419347, "ngenes": 82, "description": "Cargo trafficking to the periciliary membrane", "id": "716d31d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5620916", "value": 0.3416179344130705, "ngenes": 31, "description": "VxPx cargo-targeting to cilium", "id": "716d31d6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5620922", "value": 0.8172827396622016, "ngenes": 41, "description": "BBSome-mediated cargo-targeting to cilium", "id": "716d31d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5624138", "value": 0.10631060765222129, "ngenes": 6, "description": "Trafficking of myristoylated proteins to the cilium", "id": "716d31d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5624958", "value": 0.05451479327954982, "ngenes": 5, "description": "ARL13B-mediated ciliary trafficking of INPP5E", "id": "716d31d9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5620924", "value": 0.0398875749337079, "ngenes": 85, "description": "Intraflagellar transport", "id": "716d31da-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-4839726", "value": 0.1266934110301937, "ngenes": 438, "description": "Chromatin organization", "id": "716d31db-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3247509", "value": 0.1266934110301937, "ngenes": 438, "description": "Chromatin modifying enzymes", "id": "716d31dc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3214815", "value": 0.922408574699211, "ngenes": 109, "description": "HDACs deacetylate histones", "id": "716d31dd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214841", "value": 0.3346507781602213, "ngenes": 115, "description": "PKMTs methylate histone lysines", "id": "716d31de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214842", "value": 0.6329017450139361, "ngenes": 55, "description": "HDMs demethylate histones", "id": "716d31df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214847", "value": 0.405461658047136, "ngenes": 209, "description": "HATs acetylate histones", "id": "716d31e0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214858", "value": 0.9267901644852048, "ngenes": 109, "description": "RMTs methylate histone arginines", "id": "716d31e1-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1500931", "value": 0.5856668610407034, "ngenes": 264, "description": "Cell-Cell communication", "id": "716d31e2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373753", "value": 0.04216998412170033, "ngenes": 37, "description": "Nephrin family interactions", "id": "716d31e3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446728", "value": 0.6442541815088558, "ngenes": 194, "description": "Cell junction organization", "id": "716d31e4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-421270", "value": 0.16019450751458392, "ngenes": 123, "description": "Cell-cell junction organization", "id": "716d31e5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373756", "value": 0.6054967343924567, "ngenes": 3, "description": "SDK interactions", "id": "716d31e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-420029", "value": 0.2972309005976041, "ngenes": 50, "description": "Tight junction interactions", "id": "716d31e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418990", "value": 0.21851221407700616, "ngenes": 70, "description": "Adherens junctions interactions", "id": "716d31e8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-420597", "value": 0.30057555648381573, "ngenes": 13, "description": "Nectin/Necl  trans heterodimerization", "id": "716d31e9-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-446107", "value": 0.34479819805435974, "ngenes": 39, "description": "Type I hemidesmosome assembly", "id": "716d31ea-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446353", "value": 0.10354851918892131, "ngenes": 37, "description": "Cell-extracellular matrix interactions", "id": "716d31eb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-446343", "value": 0.2873636204741825, "ngenes": 8, "description": "Localization of the PINCH-ILK-PARVIN complex to focal adhesions", "id": "716d31ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446388", "value": 0.7202442219959402, "ngenes": 15, "description": "Regulation of cytoskeletal remodeling and cell spreading by IPP complex components", "id": "716d31ed-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-391160", "value": 0.6179133392707561, "ngenes": 34, "description": "Signal regulatory protein family interactions", "id": "716d31ee-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-397014", "value": 0.44278468748922833, "ngenes": 365, "description": "Muscle contraction", "id": "716d31ef-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-390522", "value": 0.9099295685519893, "ngenes": 61, "description": "Striated Muscle Contraction", "id": "716d31f0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445355", "value": 0.06048874616558646, "ngenes": 71, "description": "Smooth Muscle Contraction", "id": "716d31f1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576891", "value": 0.822293066330286, "ngenes": 245, "description": "Cardiac conduction", "id": "716d31f2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5576886", "value": 0.24897477630011242, "ngenes": 34, "description": "Phase 4 - resting membrane potential", "id": "716d31f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576890", "value": 0.04341555259176416, "ngenes": 15, "description": "Phase 3 - rapid repolarisation", "id": "716d31f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576892", "value": 0.8978764811258031, "ngenes": 68, "description": "Phase 0 - rapid depolarisation", "id": "716d31f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576893", "value": 0.5633517080905742, "ngenes": 32, "description": "Phase 2 - plateau phase", "id": "716d31f6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576894", "value": 0.13375822907700052, "ngenes": 19, "description": "Phase 1 - inactivation of fast Na+ channels", "id": "716d31f7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5578768", "value": 0.1634376037286026, "ngenes": 20, "description": "Physiological factors", "id": "716d31f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5578775", "value": 0.508696389072599, "ngenes": 102, "description": "Ion homeostasis", "id": "716d31f9-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9612973", "value": 0.10291960734873193, "ngenes": 249, "description": "Autophagy", "id": "716d31fa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1632852", "value": 0.09811407950169769, "ngenes": 222, "description": "Macroautophagy", "id": "716d31fb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9663891", "value": 0.3056236055452598, "ngenes": 135, "description": "Selective autophagy", "id": "716d31fc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5205647", "value": 0.07239518012501328, "ngenes": 51, "description": "Mitophagy", "id": "716d31fd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5205685", "value": 0.07571005029484179, "ngenes": 33, "description": "PINK1-PRKN Mediated Mitophagy", "id": "716d31fe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8934903", "value": 0.04826032229081501, "ngenes": 25, "description": "Receptor Mediated Mitophagy", "id": "716d31ff-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9613354", "value": 0.9588255298330869, "ngenes": 17, "description": "Lipophagy", "id": "716d3200-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9646399", "value": 0.745200724443715, "ngenes": 67, "description": "Aggrephagy", "id": "716d3201-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664873", "value": 0.21962588063129224, "ngenes": 22, "description": "Pexophagy", "id": "716d3202-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9613829", "value": 0.7804703116116549, "ngenes": 44, "description": "Chaperone Mediated Autophagy", "id": "716d3203-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9615710", "value": 0.42626322623305557, "ngenes": 60, "description": "Late endosomal microautophagy", "id": "716d3204-88c5-11eb-abfe-4d49f1a5f950"}]}]}